var title_f42_30_43488="Calf stretch";
var content_f42_30_43488=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F65646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F65646&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flexibility exercise: Calf",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Because many people have tight calf muscles, it's important to stretch them.",
"    <ol>",
"     <li>",
"      Stand facing a wall slightly farther than arm's length from the wall, feet shoulder-width apart.",
"     </li>",
"     <li>",
"      Put your palms flat against the wall at shoulder height and shoulder-width apart.",
"     </li>",
"     <li>",
"      Step forward with right leg and bend right knee. Keeping both feet flat on the floor, bend left knee slightly until you feel a stretch in your left calf muscle. It shouldn't feel uncomfortable. If you don't feel a stretch, bend your right knee until you do.",
"     </li>",
"     <li>",
"      Hold position for 10 to 30 seconds, and then return to starting position.",
"     </li>",
"     <li>",
"      Repeat with left leg.",
"     </li>",
"     <li>",
"      Continue alternating legs for at least three to five times on each leg.",
"     </li>",
"    </ol>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Go4Life. National Institute on Aging at the National Institutes of Health. Available at: file://go4life.niapublications.org (Accessed December 2, 2011).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43488=[""].join("\n");
var outline_f42_30_43488=null;
var title_f42_30_43489="Age specific rates all thyroid cancer";
var content_f42_30_43489=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F81732&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F81732&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Age-specific (crude) SEER incidence rates by 'expanded' race for thyroid cancer, both sexes SEER 17 registries for 2000-2003",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 459px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Statistics for American Indians/Alaska Natives do not include cases for the 2003 diagnosis year.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER Stat Database: Incidence - SEER 17 Regs Public-Use, Nov 2005 Sub (2000-2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43489=[""].join("\n");
var outline_f42_30_43489=null;
var title_f42_30_43490="Male genital HSV";
var content_f42_30_43490=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F81531&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F81531&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Genital herpes simplex virus, male",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43490=[""].join("\n");
var outline_f42_30_43490=null;
var title_f42_30_43491="Autonomic innervation";
var content_f42_30_43491=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69693&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69693&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Autonomic innervation of the heart",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 461px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The heart, especially the pacemaker tissue, is innervated by fibers from both the parasympathetic and sympathetic nervous systems.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43491=[""].join("\n");
var outline_f42_30_43491=null;
var title_f42_30_43492="Cycloserine: Drug information";
var content_f42_30_43492=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cycloserine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?13/49/14100?source=see_link\">",
"    see \"Cycloserine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/42/32419?source=see_link\">",
"    see \"Cycloserine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13264878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Seromycin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F155579\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Miscellaneous;",
"     </li>",
"     <li>",
"      Antitubercular Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F155560\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     In adults, some neurotoxic effects may be treated or prevented by concomitant administration of 200-300 mg of pyridoxine daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Tuberculosis:",
"     </b>",
"     Oral: Initial: 250 mg every 12 hours for 14 days, then administer 500-1000 mg/day in 2 divided doses for 18-24 months (maximum daily dose: 1000 mg)",
"     <b>",
"      or",
"     </b>",
"     10-15 mg/kg/day (1000 mg/day in 2 divided doses), usually 500-750 mg/day in 2 divided doses (",
"     <i>",
"      MMWR",
"     </i>",
"     , 2003). (",
"     <b>",
"      Note:",
"     </b>",
"     Experienced clinicians indicate most patients are unable to tolerate this dose. Serum concentrations targeted at 20-35 mcg/mL are often useful in determining the optimal dose.)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F155571\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/42/32419?source=see_link\">",
"      see \"Cycloserine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     In adults, some neurotoxic effects may be treated or prevented by the concomitant administration of 200-300 mg of pyridoxine daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Tuberculosis:",
"     </b>",
"     Oral: Children: 10-20 mg/kg/day in 2 divided doses up to 1000 mg/day for 18-24 months",
"     <b>",
"      or",
"     </b>",
"     10-15 mg/kg/day (maximum:1000 mg/day) (",
"     <i>",
"      MMWR",
"     </i>",
"     , 2003)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F155561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F155562\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling; however, the following adjustments have been used by some clinicians:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aronoff, 2007:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;50 mL/minute: No dosage adjustment necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-50 mL/minute: Administer every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: Administer every 36-48 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      MMWR",
"     </i>",
"     , 2003:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute and hemodialysis: 250 mg once daily, or 500 mg three times per week. (",
"     <b>",
"      Note:",
"     </b>",
"     Avoid in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;50 mL/minute unless the patient is receiving hemodialysis. The efficacy of 250 mg daily doses has not been established and careful monitoring is necessary for evidence of neurotoxicity. Monitor serum concentrations to minimize toxicity.)",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15795919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F155538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Seromycin&reg;: 250 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F155524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F155542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunctive treatment in pulmonary or extrapulmonary tuberculosis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F155586\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       CycloSERINE may be confused with cyclobenzaprine, cycloSPORINE",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F155577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Cardiac arrhythmia, heart failure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Coma, confusion, dizziness, drowsiness, headache, paresis, psychosis, restlessness, seizures, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     deficiency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Folate deficiency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Liver enzymes increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Dysarthria, hyperreflexia, paresthesia, tremor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic manifestations",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F155545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cycloserine or any component of the formulation; epilepsy; depression, severe anxiety, or psychosis; severe renal insufficiency; excessive concurrent use of alcohol",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F155528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: Has been associated with CNS toxicity, including seizures, psychosis, depression, and confusion; decrease dosage or discontinue use if occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Alcoholism: Use with caution in patients with a history of chronic alcoholism; increased risk of seizures.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Mental illness: Use with caution in patients with depression, severe anxiety, and/or psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with a history of seizure disorder.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Patients with potential for folate deficiency: Use with caution in patients with potential folate deficiency (malnourished, chronic anticonvulsant therapy, or elderly).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F155533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the neurotoxic effect of CycloSERINE. Specifically, the risk for seizures may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ethionamide: May enhance the adverse/toxic effect of CycloSERINE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: May enhance the adverse/toxic effect of CycloSERINE. Specifically, CNS toxicity may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F155555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (may increase CNS depression).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: May increase vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     and folic acid dietary requirements.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F155534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13494780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects have not been observed in animal reproduction studies. Cycloserine crosses the placenta and can be detected in the fetal blood and amniotic fluid. The American Thoracic Society recommends use in pregnant women only if there are no alternatives (CDC, 2003).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F155565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13494781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cycloserine levels in breast milk are similar to those found in the maternal serum.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F155548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with food; may increase vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     and folic acid dietary requirements.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F155547\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (CycloSERINE Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (40): $240.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Seromycin Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (40): $360.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F155536\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Periodic renal, hepatic, hematological tests, and plasma cycloserine concentrations",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F155539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Therapeutic levels: Tuberculosis: 20-35 mcg/mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Toxicity is greatly increased at levels &gt;30 mcg/mL",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ciclovalidin (IT);",
"     </li>",
"     <li>",
"      Closina (AU);",
"     </li>",
"     <li>",
"      Cyclocin (TW);",
"     </li>",
"     <li>",
"      Cyclokox (IN);",
"     </li>",
"     <li>",
"      Cycloserine (GB);",
"     </li>",
"     <li>",
"      Cylider (TW);",
"     </li>",
"     <li>",
"      Miroseryn (IT);",
"     </li>",
"     <li>",
"      Myzer (RU);",
"     </li>",
"     <li>",
"      Neoseryn (PE);",
"     </li>",
"     <li>",
"      Seromycin (GR, PL);",
"     </li>",
"     <li>",
"      Setavax (ES);",
"     </li>",
"     <li>",
"      Siklocap (TR);",
"     </li>",
"     <li>",
"      Tuberserine (PK)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F155527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial cell wall synthesis by competing with amino acid (D-alanine) for incorporation into the bacterial cell wall; bacteriostatic or bactericidal",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F155544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: ~70% to 90%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Widely to most body fluids and tissues including CSF, bile, sputum, lymph tissue, lungs, and ascitic, pleural, and synovial fluids",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Normal renal function: 10 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 4-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (60% to 70% as unchanged drug) within 72 hours; feces (small amounts); remainder metabolized",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed, Philadelphia, PA: American College of Physicians, 2007.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention, &ldquo;Treatment of Tuberculosis. American Thoracic Society, CDC, and Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 52(RR11):3-5. Available at",
"      <a href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm\" target=\"_blank\">",
"       file://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/30/43492/abstract-text/12836625/pubmed\" id=\"12836625\" target=\"_blank\">",
"        12836625",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Davidson PT and Le HQ, &ldquo;Drug Treatment of Tuberculosis - 1992,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1992, 43(5):651-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/30/43492/abstract-text/1379145/pubmed\" id=\"1379145\" target=\"_blank\">",
"        1379145",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Drugs for Tuberculosis,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 1993, 35(908):99-101.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/30/43492/abstract-text/8412982/pubmed\" id=\"8412982\" target=\"_blank\">",
"        8412982",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Iseman MD, &ldquo;Treatment of Multidrug-Resistant Tuberculosis,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1993, 329(11):784-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/30/43492/abstract-text/8350889/pubmed\" id=\"8350889\" target=\"_blank\">",
"        8350889",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9309 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-41.78.124.10-9FDBE1AB85-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43492=[""].join("\n");
var outline_f42_30_43492=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13264878\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155579\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155560\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155571\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155561\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155562\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15795919\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155538\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155524\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155542\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155586\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155577\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155545\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155528\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299109\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155533\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155555\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155534\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13494780\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155565\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13494781\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155548\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155547\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155536\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155539\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038592\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155527\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155544\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9309\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9309|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?13/49/14100?source=related_link\">",
"      Cycloserine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/42/32419?source=related_link\">",
"      Cycloserine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_30_43493="Ezetimibe and simvastatin: Patient drug information";
var content_f42_30_43493=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ezetimibe and simvastatin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/4/41031?source=see_link\">",
"     see \"Ezetimibe and simvastatin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/16/2311?source=see_link\">",
"     see \"Ezetimibe and simvastatin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F169626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Vytorin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021956\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691638",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to slow the progress of heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower cholesterol and other harmful types of cholesterol in the body. Good cholesterol (HDL) levels rise.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691358",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower triglycerides.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021955\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702097",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ezetimibe, simvastatin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have active liver disease or a rise in liver enzymes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696863",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 4 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid or limit drinking wine, beer, or mixed drinks to less than 3 drinks a day. Drinking too much alcohol may raise your chance of liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021961\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698248",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698316",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Runny nose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698350",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sore throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021963\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698663",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take in the evening.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021965\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11368 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-0AA24E0359-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43493=[""].join("\n");
var outline_f42_30_43493=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F169626\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021954\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021956\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021955\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021960\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021961\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021963\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021958\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021959\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021964\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021965\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/4/41031?source=related_link\">",
"      Ezetimibe and simvastatin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/16/2311?source=related_link\">",
"      Ezetimibe and simvastatin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_30_43494="Buprenorphine: Patient drug information";
var content_f42_30_43494=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Buprenorphine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/53/41816?source=see_link\">",
"     see \"Buprenorphine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/29/26071?source=see_link\">",
"     see \"Buprenorphine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F143056\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Buprenex&reg;;",
"     </li>",
"     <li>",
"      Butrans&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F143057\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Butrans&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700535",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Subutex&reg; is only used to treat drug addiction.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700435",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You will be watched closely to make sure you do not misuse, abuse, or become addicted to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915067",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause trouble breathing. Call your doctor right away if you have slow breathing, shallow breathing, or trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2989439",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Only use to treat lasting, long-term pain that cannot be helped by other drugs. Do not use for mild pain or pain that comes and goes. Keep the patch away from children. Do not use a cut patch or one that does not look right. Keep the patch away from heat. Do not use more than one 20 mcg/hour patch.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat drug addiction and withdrawal.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700944",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give the tablets to a child younger than 16 years of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2989440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not give the patch to a child younger than 18 years of age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to buprenorphine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Asthma, bowel block, or very bad lung disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697334",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have prostate disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before you use other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696692",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid use of heat sources (such as sunlamps, tanning beds, heating pads, electric blankets, heat lamps, saunas, hot tubs, heated waterbeds). Avoid long, hot baths or sunbathing. Your temperature may rise and cause too much drug to pass into your body.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024870\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698651",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Too much sweat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Poor pain control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024865\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3927405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug with other strong pain drugs or if you are using a pain patch without talking to your doctor first.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696011",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to give closely if you or a family member is giving the shot at home.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695688",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sublingual tablet: Place under your tongue and let melt.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694797",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use patches that are cut or do not look right.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695190",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you or anyone else touches the gel, wash the skin with lots of water. Do not use soap.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696286",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bathe, shower, or swim for short periods after putting on the patch. Cover the patch with plastic wrap and tape to help keep it in place.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695570",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take off old patch first.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2989499",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put patch on clean, dry, healthy skin on the chest, back, or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694628",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clip hair at site before putting patch on. Do not shave.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695471",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Move the patch site with each patch.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695146",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the patch falls off, put a new one on.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If the patch loosens, put tape over it to hold it in place.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a pain diary.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024866\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699145",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After you take off a skin patch, be sure to fold the sticky sides of the patch to each other.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699630",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away unused patches when they are no longer needed. Take them from the pouch, take off liner, and fold in half.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699657",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any unused drug by flushing down a toilet or sink.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3914730",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may also use packet that comes with this drug to throw away used patches the right way.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024872\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11493 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-125.39.66.150-851E2265C2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43494=[""].join("\n");
var outline_f42_30_43494=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143056\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143057\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024861\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024863\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024862\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024867\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024868\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024870\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024865\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024866\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024871\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024872\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/53/41816?source=related_link\">",
"      Buprenorphine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/29/26071?source=related_link\">",
"      Buprenorphine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_30_43495="Adult mosquitoes";
var content_f42_30_43495=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F82494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F82494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Adult Anopheline and Culicine mosquitoes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 585px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The head appendages of the adult mosquito consist of one proboscis (a serrated appendage used by female mosquitoes for extracting blood), a pair of antennae, and a pair of maxillary palps; these features require a microscope for visualization. The unique palp characteristics are the most reliable for differentiation between Anopheline and Culicine mosquitoes. Anopheline female palps are about the same length as the proboscis, while Anopheline male palps are club-shaped at the ends. Culicine female palps are shorter than the proboscis, and Culicine male palps are long with a tapered point.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from figures courtesy of Cheryl Whitehorn, MSc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43495=[""].join("\n");
var outline_f42_30_43495=null;
var title_f42_30_43496="Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth";
var content_f42_30_43496=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/30/43496/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/30/43496/contributors\">",
"     Jennifer Ang Chan, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/30/43496/contributors\">",
"     Matthew Kulke, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/30/43496/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/30/43496/contributors\">",
"     Richard M Goldberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/30/43496/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/30/43496/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/30/43496/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H688217\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroendocrine cells are distributed widely throughout the body, and neoplasms of these dispersed cells can arise at many sites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1970242\">",
"    <span class=\"h2\">",
"     Classification and nomenclature",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroendocrine tumors (NETs) arising at different sites within the body are classified according to their histologic features. While there are differences in terminology and grading for these tumors arising at different sites, all commonly used classification systems reflect a basic separation between more indolent, well differentiated tumors (which in the digestive system have been traditionally referred to as carcinoids and pancreatic neuroendocrine [islet cell] tumors) and far more aggressive poorly differentiated types that behave clinically more like small cell carcinoma of the lung. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/32/6665?source=see_link&amp;anchor=H262522852#H262522852\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring\", section on 'Classification and nomenclature'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Poorly differentiated neuroendocrine carcinomas are often associated with a rapid clinical course, while well-differentiated NETs generally have a much better prognosis. However, there is a spectrum of aggressiveness for well-differentiated tumors. Even in the presence of liver metastases, some patients may survive for many years. Proliferative rate, as assessed by mitotic count",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    Ki67 labeling index, is of prognostic significance, independent of tumor stage. The World Health Organization (WHO) classifies well-differentiated gastroenteropancreatic NETs into low-grade (G1) and intermediate grade (G2) categories based upon proliferative rate (",
"    <a class=\"graphic graphic_table graphicRef60365 \" href=\"mobipreview.htm?17/14/17644\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/1\">",
"     1",
"    </a>",
"    ]. All poorly differentiated neuroendocrine tumors are high-grade (G3) neuroendocrine carcinomas. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/40/6794?source=see_link&amp;anchor=H2474956#H2474956\">",
"     \"Pathology, classification, and grading of neuroendocrine tumors arising in the digestive system\", section on '2010 WHO classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic review will cover local treatment options for patients with well-differentiated metastatic gastroenteropancreatic NETs. Systemic treatment options to control tumor growth",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    symptoms of hormone hypersecretion and for treatment for poorly differentiated gastroenteropancreatic NETs are discussed elsewhere, as are the clinical presentation, imaging, and biochemical monitoring for patients with advanced gastroenteropancreatic NETs; pathology and classification of gastroenteropancreatic NETs; clinical features of primary carcinoid tumors; diagnosis of carcinoid syndrome and tumor localization; the treatment of early stage carcinoids; bronchial carcinoids; localization and treatment of pancreatic islet cell tumors; evaluation and management of neuroendocrine tumors of unknown primary site; management of symptoms of the carcinoid syndrome; carcinoid heart disease; and functioning pancreatic islet cell tumors.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=see_link\">",
"       \"Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/32/6665?source=see_link\">",
"       \"Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/40/6794?source=see_link\">",
"       \"Pathology, classification, and grading of neuroendocrine tumors arising in the digestive system\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/60/969?source=see_link\">",
"       \"Clinical characteristics of carcinoid tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/8/11400?source=see_link\">",
"       \"Diagnosis of the carcinoid syndrome and tumor localization\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/55/9082?source=see_link\">",
"       \"Bronchial carcinoid tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/61/39897?source=see_link\">",
"       \"Treatment and surveillance of non-metastatic carcinoid tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/31/16888?source=see_link\">",
"       \"Treatment of the carcinoid syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12472?source=see_link\">",
"       \"Carcinoid heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18330?source=see_link\">",
"       \"Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/13/41174?source=see_link\">",
"       \"Neuroendocrine cancer of unknown primary site\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/30/12777?source=see_link\">",
"       \"Insulinoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/57/31640?source=see_link\">",
"       \"Glucagonoma and the glucagonoma syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/34/3623?source=see_link\">",
"       \"Somatostatinoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/59/16311?source=see_link\">",
"       \"The VIPoma syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1970317\">",
"    <span class=\"h1\">",
"     NATURAL HISTORY AND TREATMENT OPTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Well-differentiated gastroenteropancreatic neuroendocrine tumors (NETs) are generally indolent malignancies, with a prolonged natural history. However, among patients with low-or intermediate grade histology and distant disease, survival is highly variable. As an example, among patients with advanced carcinoids, survival varies according to primary site and is worst for patients with lung and colon primaries (median survival 17 and 7 months, respectively), and most favorable for tumors arising in the jejunum, ileum, and cecum (median survival 55 to 65 months). This wide difference in natural history complicates the comparative assessment of benefit from individual therapies.",
"   </p>",
"   <p>",
"    Patients with metastases from a gastroenteropancreatic NET often become symptomatic from hormone hypersecretion rather than from tumor bulk. This is especially true with functioning pancreatic NETs (which account for 10 to 30 percent of tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/2\">",
"     2",
"    </a>",
"    ]) and for patients with midgut (small bowel or appendiceal) carcinoids in whom symptoms are typically absent until hepatic metastases supervene. In such cases, vasoactive substances such as serotonin enter the systemic circulation, causing the carcinoid syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9206?source=see_link\">",
"     \"Clinical features of the carcinoid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms of hormonal excess resulting from hypersecretion by functioning pancreatic NETs and carcinoids can often be well controlled with somatostatin analogs, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    . However, the degree of tumor control exerted by this class of agents is limited. Conventional cytotoxic therapies and molecularly targeted agents are of greater utility for pancreatic NET than for advanced carcinoid. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=see_link\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The majority of patients with advanced gastroenteropancreatic NETs have liver metastases. For patients who have potentially resectable disease, resection is an appropriate option, and may provide prolonged control of symptoms and tumor growth. However, the majority of patients undergoing liver resection recur, even if resection is complete. For other patients with unresectable disease, options to control symptoms include somatostatin analogs, debulking surgery, nonsurgical liver-directed therapy, and systemic antitumor therapy.",
"   </p>",
"   <p>",
"    The following sections will discuss local treatment options to control symptoms and tumor growth. Systemic options are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=see_link\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691390\">",
"    <span class=\"h1\">",
"     SURGICAL OPTIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691398\">",
"    <span class=\"h2\">",
"     Hepatic predominant metastatic disease",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691406\">",
"    <span class=\"h3\">",
"     Resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with carcinoid or pancreatic neuroendocrine tumor (NET), resection can be considered for treatment of potentially curable liver metastases in the absence of diffuse bilobar involvement, compromised liver function, or extrahepatic metastases. Among patients undergoing complete resection, the majority recur, but long-term disease-free survival is reported in up to 20 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Hepatic resection can also provide long-term symptomatic relief [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/3,6-14\">",
"     3,6-14",
"    </a>",
"    ]. These benefits can be illustrated in a series of 170 patients undergoing hepatic resection for metastatic NET [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/3\">",
"     3",
"    </a>",
"    ]. More than 90 percent had symptomatic improvement, and while the overall recurrence rate following surgery was 84 percent, five- and ten-year survival rates were 61 and 35 percent, respectively.",
"   </p>",
"   <p>",
"    Several retrospective series have also suggested that selected patients who undergo aggressive \"debulking\" of hepatic metastases, in which the majority but not all of the disease is resected, have better quality of life and longer survival relative to those who do not undergo surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/7-9,11,13,15-17\">",
"     7-9,11,13,15-17",
"    </a>",
"    ]. In one such series, the mean survival duration for patients undergoing surgery as compared to hepatic artery embolization alone was 43 versus 24 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, while debulking may benefit highly selected patients, the potential for selection bias in these series and a lack of randomized data have made it difficult to assess the long-term benefits of this approach, as compared to less invasive treatment approaches. As a result, the routine use of debulking surgery is controversial.",
"   </p>",
"   <p>",
"    For patients with carcinoid syndrome,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    should be readily available during any surgical procedure. (See",
"    <a class=\"local\" href=\"#H25195080\">",
"     'Prevention and management of carcinoid crisis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691413\">",
"    <span class=\"h3\">",
"     Management of the primary site in patients with metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;For most malignancies, there is little rationale to resect the primary site when widespread, unresectable metastases are present. In patients with carcinoid tumors, however, resection of the primary maybe beneficial if the primary site is causing symptoms, even in the setting of metastatic disease, given the sometimes prolonged survival of such patients. Additionally, if the primary and liver metastases are both amenable to potentially curative resection, surgery should be performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Small bowel carcinoid tumors are often associated with desmoplasia and fibrosis, which can result in intermittent small bowel obstruction and, in some cases, bowel ischemia. Surgical resection of the primary should therefore be considered, even in patients who have metastatic disease, in those who are experiencing intermittent obstruction or abdominal discomfort thought to be related to the primary tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/18\">",
"     18",
"    </a>",
"    ]. While some have also advocated the routine resection of asymptomatic small bowel primary tumors in patients with unresectable metastatic disease, this practice remains controversial. A systematic review of six studies in which there was a comparison between resection of the primary and no resection in patients with unresectable liver metastases from a midgut carcinoid tumor concluded that there was a trend toward longer survival in patients who underwent surgical resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/19\">",
"     19",
"    </a>",
"    ]. However, the retrospective nature of these studies make the data difficult to interpret, given the high potential for selection bias in patients taken to surgery compared to those who were not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691420\">",
"    <span class=\"h3\">",
"     Liver transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of patients with liver-isolated metastatic disease in whom orthotopic liver transplantation (OLT) has been attempted is relatively small, and the role of OLT in patients with metastatic NET is not yet established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/20-25\">",
"     20-25",
"    </a>",
"    ]. However, encouraging reports are available from the following sources:",
"   </p>",
"   <p>",
"    Results from one French multicenter study demonstrated a five-year overall survival rate of 69 percent among patients undergoing OLT for metastatic carcinoid [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/20\">",
"     20",
"    </a>",
"    ]; in contrast, the survival rate for non-carcinoid metastatic NETs was only 8 percent.",
"   </p>",
"   <p>",
"    In a report from the United Network for Organ Sharing (UNOS) database, 150 transplants were performed for metastatic NETs between 1988 and 2008 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/25\">",
"     25",
"    </a>",
"    ], including 51 for carcinoid, 29 for pancreatic islet cell tumors, and 70 for an unspecified NET. The one, three, and five-year survival rates for the 137 patients undergoing isolated OLT were 81, 65, and 49 percent, respectively, and there was no difference among the carcinoid and non-carcinoid patients. These survival rates were comparable to those of a group of 4693 patients transplanted for hepatocellular carcinoma over the similar time period.",
"   </p>",
"   <p>",
"    Despite these encouraging results, however, the majority of patients undergoing OLT for metastatic NET ultimately develop recurrent disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/20,26\">",
"     20,26",
"    </a>",
"    ]. The limited availability of donor organs in many regions has also limited the widespread use of this procedure. Further investigation is needed to evaluate the benefits of OLT for patients with metastatic carcinoids and pancreatic NETs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691427\">",
"    <span class=\"h2\">",
"     Solitary brain metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brain metastases are rare in patients with well differentiated neuroendocrine tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/27\">",
"     27",
"    </a>",
"    ]. Although data are scant, retrospective series suggest the potential for prolonged survival in patients who undergo resection in conjunction with radiation therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691434\">",
"    <span class=\"h2\">",
"     Valve replacement for carcinoid heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carcinoid heart disease occurs in approximately two-thirds of patients with the carcinoid syndrome. Carcinoid heart lesions are characterized by plaque-like, fibrous endocardial thickening that classically involves the right side of the heart, and often causes retraction and fixation of the leaflets of the tricuspid and pulmonary valves (",
"    <a class=\"graphic graphic_picture graphicRef77192 \" href=\"mobipreview.htm?14/26/14755\">",
"     picture 1",
"    </a>",
"    ). Tricuspid regurgitation is a nearly universal finding; tricuspid stenosis, pulmonary regurgitation, and pulmonary stenosis may also occur. The resulting right-sided heart failure produces significant morbidity and mortality. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12472?source=see_link&amp;anchor=H4#H4\">",
"     \"Carcinoid heart disease\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Left-sided heart disease, which occurs in less than 10 percent of patients, is almost always associated with an atrial right-to-left shunt (as with a patent foramen ovale). This permits serotonin-rich blood to enter the left heart chambers without passing through the pulmonary capillaries. High circulating concentrations of serotonin are thought to be the major effector of carcinoid heart disease. Among patients with carcinoid syndrome, individuals with carcinoid heart disease exhibit higher levels of serum serotonin and urinary 5-hydroxyindoleacetic acid (5-HIAA) excretion than do those without heart disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12472?source=see_link&amp;anchor=H2#H2\">",
"     \"Carcinoid heart disease\", section on 'Pathophysiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although evidence suggests a pathogenic role for serotonin in the development of carcinoid heart disease, it is not known if medical therapy to reduce serotonin secretion (eg, with somatostatin analogs such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    ) can prevent the development of cardiac lesions. In uncontrolled observational series, treatment has not prevented or delayed the development of valve disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12472?source=see_link&amp;anchor=H13#H13\">",
"     \"Carcinoid heart disease\", section on 'Antitumor therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The indolent nature of metastatic carcinoid, coupled with the availability of effective treatments for carcinoid syndrome, has prompted interest in valve replacement surgery for selected patients. Although valvular replacement has in some series been associated with relatively high perioperative morbidity, appropriately selected patients achieve significant symptomatic improvement. This topic is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12472?source=see_link\">",
"     \"Carcinoid heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691441\">",
"    <span class=\"h1\">",
"     NONSURGICAL LIVER-DIRECTED THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691449\">",
"    <span class=\"h2\">",
"     Hepatic artery embolization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic arterial embolization is frequently applied as a palliative technique in patients with hepatic-predominant metastatic neuroendocrine tumor (NET) who are not candidates for surgical resection. It is based on the principle that tumors in the liver derive most of their blood supply from the hepatic artery, whereas healthy hepatocytes derive most of their blood supply from the portal vein.",
"   </p>",
"   <p>",
"    Embolization can be performed via the infusion of gel foam powder into the hepatic artery through an angiography catheter (bland embolization) or in conjunction with chemotherapy (ie,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/30/9702?source=see_link\">",
"     streptozocin",
"    </a>",
"    , or drug-eluting beads) administered via the hepatic artery (chemoembolization). A third embolization technique uses radioactive isotopes (eg, yttrium-90 [90-Y]) that are tagged to glass or resin microspheres and delivered selectively to the tumor via the hepatic artery.",
"   </p>",
"   <p>",
"    The response rates associated with all of these techniques, as measured either by decreased hormone secretion, symptomatic benefit, or radiographic regression, are generally over 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/30-44\">",
"     30-44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5473965\">",
"    <span class=\"h3\">",
"     Technique and outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of randomized trials, any of the three techniques (bland embolization, chemoembolization, or radioembolization) are considered reasonable approaches for the palliation of neuroendocrine tumor patients with hepatic predominant disease who are not candidates for surgical resection; efficacy seems to be similar.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one of the largest reports of 81 patients undergoing embolization or chemoembolization for carcinoid tumor, the median response duration was 17 months, and progression-free survival (PFS) rates at one, two, and three years were 75, 35, and 11 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/34\">",
"       34",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      A second series of 69 patients with carcinoid and 54 with islet cell tumors suggested better results for carcinoid (response rate 67 versus 35 percent, median PFS 23 versus 16 months, and median overall survival 34 versus 23 months) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/45\">",
"       45",
"      </a>",
"      ]. The addition of chemotherapy to hepatic artery embolization seemed to benefit islet cell tumors but not carcinoids.",
"     </li>",
"     <li>",
"      Experience with 90-Y radioembolization in metastatic NETs is limited but growing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/40-42,46,47\">",
"       40-42,46,47",
"      </a>",
"      ]. In the largest series of 148 patients with unresectable liver metastases, 64 percent had an objective response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/40\">",
"       40",
"      </a>",
"      ]. Fatigue (7 percent) was the most common side effect.",
"      <br/>",
"      <br/>",
"      As with other techniques, radioembolization has been reported to reduce symptoms in about one-half of patients with functioning tumors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/42,46\">",
"       42,46",
"      </a>",
"      ]. A single case report describes control of refractory hypoglycemia for three months following radioembolization of a metastatic malignant insulinoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/48\">",
"       48",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In the absence of randomized trials, it is difficult to know when to choose this technique over any other nonsurgical liver-directed therapy. In many institutions, it is not considered a first-line approach, in part because of its expense.",
"     </li>",
"     <li>",
"      Concern has been raised as to a high incidence of biliary injury with TACE using drug-eluting beads [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/49\">",
"       49",
"      </a>",
"      ], but this has not been seen in all studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/39,43\">",
"       39,43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Regardless of the approach that is chosen, appropriate patient selection is important to minimize treatment- and disease-related adverse effects, which can include pain, nausea, fever, fatigue and biochemical abnormalities (elevated liver enzymes) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/50\">",
"     50",
"    </a>",
"    ]. The presence of extrahepatic disease is not a contraindication to embolization, particularly for highly symptomatic patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prophylaxis for carcinoid crisis should also be considered prior to embolization in patients with carcinoid syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=see_link&amp;anchor=H190948942#H190948942\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion\", section on 'Prevention and management of carcinoid crisis'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H25195080\">",
"     'Prevention and management of carcinoid crisis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691456\">",
"    <span class=\"h2\">",
"     RFA and cryoablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other approaches to the treatment of hepatic metastases are radiofrequency ablation (RFA) and cryoablation, which has largely been abandoned in favor of RFA. These procedures, which may be used percutaneously or laparoscopically, are less morbid than either hepatic resection or hepatic artery embolization. However, they may be applicable only to smaller lesions.",
"   </p>",
"   <p>",
"    Most published reports of RFA are small case studies of fewer than 40 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/52-57\">",
"     52-57",
"    </a>",
"    ]. One group of investigators reported on their 10-year experience with laparoscopic RFA to treat 452 neuroendocrine liver metastases in 63 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43496/abstract/56\">",
"     56",
"    </a>",
"    ]. Twenty-two underwent repeat ablation for progression of hepatic disease. Symptomatic relief was reported by 34 of 36 symptomatic patients and was maintained for a median of 11 months. The one, two, and five-year survival rates after RFA were 91, 77, and 48 percent, respectively. The size of the dominant lesion was a significant predictor of median survival (2.7, 2.9, and not reached after eight years of follow-up for &gt;5, 3 to 5, and &le;3 cm tumors, respectively).",
"   </p>",
"   <p>",
"    The place of RFA in the therapeutic management of small liver metastases from NETs, particularly in patients who are eligible for resection, is undefined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25195080\">",
"    <span class=\"h1\">",
"     PREVENTION AND MANAGEMENT OF CARCINOID CRISIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carcinoid crisis is a life-threatening form of carcinoid syndrome that may be triggered by tumor manipulation (biopsy, palpation at the bedside or during surgery) or by anesthesia. It is less commonly reported after chemotherapy, hepatic arterial embolization, or radionuclide therapy, mostly in patients with extensive tumor bulk.",
"   </p>",
"   <p>",
"    Carcinoid crisis results from the release of an overwhelming amount of biologically active compounds from the tumor (",
"    <a class=\"graphic graphic_table graphicRef79329 \" href=\"mobipreview.htm?34/59/35771\">",
"     table 2",
"    </a>",
"    ). In addition to hemodynamic instability, symptoms include flushing, diarrhea, tachycardia, arrhythmias, bronchospasm, and altered mental status.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     Octreotide",
"    </a>",
"    should be readily available during any surgical procedure. Preoperative administration of octreotide (300 micrograms subcutaneously) can reduce the incidence of carcinoid crisis and is recommended for patients with a history of carcinoid syndrome who require surgical procedures. (See",
"    <a class=\"local\" href=\"#H691406\">",
"     'Resection'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Treatment for carcinoid crisis differs from that for other causes of acute intraoperative hypotension. Symptoms are generally refractory to fluid resuscitation alone. Calcium and catecholamines may provoke release of mediators from the tumor and worsen, rather than ameliorate, the syndrome. During a carcinoid crisis, the blood pressure should be supported by infusion of plasma and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    (300 micrograms IV) given immediately. A continuous IV drip of octreotide may be needed. In patients with high risk of carcinoid crisis, an IV octreotide drip may be initiated preoperatively. Carcinoid crisis is discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/31/16888?source=see_link&amp;anchor=H624742810#H624742810\">",
"     \"Treatment of the carcinoid syndrome\", section on 'Prevention and management of carcinoid crisis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25195131\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For initial management of patients with hepatic metastases from carcinoid or pancreatic neuroendocrine tumor (NET) that is resectable with curative intent, we suggest resection rather than medical therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Resection is an appropriate treatment for liver metastases in the absence of extrahepatic metastases, diffuse bilobar involvement, or compromised liver function. (See",
"      <a class=\"local\" href=\"#H691406\">",
"       'Resection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest resection for symptomatic small bowel primary sites and for asymptomatic primaries if both the primary site and liver metastases are amenable to potentially curative resection (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The benefit of resecting asymptomatic small bowel primary sites in patients with unresectable metastatic disease has not been clearly established, and we suggest not pursuing this approach (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H691413\">",
"       'Management of the primary site in patients with metastases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients undergoing surgery for metastatic carcinoid who have a history of carcinoid syndrome, we recommend prophylactic subcutaneous administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"       octreotide",
"      </a>",
"      prior to the procedure to reduce the incidence of carcinoid crisis (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H25195080\">",
"       'Prevention and management of carcinoid crisis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/31/16888?source=see_link&amp;anchor=H624742810#H624742810\">",
"       \"Treatment of the carcinoid syndrome\", section on 'Prevention and management of carcinoid crisis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The benefits of surgical debulking or liver transplantation in patients with incompletely resectable metastatic carcinoid or pancreatic NET remain controversial, and these remain investigational approaches. (See",
"      <a class=\"local\" href=\"#H691420\">",
"       'Liver transplantation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest hepatic arterial embolization, chemoembolization, or radioembolization as an alternative to medical therapy alone as a palliative technique for symptomatic patients with hepatic-predominant unresectable carcinoid or pancreatic NET (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H691449\">",
"       'Hepatic artery embolization'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      For patients who are symptomatic from carcinoid syndrome, somatostatin analogs such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"       octreotide",
"      </a>",
"      are highly effective in controlling symptoms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=see_link&amp;anchor=H190948928#H190948928\">",
"       \"Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion\", section on 'Octreotide and other somatostatin analogs'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours of the Digestive System, 4th ed, Bosman TF, Carneiro F, Hruban RH, Theise ND (Eds), International Agency for Research on cancer (IARC), Lyon 2010. p.13.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/2\">",
"      Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 2008; 135:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/3\">",
"      Sarmiento JM, Heywood G, Rubin J, et al. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/4\">",
"      Cho CS, Labow DM, Tang L, et al. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms. Cancer 2008; 113:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/5\">",
"      Gaujoux S, Gonen M, Tang L, et al. Synchronous resection of primary and liver metastases for neuroendocrine tumors. Ann Surg Oncol 2012; 19:4270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/6\">",
"      Dousset B, Saint-Marc O, Pitre J, et al. Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg 1996; 20:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/7\">",
"      Landry CS, Scoggins CR, McMasters KM, Martin RC 2nd. Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol 2008; 97:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/8\">",
"      Frilling A, Li J, Malamutmann E, et al. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg 2009; 96:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/9\">",
"      Touzios JG, Kiely JM, Pitt SC, et al. Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 2005; 241:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/10\">",
"      Sarmiento JM, Que FG, Grant CS, et al. Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery 2002; 132:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/11\">",
"      Osborne DA, Zervos EE, Strosberg J, et al. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol 2006; 13:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/12\">",
"      Schurr PG, Strate T, Rese K, et al. Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience. Ann Surg 2007; 245:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/13\">",
"      Musunuru S, Chen H, Rajpal S, et al. Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch Surg 2006; 141:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/14\">",
"      Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol 2010; 17:3129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/15\">",
"      Knox CD, Feurer ID, Wise PE, et al. Survival and functional quality of life after resection for hepatic carcinoid metastasis. J Gastrointest Surg 2004; 8:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/16\">",
"      Givi B, Pommier SJ, Thompson AK, et al. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery 2006; 140:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/17\">",
"      Chamberlain RS, Canes D, Brown KT, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000; 190:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/18\">",
"      Gulec SA, Mountcastle TS, Frey D, et al. Cytoreductive surgery in patients with advanced-stage carcinoid tumors. Am Surg 2002; 68:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/19\">",
"      Capurso G, Rinzivillo M, Bettini R, et al. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. Br J Surg 2012; 99:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/20\">",
"      Le Treut YP, Delpero JR, Dousset B, et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg 1997; 225:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/21\">",
"      Lang H, Oldhafer KJ, Weimann A, et al. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 1997; 225:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/22\">",
"      van Vilsteren FG, Baskin-Bey ES, Nagorney DM, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival. Liver Transpl 2006; 12:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/23\">",
"      Mar&iacute;n C, Robles R, Fern&aacute;ndez JA, et al. Role of liver transplantation in the management of unresectable neuroendocrine liver metastases. Transplant Proc 2007; 39:2302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/24\">",
"      Olausson M, Friman S, Herlenius G, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl 2007; 13:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/25\">",
"      Gedaly R, Daily MF, Davenport D, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg 2011; 146:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/26\">",
"      Florman S, Toure B, Kim L, et al. Liver transplantation for neuroendocrine tumors. J Gastrointest Surg 2004; 8:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/27\">",
"      Patchell RA, Posner JB. Neurologic complications of carcinoid. Neurology 1986; 36:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/28\">",
"      Hlatky R, Suki D, Sawaya R. Carcinoid metastasis to the brain. Cancer 2004; 101:2605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/29\">",
"      Maiuri F, Cappabianca P, Del Basso De Caro M, Esposito F. Single brain metastases of carcinoid tumors. J Neurooncol 2004; 66:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/30\">",
"      Sw&auml;rd C, Johanson V, Nieveen van Dijkum E, et al. Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome. Br J Surg 2009; 96:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/31\">",
"      Moertel CG, Johnson CM, McKusick MA, et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994; 120:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/32\">",
"      Ruszniewski P, Rougier P, Roche A, et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 1993; 71:2624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/33\">",
"      Eriksson BK, Larsson EG, Skogseid BM, et al. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 1998; 83:2293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/34\">",
"      Gupta S, Yao JC, Ahrar K, et al. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J 2003; 9:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/35\">",
"      Christante D, Pommier S, Givi B, Pommier R. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy. Surgery 2008; 144:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/36\">",
"      Drougas JG, Anthony LB, Blair TK, et al. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 1998; 175:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/37\">",
"      Diamandidou E, Ajani JA, Yang DJ, et al. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR Am J Roentgenol 1998; 170:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/38\">",
"      Loewe C, Schindl M, Cejna M, et al. Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am J Roentgenol 2003; 180:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/39\">",
"      de Baere T, Deschamps F, Teriitheau C, et al. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol 2008; 19:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/40\">",
"      Kennedy AS, Dezarn WA, McNeillie P, et al. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 2008; 31:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/41\">",
"      Rhee TK, Lewandowski RJ, Liu DM, et al. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 2008; 247:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/42\">",
"      King J, Quinn R, Glenn DM, et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 2008; 113:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/43\">",
"      Gaur SK, Friese JL, Sadow CA, et al. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver. Cardiovasc Intervent Radiol 2011; 34:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/44\">",
"      Arrese D, McNally ME, Chokshi R, et al. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma. Ann Surg Oncol 2013; 20:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/45\">",
"      Gupta S, Johnson MM, Murthy R, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 2005; 104:1590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/46\">",
"      Cao CQ, Yan TD, Bester L, et al. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases. Br J Surg 2010; 97:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/47\">",
"      Memon K, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys 2012; 83:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/48\">",
"      Chandra P, Yarandi SS, Khazai N, et al. Management of intractable hypoglycemia with Yttirum-90 radioembolization in a patient with malignant insulinoma. Am J Med Sci 2010; 340:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/49\">",
"      Bhagat N, Reyes DK, Lin M, et al. Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury. Cardiovasc Intervent Radiol 2013; 36:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/50\">",
"      Lewis MA, Jaramillo S, Roberts L, et al. Hepatic artery embolization for neuroendocrine tumors: postprocedural management and complications. Oncologist 2012; 17:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/51\">",
"      Gates J, Hartnell GG, Stuart KE, Clouse ME. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 1999; 19:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/52\">",
"      Gillams A, Cassoni A, Conway G, Lees W. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 2005; 30:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/53\">",
"      Wessels FJ, Schell SR. Radiofrequency ablation treatment of refractory carcinoid hepatic metastases. J Surg Res 2001; 95:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/54\">",
"      Hellman P, Ladjevardi S, Skogseid B, et al. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 2002; 26:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/55\">",
"      Berber E, Flesher N, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002; 26:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/56\">",
"      Mazzaglia PJ, Berber E, Milas M, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 2007; 142:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43496/abstract/57\">",
"      Mazzaglia PJ, Berber E, Siperstein AE. Radiofrequency thermal ablation of metastatic neuroendocrine tumors in the liver. Curr Treat Options Oncol 2007; 8:322.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16105 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-0D0D3C1A28-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43496=[""].join("\n");
var outline_f42_30_43496=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25195131\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H688217\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1970242\">",
"      Classification and nomenclature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1970317\">",
"      NATURAL HISTORY AND TREATMENT OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H691390\">",
"      SURGICAL OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H691398\">",
"      Hepatic predominant metastatic disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H691406\">",
"      - Resection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H691413\">",
"      - Management of the primary site in patients with metastases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H691420\">",
"      - Liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H691427\">",
"      Solitary brain metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H691434\">",
"      Valve replacement for carcinoid heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H691441\">",
"      NONSURGICAL LIVER-DIRECTED THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H691449\">",
"      Hepatic artery embolization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5473965\">",
"      - Technique and outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H691456\">",
"      RFA and cryoablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25195080\">",
"      PREVENTION AND MANAGEMENT OF CARCINOID CRISIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25195131\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/16105\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/16105|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/26/14755\" title=\"picture 1\">",
"      Carcinoid heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/16105|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/14/17644\" title=\"table 1\">",
"      Nomenclature and classification for neuroendocrine tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/59/35771\" title=\"table 2\">",
"      Products of carcinoid tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/55/9082?source=related_link\">",
"      Bronchial carcinoid tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/11/12472?source=related_link\">",
"      Carcinoid heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18330?source=related_link\">",
"      Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/60/969?source=related_link\">",
"      Clinical characteristics of carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9206?source=related_link\">",
"      Clinical features of the carcinoid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/8/11400?source=related_link\">",
"      Diagnosis of the carcinoid syndrome and tumor localization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/57/31640?source=related_link\">",
"      Glucagonoma and the glucagonoma syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/30/12777?source=related_link\">",
"      Insulinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/32/6665?source=related_link\">",
"      Metastatic gastroenteropancreatic neuroendocrine tumors: Presentation, prognosis, imaging, and biochemical monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=related_link\">",
"      Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/13/41174?source=related_link\">",
"      Neuroendocrine cancer of unknown primary site",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/40/6794?source=related_link\">",
"      Pathology, classification, and grading of neuroendocrine tumors arising in the digestive system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/34/3623?source=related_link\">",
"      Somatostatinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/59/16311?source=related_link\">",
"      The VIPoma syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/61/39897?source=related_link\">",
"      Treatment and surveillance of non-metastatic carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/31/16888?source=related_link\">",
"      Treatment of the carcinoid syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_30_43497="Pityriasis rubra pilaris";
var content_f42_30_43497=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pityriasis rubra pilaris",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/30/43497/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/30/43497/contributors\">",
"     Andreas Katsambas, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/30/43497/contributors\">",
"     Clio Dessinioti, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/30/43497/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/30/43497/contributors\">",
"     Kristina Callis Duffin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/30/43497/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/30/43497/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/30/43497/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 10, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H6824927\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pityriasis rubra pilaris (PRP) is a rare papulosquamous inflammatory dermatosis of unknown origin and considerable clinical heterogeneity (",
"    <a class=\"graphic graphic_table graphicRef87505 \" href=\"mobipreview.htm?6/16/6412\">",
"     table 1",
"    </a>",
"    ). The cardinal clinical features of PRP are hyperkeratotic follicular papules, orange-red scaling plaques, and palmoplantar hyperkeratosis (",
"    <a class=\"graphic graphic_picture graphicRef86471 graphicRef86473 graphicRef86472 graphicRef86475 graphicRef86474 graphicRef86476 \" href=\"mobipreview.htm?43/47/44794\">",
"     picture 1A-F",
"    </a>",
"    ). Well-demarcated areas of spared skin (also known as &ldquo;islands of sparing&rdquo;) are a frequent finding in patients with generalized involvement. Erythroderma may occur as a complication of PRP.",
"   </p>",
"   <p>",
"    The treatment of PRP can be challenging. Systemic retinoids and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    are the most commonly employed therapies, and limited data suggest that biologic TNF-alpha inhibitors may be effective. Multiple other therapies have also been utilized for PRP.",
"   </p>",
"   <p>",
"    The pathogenesis, diagnosis, and treatment of PRP will be reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H187071461\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A disorder with features consistent with PRP was first reported in 1828 as a variant of psoriasis, and in 1856, &ldquo;pityriasis pilaris&rdquo; was identified as an independent disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/1\">",
"     1",
"    </a>",
"    ]. The term &ldquo;pityriasis rubra pilaris&rdquo; was coined in 1889, and remains the accepted terminology for this disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6824934\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and prevalence of PRP is not precisely known. The disease has been estimated to account for 1 in 5000 new patients who present with skin disease in Great Britain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ]. PRP occurs in individuals of all racial backgrounds and appears to affect both genders equally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both adults and children may develop PRP. The disorder has a bimodal age distribution with peaks during the first and fifth decades of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6824941\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathways that lead to the development of PRP are unclear. The detection of upregulated expression of TNF-alpha in lesional skin from two patients with PRP and the observation that TNF-alpha inhibitors improve PRP raise the question of whether TNF-alpha plays a significant pathogenic role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/4\">",
"     4",
"    </a>",
"    ]. Further study is necessary to determine the role of TNF-alpha in PRP.",
"   </p>",
"   <p>",
"    In addition, abnormalities in vitamin A metabolism, an aberrant response to infection, and genetic predisposition have been proposed as factors that may contribute to PRP:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Abnormal vitamin A metabolism",
"      </strong>",
"      &ndash; The recognition of similarities between the follicular hyperkeratosis of PRP and the cutaneous manifestations of vitamin A deficiency (phrynoderma) led to speculation that vitamin A is involved in the pathogenesis of PRP. After early theories of vitamin A deficiency as a cause of the disease were not substantiated, investigations to determine whether other vitamin A-related factors contribute to PRP were performed. Although a study of 11 adults and children with PRP found that PRP was associated with decreased levels of retinol binding protein (a specific carrier of vitamin A) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/5\">",
"       5",
"      </a>",
"      ], a subsequent study of three patients failed to confirm this finding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/6\">",
"       6",
"      </a>",
"      ]. Thus, a role for aberrant vitamin A metabolism in PRP remains uncertain. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/14/21736?source=see_link&amp;anchor=H8#H8\">",
"       \"Overview of vitamin A\", section on 'Deficiency'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Infection",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      The consideration of infection as a contributor to PRP is based upon case reports documenting the development of PRP following streptococcal and viral infections [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. In particular, the coexistence of human immunodeficiency virus (HIV) infection and PRP has been documented in several case reports, and HIV-associated PRP has improved following the initiation of antiretroviral therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H427351863\">",
"       'Type VI (HIV-associated)'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Genetics",
"      </strong>",
"      &ndash;",
"      <strong>",
"      </strong>",
"      Genetic factors play a role in at least some cases of PRP. Although most patients have acquired disease, familial forms of PRP have been described, including cases that appear to result from autosomal dominant or autosomal recessive transmission [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. Autosomal dominant PRP has been linked to a mutation in the",
"      <em>",
"       CARD14",
"      </em>",
"      gene (MIM #173200) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/10\">",
"       10",
"      </a>",
"      ]. Whether genetic predisposition plays a role in the development of acquired PRP is unknown.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other factors that have been associated with the development of PRP or exacerbations of PRP include trauma and ultraviolet light [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7,13-16\">",
"     7,13-16",
"    </a>",
"    ]. In one series of 30 children with PRP, the Koebner phenomenon or trauma preceded the onset of PRP in three children (10 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7\">",
"     7",
"    </a>",
"    ]. Ultraviolet light exposure from the sun or artificial sources infrequently has been reported as an exacerbating factor for PRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Drugs typically are not considered inciting factors for PRP. However,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/45/9944?source=see_link\">",
"     sorafenib",
"    </a>",
"    therapy preceded a PRP-like eruption in one patient with metastatic germ cell cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6824948\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PRP consists of a spectrum of six clinical subtypes. The subtypes of PRP are defined by age of onset, lesion morphology and distribution, disease course, and an association with HIV infection (",
"    <a class=\"graphic graphic_table graphicRef87505 \" href=\"mobipreview.htm?6/16/6412\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3,18,19\">",
"     3,18,19",
"    </a>",
"    ]. Type I PRP is the most common form of PRP; type III and type IV are the most common presentations in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7,13\">",
"     7,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Shared features that are present with variable frequency in the subtypes of PRP include follicular hyperkeratosis, orange-red plaques with fine overlying scale, and palmoplantar hyperkeratosis. When large areas of skin are involved, islands of unaffected skin (also known as &ldquo;islands of sparing&rdquo;) are often evident. Pruritus is common and palmoplantar hyperkeratosis may result in the development of painful fissures.",
"   </p>",
"   <p>",
"    The orange-red color of skin lesions classically described in PRP may not be clearly evident in individuals with dark skin. The orange-red color may be less prominent than in fairer-skinned individuals, and hyperpigmentation or hypopigmentation may be present.",
"   </p>",
"   <p>",
"    The clinical subtypes of PRP are reviewed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427351550\">",
"    <span class=\"h2\">",
"     Type I (classic adult)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type I PRP, an adult-onset form, is the most common subtype of PRP. This subtype is estimated to account for 55 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients with type I PRP typically present with a cutaneous eruption which progresses in a cephalocaudal manner, beginning with the face and spreading to the trunk, arms, and legs over the course of a few weeks to a few months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ]. Hyperkeratotic red to orange follicular papules and plaques accompanied by islands of sparing, and orange-hued hyperkeratosis on the palms and soles are characteristic findings (",
"    <a class=\"graphic graphic_picture graphicRef86471 graphicRef86473 graphicRef86472 graphicRef86475 graphicRef86474 graphicRef86476 \" href=\"mobipreview.htm?43/47/44794\">",
"     picture 1A-F",
"    </a>",
"    ). Scaling is fine and powdery (pityriasiform).",
"   </p>",
"   <p>",
"    Erythroderma (generalized redness involving more than 90 percent of the body surface area) accompanied by ectropion may develop in PRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"     20",
"    </a>",
"    ]. However, due to a paucity of data on this phenomenon, the frequency with which this occurs in type I PRP is unclear.",
"   </p>",
"   <p>",
"    Approximately 25 percent of the patients we follow at the First Department of Dermatology of the University of Athens for PRP have a history of erythroderma requiring hospitalization. However, our experience likely overestimates the frequency of erythroderma in PRP since patients referred to our hospital-based clinic may be more likely to have severe PRP than patients seen in the general outpatient setting.",
"   </p>",
"   <p>",
"    In addition to the skin findings, other abnormalities may occur. Patients may develop rough, thickened nail plates with distal crumbling, yellow-brown discoloration of the nail plate, and the accumulation of subungual debris [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"     20",
"    </a>",
"    ]. Moreover, prolonged facial involvement may lead to ectropion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"     20",
"    </a>",
"    ], and lymphadenopathy may develop in the setting of extensive skin involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"     20",
"    </a>",
"    ]. Associated arthropathy (usually seronegative arthritis) also has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/21-23\">",
"     21-23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the clinical manifestations of type I PRP can be severe, type I PRP generally has a favorable long-term prognosis. Approximately 80 percent of patients achieve spontaneous remission within three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427351778\">",
"    <span class=\"h2\">",
"     Type II (atypical adult)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type II PRP occurs in adults, but lacks the cephalocaudal progression seen in type I PRP. The most prominent features in this variant are an ichthyosiform dermatitis that tends to be most prominent on the lower extremities. The palmoplantar hyperkeratosis tends to be coarse with lamellated scale. Sparse scalp hair is occasionally present.",
"   </p>",
"   <p>",
"    The prognosis of type II PRP is less favorable than type I PRP. The disease may have a protracted course of more than 20 years. Fewer than 20 percent of patients achieve clinical resolution within three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427351705\">",
"    <span class=\"h2\">",
"     Type III (classic juvenile)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of type I and type III PRP are similar, with the age of onset as the distinguishing factor (",
"    <a class=\"graphic graphic_picture graphicRef87152 graphicRef87153 graphicRef87154 \" href=\"mobipreview.htm?17/48/18186\">",
"     picture 2A-C",
"    </a>",
"    ). While type I PRP develops in adulthood, type III PRP typically begins around 5 to 10 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"     20",
"    </a>",
"    ]. Type III PRP is less common than type I PRP, accounting for approximately 10 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar to type I PRP, erythroderma can occur in type III PRP. One retrospective series that included 17 children with type III PRP found that 4 of these children (24 percent) had erythroderma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prognosis of type III PRP is excellent. Most patients experience disease resolution after one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"     20",
"    </a>",
"    ]. Rarely, the disease is persistent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427351790\">",
"    <span class=\"h2\">",
"     Type IV (circumscribed juvenile)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This form of PRP accounts for approximately 25 percent of cases of PRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ]. Type IV PRP primarily occurs in prepubertal children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ]. Young adults may also be affected.",
"   </p>",
"   <p>",
"    Patients present with sharply demarcated areas of erythema and follicular hyperkeratosis on the elbows and knees. Palmoplantar hyperkeratosis may be present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The disease may demonstrate a relapsing and remitting course. Approximately one-third of patients achieve disease remission within three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"     20",
"    </a>",
"    ]. Progression to widespread, classic PRP usually does not occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427351843\">",
"    <span class=\"h2\">",
"     Type V (atypical juvenile)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type V PRP is relatively uncommon, representing around 5 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ]. The majority of familial cases of PRP fall into this category. The disease manifestations begin in the first few years of life and include follicular hyperkeratosis and generalized ichthyosiform dermatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/13\">",
"     13",
"    </a>",
"    ]. Erythema is usually present, but not prominent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ]. Occasional patients exhibit scleroderma-like changes on the palms and soles. The disease course is usually chronic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427351863\">",
"    <span class=\"h2\">",
"     Type VI (HIV-associated)",
"    </span>",
"    &nbsp;&mdash;&nbsp;PRP may occur in the setting of HIV-infection, in some cases representing the initial manifestations of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/9,19,26\">",
"     9,19,26",
"    </a>",
"    ]. Patients develop widely-distributed erythematous follicular papules with prominent keratotic spicules and inflammatory plaques. The presence of nail, palmar, and plantar changes is variable. Erythroderma is a frequent complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HIV-associated PRP may occur in concert with other disorders characterized by follicular occlusion, including acne conglobata, hidradenitis suppurativa, and lichen spinulosus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/9,19,27,28\">",
"     9,19,27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H567847\">",
"    <span class=\"h2\">",
"     Mucosal involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral involvement in PRP is rare and may appear as white papules or plaques on the palate, buccal mucosa,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tongue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/29\">",
"     29",
"    </a>",
"    ]. Discomfort may be present.",
"   </p>",
"   <p>",
"    Ocular complications reported in the setting of PRP include cicatricial ectropion and peripheral ulcerative keratitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. The development of bilateral herpes simplex virus keratitis was reported in one patient with PRP during treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H351320360\">",
"    <span class=\"h1\">",
"     ASSOCIATED DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to HIV infection, several immunodeficient states and autoimmune disorders have been reported in association with PRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/33\">",
"     33",
"    </a>",
"    ], suggesting that immunologic dysfunction may be a contributing factor. In addition, several case reports document the occurrence of PRP in the setting of internal malignancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/34-40\">",
"     34-40",
"    </a>",
"    ]. The relationship between PRP and these types of disorders remains uncertain. With the exception of testing for HIV infection, we do not routinely screen patients for associated diseases in the absence of signs of symptoms suggestive of an underlying disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6824990\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PRP is based on the recognition of consistent clinical and histopathologic features. There are no specific serologic markers for PRP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352175\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 4 mm punch biopsy is typically utilized to obtain a specimen for histological examination. Findings classically seen include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/41\">",
"     41",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Orthokeratosis with spotty parakeratosis (alternating orthokeratosis and parakeratosis in vertical and horizontal directions; parakeratosis surrounding follicular ostia)",
"     </li>",
"     <li>",
"      Epidermal acanthosis",
"     </li>",
"     <li>",
"      Intact granular layer",
"     </li>",
"     <li>",
"      Mild perivascular lymphohistiocytic infiltrate in the dermis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Occasional additional findings include epidermal spongiosis and focal acantholytic dyskeratosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352191\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of PRP varies according to the clinical subtype. The most common disorder in the differential for type I and type III PRP is psoriasis vulgaris.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Psoriasis vulgaris",
"      </strong>",
"      &ndash; Psoriasis vulgaris can be difficult to distinguish from PRP due to the fact that both conditions may present with localized or widespread erythematous, scaly plaques. PRP is characterized by red to orange follicular papules and plaques and orange palmoplantar keratoderma. Psoriasis is characterized by silvery, coarse scales that are loosely adhered to sharply demarcated red (erythematous) plaques. These scales contrast with the finer scales that develop in PRP. Also, typical nail changes (eg, oil spots, pitting) of psoriasis are useful in distinguishing between psoriasis and PRP (",
"      <a class=\"graphic graphic_picture graphicRef70962 graphicRef66374 \" href=\"mobipreview.htm?15/56/16263\">",
"       picture 3A-B",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Histological examination also is of value. Unlike PRP, the granular layer is absent in psoriasis. In addition, collections of polymorphonuclear leukocytes (Munro microabscesses) are often found in the epidermis in psoriasis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The distribution of early PRP on the face and photo-exposed body areas may stimulate consideration of a photo-aggravated disorder. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18426?source=see_link\">",
"     \"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients who present with erythroderma, the possibility of other diseases that cause erythroderma must be considered. A medical history, careful physical examination for associated clinical features, and skin biopsy can help to determine the underlying cause. Examples of diseases that may present with erythroderma include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Psoriasis",
"     </li>",
"     <li>",
"      Atopic dermatitis",
"     </li>",
"     <li>",
"      Drug eruptions",
"     </li>",
"     <li>",
"      Cutaneous T-cell lymphoma",
"     </li>",
"     <li>",
"      Congenital ichthyoses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the case of inconclusive histology, immunohistochemistry and T cell receptor gene rearrangement studies (by PCR) may be necessary to rule out cutaneous T-cell lymphoma.",
"   </p>",
"   <p>",
"    Type II and V PRP may present with ichthyosiform changes, and congenital or acquired ichthyoses should be considered in the differential diagnosis of these subtypes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24586?source=see_link&amp;anchor=H3#H3\">",
"     \"The genodermatoses\", section on 'Ichthyosiform dermatoses'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with type IV PRP, which is characterized by localized plaques with follicular hyperkeratosis, other disorders with follicular hyperkeratosis in limited areas, such as lichen spinulosus and keratosis pilaris, should be considered.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Lichen spinulosus",
"      </strong>",
"      &ndash; Lichen spinulosus is an uncommon disorder that most commonly presents in children and adolescents as circumscribed plaques with follicular papules that bear keratotic spines (",
"      <a class=\"graphic graphic_picture graphicRef87590 \" href=\"mobipreview.htm?6/55/7030\">",
"       picture 4",
"      </a>",
"      ). The neck, abdomen, and upper and lower extremities are sites of disease predilection.",
"     </li>",
"     <li>",
"      <strong>",
"       Keratosis pilaris (follicular hyperkeratosis)",
"      </strong>",
"      &ndash; Keratosis pilaris is a common skin condition often associated with atopy. Patients present with spiny follicular papules on the upper arms, thighs, and buttocks (",
"      <a class=\"graphic graphic_picture graphicRef68488 graphicRef60786 \" href=\"mobipreview.htm?33/23/34168\">",
"       picture 5A-B",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6824997\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of PRP is largely based upon anecdotal reports of clinical experience. Because no controlled trials have been performed, there is uncertainty regrading the true efficacy of individual treatments. No treatments have been approved by the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) for use in PRP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352246\">",
"    <span class=\"h2\">",
"     Approach to therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of PRP involves the combined use of systemic and topical therapies. Topical therapies help with the management of associated symptoms and may be sufficient as monotherapy for patients with limited disease. However, most patients require systemic therapy to attain control of PRP.",
"   </p>",
"   <p>",
"    Oral retinoids (synthetic vitamin A derivatives) are the preferred first-line systemic treatments for children and adults with PRP. Case reports and case series support the efficacy of systemic retinoids in PRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7,31,42-47\">",
"     7,31,42-47",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H427352254\">",
"     'Systemic retinoids'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Multiple other treatments are utilized for PRP.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    has appeared effective in case reports and case series, and is an alternative treatment option for patients who are not good candidates for systemic retinoids or who fail to respond to systemic retinoid therapy. Additional agents such as biologic TNF-alpha inhibitors,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , and phototherapy may be useful for patients who fail to respond adequately to retinoid or methotrexate therapy.",
"   </p>",
"   <p>",
"    Data on the treatment of HIV-associated PRP are limited. Improvement after treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    alone, systemic retinoids plus zidovudine, or triple antiviral therapy has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H562911\">",
"    <span class=\"h2\">",
"     Topical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical treatments used for PRP include medium to high potency topical corticosteroids (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"mobipreview.htm?38/56/39809\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7,48\">",
"     7,48",
"    </a>",
"    ], keratolytics, tar, calcipotriene (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/54/5988?source=see_link\">",
"     calcipotriol",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/49\">",
"     49",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/52/1862?source=see_link\">",
"     topical tretinoin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/50\">",
"     50",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/17/19732?source=see_link\">",
"     tazarotene",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/51\">",
"     51",
"    </a>",
"    ]. Topical treatments are usually combined with a systemic therapy for PRP types affecting a large body surface area. For patients with limited skin involvement, local therapy may be beneficial as monotherapy.",
"   </p>",
"   <p>",
"    Topical keratolytics (such as 10% urea or 5% salicylic acid) may be useful for managing hyperkeratosis and palmoplantar keratoderma. In addition, the application of emollients and the administration of systemic antihistamines for pruritus may help to reduce associated symptoms. In our experience, daily application of topical emollients is beneficial for improving skin texture and the degree of scaling, erythema, and induration of the lesions.",
"   </p>",
"   <p>",
"    Data on the use of topical agents in PRP are derived mainly from case reports. As a result, there are no high-quality evidence-based data regarding efficacy and safety of topical treatment. Treatment with topical corticosteroids should in general be limited to small body areas and for a short period of time due to the risk of side effects, such as skin atrophy, telangiectasias, and systemic absorption. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=see_link&amp;anchor=H16#H16\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352231\">",
"    <span class=\"h2\">",
"     Systemic therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352357\">",
"    <span class=\"h3\">",
"     First-line systemic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic retinoids are used as first-line systemic therapy for adults and children with PRP based upon data from case reports and clinical experience. The response to treatment is variable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352254\">",
"    <span class=\"h4\">",
"     Systemic retinoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preferred use of retinoids for patients with PRP is based upon the beneficial effects of retinoids observed in case reports and small case series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7,31,42-47\">",
"     7,31,42-47",
"    </a>",
"    ]. The most common retinoids used for the treatment of PRP are",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    . Case reports suggest that a newer retinoid,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/45/25299?source=see_link\">",
"     alitretinoin",
"    </a>",
"    , may also be effective for PRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The response to retinoid therapy is usually evident within three to six months, although longer courses of treatment are necessary in some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/42\">",
"     42",
"    </a>",
"    ]. Examples of reports documenting treatment efficacy include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an early prospective study in which 45 patients with PRP were treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"       isotretinoin",
"      </a>",
"      (mean dose 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day), 28 of 45 patients (62 percent) were noted by physician evaluators to have marked improvement within four weeks, and all 34 patients who returned for physician evaluation after 12 to 16 weeks of treatment had marked improvement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among 15 patients treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"       isotretinoin",
"      </a>",
"      (primarily 40 mg twice daily) in a retrospective study of adolescents and adults with PRP, 10 patients (67 percent) achieved complete clearance within an average of 25 weeks (range 16 to 44 weeks), two achieved partial clearing after 16 and 24 weeks, and three patients failed to respond after 20 to 24 weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective review of 18 patients with PRP, among 15 patients who were treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"       isotretinoin",
"      </a>",
"      (0.5 to 2.2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day), 7 (47 percent) achieved complete clearance (most within seven months), three (20 percent) achieved partial clearance, and five (33 percent) failed to respond to therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/44\">",
"       44",
"      </a>",
"      ]. The average dose of isotretinoin for patients who achieved complete clearance was 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day.",
"     </li>",
"     <li>",
"      In a retrospective study of 30 adolescents and children with PRP who were under the age of 20 years, five of six patients with type III PRP who were treated with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"       isotretinoin",
"      </a>",
"      (0.75 to 1.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) achieved 90 to 100 percent disease clearance within six months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7\">",
"       7",
"      </a>",
"      ]. In contrast, only one of six patients treated with vitamin A (&gt;100,000 U per day) had excellent improvement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In clinical practice, typical retinoid doses used for adults with PRP are",
"    <strong>",
"     1",
"     <span class=\"nowrap\">",
"      mg/kg",
"     </span>",
"     per day of",
"    </strong>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    and",
"    <strong>",
"     0.5",
"     <span class=\"nowrap\">",
"      mg/kg",
"     </span>",
"     per day of",
"    </strong>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    . The appropriate dose regimen for systemic retinoids for PRP is less established in children.",
"   </p>",
"   <p>",
"    Adverse effects of retinoid therapy include dry skin and mucous membranes, hyperlipidemia, transaminase elevations, and visual or bone changes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/54\">",
"     54",
"    </a>",
"    ]. Premature epiphyseal closure is a rare side effect of retinoid therapy that may occur in children, particularly in children treated with high doses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/55\">",
"     55",
"    </a>",
"    ]. Retinoids are teratogenic and must not be used by women who are pregnant or who are at risk of becoming pregnant but decline strict use of reliable contraceptives (two complementary forms of contraception including a barrier method) to prevent pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/42/22184?source=see_link&amp;anchor=H7#H7\">",
"     \"Oral isotretinoin therapy for acne vulgaris\", section on 'Isotretinoin safety'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because alcohol ingestion may stimulate the in vivo conversion of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    to etretinate (a retinoid with an exceptionally long elimination half-life), pregnancy must be avoided during and for three years after treatment with acitretin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/56\">",
"     56",
"    </a>",
"    ]. Thus, treatment with acitretin is not recommended in women of childbearing potential [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/57\">",
"     57",
"    </a>",
"    ]. Pregnancy must be avoided during and for six weeks after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/58\">",
"     58",
"    </a>",
"    ]. Participation in the iPLEDGE program (",
"    <a class=\"external\" href=\"file://www.ipledgeprogram.com/\">",
"     www.ipledgeprogram.com",
"    </a>",
"    ), which is required for prescribing isotretinoin in the United States, requires that females treated with isotretinoin continue use of two forms of contraception until one month after the last isotretinoin dose.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352372\">",
"    <span class=\"h3\">",
"     Second-line systemic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    (5 to 25 mg per week) can be used as next-line treatment for patients who fail systemic retinoids or who have comorbidities or other characteristics that prohibit the use of systemic retinoid therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/47,54,59\">",
"     47,54,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352268\">",
"    <span class=\"h4\">",
"     Methotrexate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small retrospective studies have supported the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    in PRP. Although one author&rsquo;s 1980 review of personal clinical experience and published cases identified a response to methotrexate in only 17 of 44 patients (39 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"     3",
"    </a>",
"    ], other studies have found more favorable results. Among eight patients with type I PRP treated with 10 to 25 mg per week of methotrexate in a retrospective study, all achieved favorable responses within several months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/42\">",
"     42",
"    </a>",
"    ]. The average duration of treatment was six months (range 1 to 12 months). In another retrospective study, all five adults with PRP improved with methotrexate, including two who had previously failed to respond to retinoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/47\">",
"     47",
"    </a>",
"    ]. The average duration of treatment was 12 months.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    has also been used in combination with systemic retinoids in difficult cases. In a retrospective study that included six patients who were given combination therapy with a retinoid and methotrexate (5 to 30 mg per week) because of severe disease and five patients for whom methotrexate was added to a systemic retinoid due to a failure to respond to the retinoid alone, 8 of 11 patients achieved at least 50 percent improvement, and four patients achieved greater than 95 percent improvement by 16 weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/45\">",
"     45",
"    </a>",
"    ]. Although treatment appeared to be well-tolerated, increased risk for hepatoxicity is a concern with combination therapy.",
"   </p>",
"   <p>",
"    Gastrointestinal distress is a common adverse effect of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    . Additional serious adverse effects include pancytopenia, hepatotoxicity, and pneumonitis. Methotrexate is teratogenic and should not be given in pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/61/11223?source=see_link\">",
"     \"Major side effects of low-dose methotrexate\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352387\">",
"    <span class=\"h3\">",
"     Additional therapies",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352330\">",
"    <span class=\"h4\">",
"     Biologic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biologic therapies have been used as treatments for PRP (adult- or juvenile-onset) in case series and case reports. In the majority of cases, biologic TNF-alpha inhibitors (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/60-63\">",
"     60-63",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/6-54,56,57,59,60,64-69\">",
"     6-54,56,57,59,60,64-69",
"    </a>",
"    ], or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/24/39303?source=see_link\">",
"     adalimumab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/4,69-72\">",
"     4,69-72",
"    </a>",
"    ]) were used after failure of preceding treatments, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    . In addition, most patients received short-term treatment, given in combination with acitretin or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    . In our practice, a 27-year-old woman with a 14-year history of type III PRP that had been refractory to systemic retinoids and narrowband UVB phototherapy appeared to benefit from long-term anti-TNF-alpha monotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/25\">",
"     25",
"    </a>",
"    ]. The patient responded to periodic infusions of infliximab (5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    every seven weeks after induction), achieving 80 percent clearance after 2.5 years. Treatment was well-tolerated.",
"   </p>",
"   <p>",
"    A systematic review of type I PRP reported 15 patients treated with biologic anti-TNF agents, of whom 12 (80 percent) responded completely to treatment, two responded partially, and one failed to respond. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/69\">",
"     69",
"    </a>",
"    ]. Six patients received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/24/39303?source=see_link\">",
"     adalimumab",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    as monotherapy and the remainder were simultaneously treated with other agents (primarily",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/1/39958?source=see_link\">",
"     acitretin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ). The mean time for an initial response to treatment among partial or complete responders was five weeks, and among patients who experienced a complete response, a mean of five months was required to reach maximal improvement. However, since 80 percent of type I PRP patients achieve spontaneous remission within three years, the absence of controlled trials makes it difficult to evaluate the efficacy of anti-TNF treatment in type I PRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another biologic agent,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/46/742?source=see_link\">",
"     ustekinumab",
"    </a>",
"    , a human monoclonal antibody that targets IL-12 and IL-23, was reported to improve type I PRP in two patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. However, there is no evidence that IL-12 and IL-23 are involved in the pathogenesis of PRP and sufficient data to confirm the efficacy of this therapy are lacking. Thus, we cannot recommend the routine use of ustekinumab for PRP. Some authors have suggested reserving its use for patients who fail to respond with conventional systemic therapies or anti-TNF-alpha biologic agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reactivation or exacerbations of infections are potential side effects of biologic TNF-alpha inhibitors and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/46/742?source=see_link\">",
"     ustekinumab",
"    </a>",
"    . Thus, pretreatment laboratory investigations for these agents include screening for hepatitis B and hepatitis C, as well as screening for tuberculosis using a purified protein derivative (PPD) skin test or interferon-gamma release assay and a chest radiograph if indicated (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    ). Testing for human immunodeficiency virus infection should also be considered.",
"   </p>",
"   <p>",
"    The adverse effects of biologic therapies are reviewed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/55/40825?source=see_link\">",
"     \"Tumor necrosis factor-alpha inhibitors: An overview of adverse effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/6/40042?source=see_link&amp;anchor=H42#H42\">",
"     \"Treatment of psoriasis\", section on 'Ustekinumab'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H563751\">",
"    <span class=\"h4\">",
"     Phototherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although a few case reports document photoexacerbation of PRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/14,76-78\">",
"     14,76-78",
"    </a>",
"    ], phototherapy may be useful in some patients. PUVA therapy has yielded variable results in case reports and a small case series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/77,79,80\">",
"     77,79,80",
"    </a>",
"    ], and successful treatment with narrowband UVB has been reported in at least two patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. In a retrospective study, the Goeckerman treatment regimen, which combines topical tar and UVB phototherapy, was associated with a good response in one of eight children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7\">",
"     7",
"    </a>",
"    ]; however, this treatment failed to result in clinically significant improvement in any of 17 patients in a separate retrospective series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The combination of retinoids and phototherapy may be effective.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/1/39958?source=see_link\">",
"     Acitretin",
"    </a>",
"    combined with narrowband UVB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/83,84\">",
"     83,84",
"    </a>",
"    ], UVA1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/85\">",
"     85",
"    </a>",
"    ], or PUVA (Re-PUVA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/31,86,87\">",
"     31,86,87",
"    </a>",
"    ] has been reported as beneficial in small numbers of patients.",
"   </p>",
"   <p>",
"    Due to the possibility of photoexacerbation of PRP, performing phototesting prior to the initiation of treatment is suggested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20,88\">",
"     20,88",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1140890749\">",
"    <span class=\"h4\">",
"     Immunosuppressants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunosuppressants, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/89-91\">",
"     89-91",
"    </a>",
"    ] and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3,92,93\">",
"     3,92,93",
"    </a>",
"    ], have been reported to be effective for PRP in case reports. However, cyclosporine (6",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day for six to eight weeks) was associated with minimal clinical improvement in a series of three adults with PRP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/94\">",
"     94",
"    </a>",
"    ]. The limited data to support the efficacy of these agents and concerns regarding the potential for severe adverse effects limit the use of these agents. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=see_link\">",
"     \"Pharmacology and side effects of cyclosporine and tacrolimus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/63/10232?source=see_link&amp;anchor=H7#H7\">",
"     \"Pharmacology and side effects of azathioprine when used in rheumatic diseases\", section on 'Adverse effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H427352338\">",
"    <span class=\"h4\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Additional therapies that have been reported to be effective in individual patients with PRP include fumaric acid esters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/95\">",
"     95",
"    </a>",
"    ], penicillin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/96,97\">",
"     96,97",
"    </a>",
"    ], extracorporeal photochemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/98\">",
"     98",
"    </a>",
"    ], and intravenous immunoglobulin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/30/43497/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6825039\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis of PRP is dependent upon the clinical subtype. (See",
"    <a class=\"local\" href=\"#H6824948\">",
"     'Clinical manifestations'",
"    </a>",
"    above.).",
"   </p>",
"   <p>",
"    Recurrence of PRP after treatment cessation is unpredictable. Patients may remain in remission or may experience disease recurrence after the discontinuation of systemic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1140890684\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pityriasis rubra pilaris (PRP) is a rare papulosquamous inflammatory dermatosis. The cardinal clinical features of PRP include follicular hyperkeratosis, palmoplantar hyperkeratosis, and orange-red scaling plaques.",
"     </li>",
"     <li>",
"      PRP is classified into six clinical types (I-VI) according to age at onset, clinical presentation, and expected prognosis (",
"      <a class=\"graphic graphic_table graphicRef87505 \" href=\"mobipreview.htm?6/16/6412\">",
"       table 1",
"      </a>",
"      ). PRP occurs in both adults and children. (See",
"      <a class=\"local\" href=\"#H6824934\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Classical PRP is the most common form of PRP. It is divided into adult-onset (type I) and juvenile onset (type III) forms, with similar clinical characteristics (",
"      <a class=\"graphic graphic_picture graphicRef86471 graphicRef86473 graphicRef86472 graphicRef86475 graphicRef86474 graphicRef86476 graphicRef87152 graphicRef87153 graphicRef87154 \" href=\"mobipreview.htm?0/9/152\">",
"       picture 1A-F, 2A-C",
"      </a>",
"      ). Other types are atypical adult (type II) PRP, circumscribed juvenile (type IV), atypical juvenile (type V), and HIV-associated (type VI) PRP.",
"     </li>",
"     <li>",
"      The most common clinical subtype of PRP, type I (classic adult) PRP, occurs in adults and is characterized by follicular hyperkeratosis, orange-red inflammatory plaques, and palmoplantar hyperkeratosis. Well-demarcated areas of uninvolved skin (&ldquo;islands of sparing&rdquo;) are a common finding. Erythroderma may occur. (See",
"      <a class=\"local\" href=\"#H6824948\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common forms of PRP in children are type III (classic juvenile) and type IV (circumscribed juvenile). The clinical features of type III PRP are identical to type I PRP. Type IV PRP is a unique form that presents with sharply demarcated erythematous plaques with prominent follicular hyperkeratosis. The elbows and knees are common sites of involvement. (See",
"      <a class=\"local\" href=\"#H6824948\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PRP occurs in association with HIV infection (type VI PRP). Widespread hyperkeratotic and erythematous follicular papules are typically present. Erythroderma is a frequent complication. (See",
"      <a class=\"local\" href=\"#H427351863\">",
"       'Type VI (HIV-associated)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of PRP is made based upon the clinical and pathological findings. The differential diagnosis includes psoriasis, drug eruptions, cutaneous T cell lymphoma, keratosis pilaris, and ichthyosis. (See",
"      <a class=\"local\" href=\"#H6824990\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Data are limited on the treatments for PRP. Patients with limited disease (eg, type IV PRP) may be managed with topical therapy. For adults and children with more extensive PRP, we suggest treatment with a systemic retinoid such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"       isotretinoin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/1/39958?source=see_link\">",
"       acitretin",
"      </a>",
"      as initial therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Due to the need to abstain from pregnancy for three years after treatment with acitretin, use of acitretin is not recommended in women of reproductive potential.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       Methotrexate",
"      </a>",
"      is an alternative treatment option for patients with PRP. (See",
"      <a class=\"local\" href=\"#H6824997\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      TNF-alpha inhibitors,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      may be effective for patients who fail to respond to retinoids and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H427352387\">",
"       'Additional therapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/1\">",
"      Devergie MGA. Pityriasis pilaris, maladie de peau non decrite par les dermatologists. Gazette Hebdomadaire de medicine et de chirurgie 1856; 3:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/2\">",
"      Besnier E. Observations pour servir a l&rsquo;histoire Clinique du pityriasis rubra pilaire. Ann Derm Syph Ser 1889; 10:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/3\">",
"      Griffiths WA. Pityriasis rubra pilaris. Clin Exp Dermatol 1980; 5:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/4\">",
"      Zhang YH, Zhou Y, Ball N, et al. Type I pityriasis rubra pilaris: upregulation of tumor necrosis factor alpha and response to adalimumab therapy. J Cutan Med Surg 2010; 14:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/5\">",
"      Finzi AF, Altomare G, Bergamaschini L, Tucci A. Pityriasis rubra pilaris and and retinol-binding protein. Br J Dermatol 1981; 104:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/6\">",
"      Stoll DM, King LE Jr, Chytil F. Serum levels of retinol binding protein in patients with pityriasis rubra pilaris. Br J Dermatol 1983; 108:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/7\">",
"      Allison DS, El-Azhary RA, Calobrisi SD, Dicken CH. Pityriasis rubra pilaris in children. J Am Acad Dermatol 2002; 47:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/8\">",
"      Kawara S, Miyake M, Oiso N, Kawada A. Pityriasis rubra pilaris with preceding cytomegalovirus infection. Dermatology 2009; 219:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/9\">",
"      Blasdale C, Turner RJ, Leonard N, et al. Spontaneous clinical improvement in HIV-associated follicular syndrome. Clin Exp Dermatol 2004; 29:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/10\">",
"      Fuchs-Telem D, Sarig O, van Steensel MA, et al. Familial pityriasis rubra pilaris is caused by mutations in CARD14. Am J Hum Genet 2012; 91:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/11\">",
"      Vanderhooft SL, Francis JS, Holbrook KA, et al. Familial pityriasis rubra pilaris. Arch Dermatol 1995; 131:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/12\">",
"      Vasher M, Smithberger E, Lien MH, Fenske NA. Familial pityriasis rubra pilaris: report of a family and therapeutic response to etanercept. J Drugs Dermatol 2010; 9:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/13\">",
"      Yang CC, Shih IH, Lin WL, et al. Juvenile pityriasis rubra pilaris: report of 28 cases in Taiwan. J Am Acad Dermatol 2008; 59:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/14\">",
"      Evangelou G, Murdoch SR, Palamaras I, Rhodes LE. Photoaggravated pityriasis rubra pilaris. Photodermatol Photoimmunol Photomed 2005; 21:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/15\">",
"      Iredale HE, Meggitt SJ. Photosensitive pityriasis rubra pilaris. Clin Exp Dermatol 2006; 31:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/16\">",
"      Davidson CL Jr, Winkelmann RK, Kierland RR. Pityriasis rubra pilaris. A follow-up study of 57 patients. Arch Dermatol 1969; 100:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/17\">",
"      Paz C, Querfeld C, Shea CR. Sorafenib-induced eruption resembling pityriasis rubra pilaris. J Am Acad Dermatol 2011; 65:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/18\">",
"      Griffiths WA, Ozluer S. [Pityriasis rubra pilaris]. Ann Dermatol Venereol 2001; 128:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/19\">",
"      Miralles ES, N&uacute;&ntilde;ez M, De Las Heras ME, et al. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol 1995; 133:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/20\">",
"      Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol 2010; 11:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/21\">",
"      Fiallo P, Tagliapietra AG, Santoro G. Arthropathic pityriasis rubra pilaris. Br J Dermatol 1996; 134:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/22\">",
"      Conaghan PG, Sommer S, McGonagle D, et al. The relationship between pityriasis rubra pilaris and inflammatory arthritis: case report and response of the arthritis to anti-tumor necrosis factor immunotherapy. Arthritis Rheum 1999; 42:1998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/23\">",
"      Lister RK, Perry JD, Cerio R. Pityriasis rubra pilaris and a seronegative polyarthritis. Br J Dermatol 1997; 137:318.",
"     </a>",
"    </li>",
"    <li>",
"     Wood GS, Reizner GT. Other papulosquamous disorders. In: Dermatology, 3rd ed, Bolognia JL, Jorizzo JL, Schaffer JV.  (Eds), Elsevier, 2012. Vol 1, p.157.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/25\">",
"      Dessinioti C, Vergou T, Moustou E, et al. Long-term infliximab treatment for refractory type III juvenile pityriasis rubra pilaris. Eur J Dermatol 2011; 21:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/26\">",
"      De D, Dogra S, Narang T, et al. Pityriasis rubra pilaris in a HIV-positive patient (Type 6 PRP). Skinmed 2008; 7:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/27\">",
"      Gonz&aacute;lez-L&oacute;pez A, Velasco E, Pozo T, Del Villar A. HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy. Br J Dermatol 1999; 140:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/28\">",
"      Martin AG, Weaver CC, Cockerell CJ, Berger TG. Pityriasis rubra pilaris in the setting of HIV infection: clinical behaviour and association with explosive cystic acne. Br J Dermatol 1992; 126:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/29\">",
"      Martinez Calixto LE, Suresh L, Matsumura E, et al. Oral pityriasis rubra pilaris. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/30\">",
"      Paranjothy B, Shunmugam M, MacKenzie J, Azuara-Blanco A. Peripheral ulcerative keratitis in pityriasis rubra pilaris. Eye (Lond) 2007; 21:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/31\">",
"      Gemmeke A, Sch&ouml;nlebe J, Koch A, Wollina U. Pityriasis rubra pilaris--a retrospective single center analysis over eight years. J Dtsch Dermatol Ges 2010; 8:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/32\">",
"      Kitzmann AS, Goins KM, Syed NA, Wagoner MD. Bilateral herpes simplex keratitis with unilateral secondary bacterial keratitis and corneal perforation in a patient with pityriasis rubra pilaris. Cornea 2008; 27:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/33\">",
"      Sehgal VN, Srivastava G. (Juvenile) Pityriasis rubra pilaris. Int J Dermatol 2006; 45:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/34\">",
"      Garretson CB, Machan ML, Krejci-Manwaring J, et al. Letter: Adenocarcinoma of the lung associated with pityriasis rubra pilaris. Dermatol Online J 2011; 17:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/35\">",
"      Kurzydlo AM, Gillespie R. Paraneoplastic pityriasis rubra pilaris in association with bronchogenic carcinoma. Australas J Dermatol 2004; 45:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/36\">",
"      Batinac T, Kujundzi�� M, Peternel S, et al. Pityriasis rubra pilaris in association with laryngeal carcinoma. Clin Exp Dermatol 2009; 34:e917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/37\">",
"      S&aacute;nchez-Rega&ntilde;a M, L&oacute;pez-Gil F, Salleras M, Umbert P. Pityriasis rubra pilaris as the initial manifestation of internal neoplasia. Clin Exp Dermatol 1995; 20:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/38\">",
"      Batchelor RJ, Yung A, Merchant W, Goodfield MJ. Pityriasis rubra pilaris as the initial presentation of renal cell carcinoma? Clin Exp Dermatol 2005; 30:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/39\">",
"      Sharma S, Weiss GR, Paulger B. Pityriasis rubra pilaris as an initial presentation of hepatocellular carcinoma. Dermatology 1997; 194:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/40\">",
"      Reinhardt LA, Rosen T. Pityriasis rubra pilaris as the initial manifestation of leukemia. Cutis 1983; 31:100.",
"     </a>",
"    </li>",
"    <li>",
"     Weedon D. The psoriasiform reaction pattern. In: Weedon's Skin Pathology, 3rd ed, Elsevier Limited, 2010. p.71.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/42\">",
"      Dicken CH. Treatment of classic pityriasis rubra pilaris. J Am Acad Dermatol 1994; 31:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/43\">",
"      Goldsmith LA, Weinrich AE, Shupack J. Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin). J Am Acad Dermatol 1982; 6:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/44\">",
"      Borok M, Lowe NJ. Pityriasis rubra pilaris. Further observations of systemic retinoid therapy. J Am Acad Dermatol 1990; 22:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/45\">",
"      Clayton BD, Jorizzo JL, Hitchcock MG, et al. Adult pityriasis rubra pilaris: a 10-year case series. J Am Acad Dermatol 1997; 36:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/46\">",
"      Cohen PR, Prystowsky JH. Pityriasis rubra pilaris: a review of diagnosis and treatment. J Am Acad Dermatol 1989; 20:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/47\">",
"      Chapalain V, Beylot-Barry M, Doutre MS, et al. Treatment of pityriasis rubra pilaris: a retrospective study of 14 patients. J Dermatolog Treat 1999; 10:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/48\">",
"      Selvaag E, Haedersdal M, Thomsen K. Pityriasis rubra pilaris: a retrospective study of 12 patients. J Eur Acad Dermatol Venereol 2000; 14:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/49\">",
"      Van de Kerkhof PC, Steijlen PM. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol 1994; 130:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/50\">",
"      Caldarola G, Zampetti A, De Simone C, et al. Circumscribed pityriasis rubra pilaris type IV. Clin Exp Dermatol 2007; 32:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/51\">",
"      Karimian-Teherani D, Parissa M, Tanew A. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment. Pediatr Dermatol 2008; 25:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/52\">",
"      Molin S, Ruzicka T. Treatment of refractory pityriasis rubra pilaris with oral alitretinoin: case report. Br J Dermatol 2010; 163:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/53\">",
"      Schmitt L, Inhoff O, Dippel E. Oral alitretinoin for the treatment of recalcitrant pityriasis rubra pilaris. Case Rep Dermatol 2011; 3:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/54\">",
"      van Dooren-Greebe RJ, van de Kerkhof PC. Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris. J Am Acad Dermatol 1995; 32:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/55\">",
"      DiGiovanna JJ. Isotretinoin effects on bone. J Am Acad Dermatol 2001; 45:S176.",
"     </a>",
"    </li>",
"    <li>",
"     Patton TJ, Zirwas MJ, Wolverton SE. Systemic retinoids. In: Comprehensive Dermatologic Drug Therapy, 2nd ed, Wolverton SE (Ed), Elsevier, 2007. p.275.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/57\">",
"      Ormerod AD, Campalani E, Goodfield MJ, BAD Clinical Standards Unit. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol 2010; 162:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/58\">",
"      Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/59\">",
"      Durairaj VD, Horsley MB. Resolution of pityriasis rubra pilaris-induced cicatricial ectropion with systemic low-dose methotrexate. Am J Ophthalmol 2007; 143:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/60\">",
"      Garcovich S, Di Giampetruzzi AR, Antonelli G, et al. Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series. J Eur Acad Dermatol Venereol 2010; 24:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/61\">",
"      Davis KF, Wu JJ, Murase JE, et al. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy. Arch Dermatol 2007; 143:1597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/62\">",
"      Seckin D, Tula E, Ergun T. Successful use of etanercept in type I pityriasis rubra pilaris. Br J Dermatol 2008; 158:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/63\">",
"      Cox V, Lesesky EB, Garcia BD, O'Grady TC. Treatment of juvenile pityriasis rubra pilaris with etanercept. J Am Acad Dermatol 2008; 59:S113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/64\">",
"      Albert MR, Mackool BT. Pityriasis rubra pilaris. Int J Dermatol 1999; 38:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/65\">",
"      Gelmetti C, Schiuma AA, Cerri D, Gianotti F. Pityriasis rubra pilaris in childhood: a long-term study of 29 cases. Pediatr Dermatol 1986; 3:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/66\">",
"      Meier S. Development of the chick embryo mesoblast: pronephros, lateral plate, and early vasculature. J Embryol Exp Morphol 1980; 55:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/67\">",
"      Manoharan S, White S, Gumparthy K. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab. Australas J Dermatol 2006; 47:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/68\">",
"      Ruiz-Genao DP, Lopez-Estebaranz JL, Naz-Villalba E, et al. Pityriasis rubra pilaris successfully treated with infliximab. Acta Derm Venereol 2007; 87:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/69\">",
"      Petrof G, Almaani N, Archer CB, et al. A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists. J Eur Acad Dermatol Venereol 2013; 27:e131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/70\">",
"      Walling HW, Swick BL. Pityriasis rubra pilaris responding rapidly to adalimumab. Arch Dermatol 2009; 145:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/71\">",
"      Schreml S, Zeller V, Babilas P, et al. Pityriasis rubra pilaris successfully treated with adalimumab. Clin Exp Dermatol 2010; 35:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/72\">",
"      O'Kane D, Devereux CE, Walsh MY, Hoey SE. Rapid and sustained remission of pityriasis rubra pilaris with adalimumab treatment. Clin Exp Dermatol 2010; 35:e155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/73\">",
"      Wohlrab J, Kreft B. Treatment of pityriasis rubra pilaris with ustekinumab. Br J Dermatol 2010; 163:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/74\">",
"      Ruiz Villaverde R, S&aacute;nchez Cano D. Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy. Eur J Dermatol 2010; 20:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/75\">",
"      Balestri R, Bardazzi F, Antonucci A. Should ustekinumab really be used as first-line biological therapy in pityriasis rubra pilaris? Br J Dermatol 2010; 163:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/76\">",
"      Yaniv R, Barzilai A, Trau H. Pityriasis rubra pilaris exacerbated by ultraviolet B phototherapy. Dermatology 1994; 189:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/77\">",
"      Kaskel P, Grundmann-Kollmann M, Schiller PI, et al. Bath-PUVA as a treatment for Pityriasis rubra pilaris provoked by ultraviolet B. Br J Dermatol 1999; 140:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/78\">",
"      Marguery MC, Durand-Malgouyres C, Bayle-Lebey P, et al. Photosensitive and phototriggered pityriasis rubra pilaris. Photodermatol Photoimmunol Photomed 1994; 10:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/79\">",
"      Mainardi L, Caccialanza M, Piccinno R. [Efficacy of photochemotherapy in a case of pityriasis rubra pilaris]. G Ital Dermatol Venereol 1990; 125:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/80\">",
"      Lynch WS, Martin JS, Roenigk HH Jr. Clinical results of photochemotherapy. The Cleveland Clinic experience. Cutis 1977; 20:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/81\">",
"      Vergilis-Kalner IJ, Mann DJ, Wasserman J, et al. Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy. J Drugs Dermatol 2009; 8:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/82\">",
"      Betto P, Vassilopoulou A, Colombari R, Veller-Fornasa C. Acute juvenile pityriasis rubra pilaris: a case report after mononucleosis infection. G Ital Dermatol Venereol 2008; 143:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/83\">",
"      Kirby B, Watson R. Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01). Br J Dermatol 2000; 142:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/84\">",
"      Booth AV, Ma L. Pityriasis rubra pilaris, type 1. Dermatol Online J 2005; 11:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/85\">",
"      Herbst RA, Vogelbruch M, Ehnis A, et al. Combined ultraviolet A1 radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris. Br J Dermatol 2000; 142:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/86\">",
"      Klein A, Szeimies RM, Landthaler M, Karrer S. Exacerbation of pityriasis rubra pilaris under efalizumab therapy. Dermatology 2007; 215:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/87\">",
"      Neess CM, Hinrichs R, Dissemond J, et al. Treatment of pruritus by capsaicin in a patient with pityriasis rubra pilaris receiving RE-PUVA therapy. Clin Exp Dermatol 2000; 25:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/88\">",
"      Kaskel P, Peter RU, Kerscher M. Phototesting and phototherapy in pityriasis rubra pilaris. Br J Dermatol 2001; 144:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/89\">",
"      Wetzig T, Sticherling M. Juvenile pityriasis rubra pilaris: successful treatment with ciclosporin. Br J Dermatol 2003; 149:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/90\">",
"      Usuki K, Sekiyama M, Shimada T, et al. Three cases of pityriasis rubra pilaris successfully treated with cyclosporin A. Dermatology 2000; 200:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/91\">",
"      Rosenbach A, Lowe NJ. Pityriasis rubra pilaris and cyclosporine. Arch Dermatol 1993; 129:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/92\">",
"      Hunter GA, Forbes IJ. Treatment of pityriasis rubra pilaris with azathioprine. Br J Dermatol 1972; 87:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/93\">",
"      Schram ME, Borgonjen RJ, Bik CM, et al. Off-label use of azathioprine in dermatology: a systematic review. Arch Dermatol 2011; 147:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/94\">",
"      Gupta AK, Ellis CN, Nickoloff BJ, et al. Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. Arch Dermatol 1990; 126:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/95\">",
"      Coras B, Vogt TH, Ulrich H, et al. Fumaric acid esters therapy: a new treatment modality in pityriasis rubra pilaris? Br J Dermatol 2005; 152:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/96\">",
"      Popova L, Darlenski R, Tsankov N. Penicillin and vitamin A as possible therapeutic agents in pityriasis rubra pilaris. J Dtsch Dermatol Ges 2010; 8:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/97\">",
"      Ahn SY, Kim JH, Ahn SK, Oh YS. Clinical improvement of pityriasis rubra pilaris with antibiotic therapy. Eur J Dermatol 2011; 21:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/98\">",
"      Hofer A, M&uuml;llegger R, Kerl H, Wolf P. Extracorporeal photochemotherapy for the treatment of erythrodermic pityriasis rubra pilaris. Arch Dermatol 1999; 135:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/30/43497/abstract/99\">",
"      Kerr AC, Ferguson J. Type II adult-onset pityriasis rubra pilaris successfully treated with intravenous immunoglobulin. Br J Dermatol 2007; 156:1055.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15283 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-125.39.66.147-2DA2A50332-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43497=[""].join("\n");
var outline_f42_30_43497=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1140890684\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6824927\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H187071461\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6824934\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6824941\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6824948\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427351550\">",
"      Type I (classic adult)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427351778\">",
"      Type II (atypical adult)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427351705\">",
"      Type III (classic juvenile)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427351790\">",
"      Type IV (circumscribed juvenile)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427351843\">",
"      Type V (atypical juvenile)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427351863\">",
"      Type VI (HIV-associated)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H567847\">",
"      Mucosal involvement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H351320360\">",
"      ASSOCIATED DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6824990\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427352175\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H427352191\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6824997\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427352246\">",
"      Approach to therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H562911\">",
"      Topical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H427352231\">",
"      Systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H427352357\">",
"      - First-line systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H427352254\">",
"      Systemic retinoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H427352372\">",
"      - Second-line systemic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H427352268\">",
"      Methotrexate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H427352387\">",
"      - Additional therapies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H427352330\">",
"      Biologic agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H563751\">",
"      Phototherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1140890749\">",
"      Immunosuppressants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H427352338\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6825039\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1140890684\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/15283\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15283|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/17/17684\" title=\"picture 1A\">",
"      Pityriasis rubra pilaris with islands of sparing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/19/18743\" title=\"picture 1B\">",
"      Pityriasis rubra pilaris islands of sparing close view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/61/13270\" title=\"picture 1C\">",
"      Pityriasis rubra pilaris follicular papules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/19/31032\" title=\"picture 1D\">",
"      Pityriasis rubra pilaris follicular papules in dark skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?40/19/41269\" title=\"picture 1E\">",
"      Pityriasis rubra pilaris plantar hyperkeratosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/21/30039\" title=\"picture 1F\">",
"      Pityriasis rubra pilaris face and scalp involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/47/26354\" title=\"picture 2A\">",
"      Classic juvenile pityriasis rubra pilaris",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/42/2724\" title=\"picture 2B\">",
"      Classic juvenile pityriasis rubra pilaris - Legs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/4/43075\" title=\"picture 2C\">",
"      Classic juvenile pityriasis rubra pilaris - Back",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/7/15474\" title=\"picture 3A\">",
"      Nail psoriasis pits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/51/33585\" title=\"picture 3B\">",
"      Nail psoriasis oil drop",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/55/7030\" title=\"picture 4\">",
"      Lichen spinulosus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/26/18854\" title=\"picture 5A\">",
"      Keratosis pilaris dark skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/3/26672\" title=\"picture 5B\">",
"      Keratosis pilaris fair skin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15283|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/16/6412\" title=\"table 1\">",
"      Classification of pityriasis rubra pilaris",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/56/39809\" title=\"table 2\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/61/11223?source=related_link\">",
"      Major side effects of low-dose methotrexate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/42/22184?source=related_link\">",
"      Oral isotretinoin therapy for acne vulgaris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/14/21736?source=related_link\">",
"      Overview of vitamin A",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/63/10232?source=related_link\">",
"      Pharmacology and side effects of azathioprine when used in rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/27/28090?source=related_link\">",
"      Pharmacology and side effects of cyclosporine and tacrolimus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18426?source=related_link\">",
"      Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24586?source=related_link\">",
"      The genodermatoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/6/40042?source=related_link\">",
"      Treatment of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/55/40825?source=related_link\">",
"      Tumor necrosis factor-alpha inhibitors: An overview of adverse effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_30_43498="Birth center consent 1";
var content_f42_30_43498=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72798%7EOBGYN%2F53826%7EOBGYN%2F65561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72798%7EOBGYN%2F53826%7EOBGYN%2F65561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 623px\">",
"   <div class=\"ttl\">",
"    Birth center consent form",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 603px; height: 749px; background-image: url(data:image/gif;base64,R0lGODlhWwLtAtUAAP///8DAwEBAQICAgAAAAODg4PDw8KCgoNDQ0DAwMGBgYHBwcCAgILCwsJCQkFBQUBAQEN/f3+/v78/Pz8vLy+fn5/f39+vr6+Pj49PT0/Pz8/v7+9fX19vb28fHx8PDw2RkZL+/v5eXl3d3d1dXV2tra7i4uGhoaFtbW4+Pj5OTk0tLS0dHRwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAABbAu0CAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb5pCAEBZgcDB2MNAwMNbgHKSgXCBr/U1YcDEATaBAkFYwIEAk8B29tM4NribQPaSA0M5QLebwsCC9b4+Ujs4QML8MPEgFPXBIEAeNwIIkGgTUEAZuvaGTmwLQG6gG4G6tu4MVsCIg4QADhQT4AAB9MAFFCGYIAABd4cCHggEoCzAQUUvEypUcgB/50nk/ALuBKnzAfDcjbECcCAzJcYix0wcOCY1AAPBBxDoHMAkZ8mHRDh+vKBRCIGskEgitRn1gfHhBQtcBRjgZIK4o4EKtanMbIDph2Ax0DZPI6Ie20bgFEIuopCyBHIpo1Bgm0MhPCjzM1xOCEKyn0+MjSyNs4EookOUADhtnsAwDGAJw4carPb4oaOJ6SB6LNDfBOAXeSxto82T5fzFgA1AdCi1dkupyD26sTYd+3e1hZAA5EGSktGupu8tmH8RJbWSJHAsPYQi5ROTgApv8AOtDkIYCA0BJG7eWPbAsZYB8EBDaiFYDbitPeeNswQ5s0CwGl23kTaWJUhffZp4/+VWQlMw9VIF8Jn4AEBIAQAApclIE12MN5iAIWiQZTMA5e5R98wkvF4IT9CGOChdeKYVZgyQxoxX49CDMkkANnAJiQBYvXkmXSjaWSkMvcxREBcQMp3YREgDnHZAzs2ScCHxy0Q15ZIrkmkhc/NGeOduDiD0AMG5GjZhUwG+uNZQ2pk3GKkjfmkk2MmCUCho10p6ZyHevhkmF/pZ4SVGi0qJwKudVapnD2FaSWeqL6yQEpNpZMfASIJqqOs6ElUwIYahZYZE0s2KueT8FSnEq6R2tlTrgTsOtaGAGA6xK3JshqSrkMEm+ajcjLn0nnUbjqaqcWmKq4qyS4gDG4HvIr/Im4+zgrooO41cBkE03SqzQMNBHCAAI2ptC0BCnjlqcBj8rPfvPUWe2yWn42X777DENaAvBUKQSMEBF4mTEMB7NZuQIUqkC+NqtX3ML92ggvBxIeN6zIpoQ5ZAGc5fpwmk/yUE1dP7ZXTr2TlXMuojk3hdhpEpy6MpTo9bzOMcMdVbLFo/zUrmldCk3q1T78NU6pEUBP98tiiIOCAMgcc5tQACBjwotv8NfX2i+kZNkQwNTVVjDEtBynM38PAnZIw3gg+Ftqs4j1WADUpviLjQ1CF9mFzRdMvEQXs3RhdAzig9os2sRaZMp6jtXfaQjhu+d2ks0r26744C/vstG8k/3vtuOeu++689+7778AHL/zwxBdv/PHIJ6/88sw37/zz0Ecv/fTUV2/99dhnr/323Hfv/ffghy/++OSXb/756Kev/vqjc4n2SBjp6xeXeg3hPlFcvsdlTe5zWcBKRGCKEe4SFm/s7X3Nwhr8buI+qzTQX4hjnwQHcZODvE8ACnSJYzCIQCIAzB8Q8MpKAOY1DC4AYwlkR8BwQg4PXo4ijGlAVmLDwQI96kCOYYwyLFggk9AvOTuEQN8mSEQ+aHAIGLSfdBR4BKId8VEBSaJ36tSk+FERikVIS19SFxsmNmkAu5JisxQiRtOYyYtFTCMenthFJeZQCToygFaGQDQpJv/IhUNoIR37dQAIHKGMVUSZGNkISD0CIAFbVKMi7UDI6HhmGwpR09H26BiHyIuJYgOa0+QTyUemo4oNqE0GycgbcggDG65bpCrjQMhRvjEJRGsOyKLIAAGgEI9mpGQAO9nGIuiIAQEYJBm9SA4BJECIq0ymHFrpxl4iQWxSrKNX+pg3LOayikXwTSqdScl9CZMIhXxOn4SlzHKygZmaWSIcA5KWuEhTM8jE5jWtSQQGkHMk3JTnbFyJRGLWKS3EMadAzYDOMTqmliYJaJMsAo57GIQbxxCjAkIkz+TgciwQSIA/7BkbhNpDnjBs5kFN8lFDIgCHA03pGApQTQRQrnH/gKtmZP6WEriJzqWRE51NWOU2IsTNCJJjW+piGpma6lQlLSVqT+92OZU69alQjapUp0rVqlr1qljNqla3ylXtwW2Ia5BKEiy3TVHMhRWcCwwWkrEMN4g1CcFoahqDWQ4I3HMNpwpOqBjADIMIQKZH8CY9PvqFJxkBamUVhGCjoMnG5OyTS3gML8+QV/uh5q5sMEn9ege1WqooI+Giz5EuQzCxCUVqaKisFgxbhO1slhC3Y4JZVtaAlu2LMoSFK8fig9fQAmA7xkRtGhzlO4ToJQDIsUlJVtW+Gb2Eci55Sd6UwZr9rCQrUEFiaHHDKn0p5YPHGABQ4BIZdFC3KQ54/0t8qLuvtshQALwFS1D8cgDACIYwdvtKSU6SkrnUJXL1eACN5MoZNEXuKZrTDGPoErj0zoS3AVju4AzTFQM4VwHdlXBz6wETm5iXMUB9ikN8gt/XWoeK/p1JUnYTMG8Q0B6HkQpVwsuY9j4tK/HlCxHeu4DLdFIy3YhMcg/wluMq48KH6VhC2elgfA1BKva1Wj/QiDvhYJZrdZ3GZjCTOueAjBvZYMxvkBZadCClu478zT0eu6Y+bQ1bt1kOdHhjIOqceJPgFA1yJIMaFzvHtE9Ohzbm4eY3HyfMhUYUibIsZc7YchvCatpktKycykhZ0c+K2T2Mw0t05LHSg9ZkvP+cQ+bZfAbU9ZHzbx0JABrRmQg04q12y4GcLVsaAK+CZFNypOjpQBpbQetdaQ4owiGddDhSZgy7AAAPPrkZOZWhbgEaICLaTCpTtD6GU/QDOdQVADcq8RhrdOWN3UzjOA14VQLSPSQHLZoZtkGRiljEDdAFBzziuZczhuSxKQJaCCASTl9eJZYpYS3ajCH3qglgAGh55dhrtlSOGJOjYX0qSsnGynm+S7jWTgZAg6a3iwB74k/XZ99tJjh/4BEiN4dxMgQ6BrrVzW45uRs+0OLTIcsstfZo6EsZX3Y2hJWMVTOg3NpI2IFS1A7JOESutFtP0F7FJWuHqUdeWqGnscX/RLrUg0HXBolz7mFYyR1EIphikDL6naS2ywlO90mZRFTbmwHg6F1EG9LQTfPvKYnFI55RltsVqHbxnofqyrA62hf/HMSD8TNXhxcSMN4qKtnpj2cZWJq8ZCNtiORUg1cTm450n1fNo7JbJ1NnhHAmKfN9GLgFMZSm3O+v1Ym4vPP5SB7/HDZ/MvLuEbU5uB7odID98kYwGzr8+KRjc+OzmPrNhUJP/FF5xfZhj5yfapY1rySJtVi2CGUEFCnqA3s1voc84+l0ad4Av1ZX9KCcRI/84mTeV6W1WZpAP//QWx9TlbUbgMUp6lcnTNJH5XAP0qcj2Ed8vwMtDMAT7dAe/0P0ftBiYo6SDQamNErSMhX3JEZCaXWCKdZiBNTHb8mCeeoALrz0KrGCd1/mFXt3LUTAawlodHTUf/PHbACDIamhJOvnehQIhAYoeUdQghdYf3lGRZrHJEm4aOSnECcoJ90CEoOWfYtmYE1xD1VoLe+nEgaQDCpSgva3ghKBe7zDDwmAIhWXFhD1EAHjevs3GfsRYQaWgeGgL8eHenaVL/xQHU73EEYyMRUnZXXID+YSAA6wK1NYWviiL4L0LXM3GSxjhV+ice6Sd1SYIZjYL9DSF1OSGcKBQeZFf3SSiIvYFB6BIg0Qh2Hyiu3ghmsIh17xhQYjDGJCJcg1aUpoE/+8VyBNOCa2MTF7WCyNyCEnwxrpoIe+5Scb9RyB2G9fiDHCIBtShoovZ4a3V28mlju+tyvOhyhfmGiQ5SiuBgHWpoTbwR0pwWvwRWu2whlesY5nqIMHN3+SxoCSWCdhszk0A4P0NzMVMSZDYHpDgBsi4Wql6IBzFmzhOCSwOIIS8ZBy8oUCiXsGYDSUiIXt1zD4dy30VhE1wX/3WJJY5jOttg3o6FtyJBq7wmZY84VUAxH0WCcN6GrxxztBhTo7Rjo1sTpy81Mrkj95dFS+OBWO4zhFkDk+aTrntRKeA5QqcTYClFbUNlPz0HGhozanMw+qg4up0zpZdDZtMzc/pZX/a8Mf9jZUm9NxZRkMzKKVz0KVVxkcTakSYAmUUukddwmUhjOV+VUELWEMiQM5AwQ4kPOXHfeXdddWTFVNWhmZR7WTSdY5BqCUyXc2IYE5mkk5YGk4YRhBc6kMdfmVGMFW3dhVrjAZJlEZiaWasCkKj5YsHRabtnmbuJmburmbvNmbvvmbwBmcwjmcxFmcxnmcyJmcyrmczNmczvmc0Bmd0jmd1Fmd1nmd2Jmd6TMxTAVWUcCTeUBlTiCeWxAer6mdtVMAFMUiAfMSV4Aym8Ir5MkFOfkE9flHXkNHTvAT5dQcJrFuSFAVEjRih4QRNVEMXkkXYuEMAcEajokya+Ni/+4BHmfTN/+zIgrqOjiFVP4SF5eZOiJymS2TGjY0mAHhUg6AEnJhDM9xoQ3XFLGyU21zK5ATOMEge06xHzzhnUUUTEECoJyjGw4hGLK3U+KDHKCyKcvgIrGBLwrwAMsQgY9CcfDGH1ohL6pBmFcaZPZzfU7KRPz5W2yYDOLgo7HhNRZRP8OBXMPgAPnCpA8WhyzSABThHWjiAB/hAApoEgaxMQUCjYXxDha2hu8QEEWXTGa6IqKIInHoQznBGPBVUd4TYeW1lMjRimfqYY4xDPyIJvxCZMIQh3UCqh3DRM+AMomqihZGLyLDetEgHV7zWiOINc6QRKgqDnnRJKrYpP85wQw/mKlUBI2wGqbwKUfKlKp1YjY6kUAqAUyKqA5COalYk6Q+Ba21wSOw+iiVyi8uQZQjWEOOdX3YWgQEoqeZeqZmKkiXM6t9Yi6NOq7wWScukhcHQFFUhDLBqqln+gznGhvHShAGkBlPmm7i8Awp8kPkgwDEAUx3kxY+sWnjCqxCYK6fCrDaOhIW26WZmqrNenSt1hcRmK5es64KZqanOq65erELgC8ZCW1IxKn6KbLEyk5aqEqJKqqV+gwzU1NFdaR3Y08uUR0u0WMCErH4qgBEm6ld8QBVogBisbSJdLL6SgQPICzqWQ9YwwAry7Dw6UEK1q4TJa6aCir+YID/fgQAAqarmxobTqutItuuJxQQ6XKsowUbT1oSNlEYCDAY4iUs/8Y9NjRUrBINDQujIPoohHu4eJlk8xANFuoNbWO4xdEYk8kfkRu5RUAUhcMaFxq5Hyo3NnE3cpGVhWsTzCG5mMsfCVATFJVMNuU6jPO5ies2eROt3hOwJBcF9wkGHIsIGqUAwhKHv2k5iFm8xnu8yJu8yru8zNu8zvu80Pu8uVsFLIUFUPcFF8oI0VATS/Wb3kRS4Bu+4ju+5Fu+5nu+6Ju+6ru+7Nu+5atQ6Bm/8ju/9Fu/9nu/+Ju/+ru//Nu//vu/ABzAAjzABFzABnzACJzACrzADNzADvzA/xAcwRI8wRRcwRZ8wRicwRq8wRyMC8QbvSAcwiI8wiRcwiY8wtNbPB98wizcwi78wjCMwlrwve5bwzZ8wzicwzq8wzgMv8hDwzwcxEI8xERcxD3cwUicxEq8xEzcxE78xFAcxVI8xVRcxVZ8xcCTOfJBO/6ZAPB7n5OFxXkEAcb0xUgQxrwbSbsrLmbKtJfZUzbKoMNimKDbs3K8ItPwoW+8OUw5D2yVlSvBDAg6Oqlpv22MEmUZupcpxzSaN90bN3fsueCRyKNpZEe0EnUaunFTDPjDFGm5EWZKICliEW4bqCG7JvXjsa3RLEgBpRtbppahEAOwhjJhMQ8hpWuaAP95UcugugA+fL+hzBixXMpR6jaoXE8ulhl2hxVi66OjrBB0Wqq4hhT1sCLrlsnh8FcBE0y1xVckcUhuWrPWwKaDEQ2tK6xrm5P+0GpeIaUB+8o20boae7GhybCzqqt8tTH+S85Hh1wpgc4SKx/3QCDMlseZcavxvE3KKg4e66Mpe3vJLAwyASp5szKIcbClk6gAja9ARS/0crHaitC9y6/PASoHA7PMqq1rwiX7XBgZTRAbjdJo4dHnpp8i3UkDW8sGeK1qa4CkZxXgIDAPQMagrBAara8cbQQ6ISyrqxIfcdNKcnApndQkzWzstM9GDdNILdNEsNSsJxLqCc+9u9P/zMYcuOpOaruzQVJT4sR617sLqXrUIsu2ibQiv3pJAFqveDvSUk22D2DPCqaroOLLybW/ca3Vc/0Sdc0QfqxRee3FJjG1Q3C3kV2vdicOZEshajsShQG8fl0dWttj57kLnxsktYu6g9M3qeo2idM2kzxApIuXbxy6KhHbofO/pS25itw4qZ25CsHad+Pauu1Two1UnwvHkYEWhkm7Rek7XSvGWvDcq/TW0C0F1F3d2J3d2r3d3N3d3v3d4B3e4j3e5F3e5n3e6J3e6r3e7N3e7v3e8B3f8j3f9F3f9n3f+J3f+r3f/N3fBFwUpNMyRWEX/QMRDOQ+YDXISkBsLM3g/w7EJaUDQfFxE/NAZD7UVEqGQYfRPwK0ov3jDaTzZExBbBHuFjOhohCUuYGrYFs04L7YPxKusRy+4vUtfHrxKloofB+Rfv3SEgR5xtJ3Z59UKczAZymBEKqbLGfXSWxm0ef348LHqZpiHV4zZp5UGcxRIeygxmOyG7X4G/QBK2ry5JB13z1CV8riGlkpET1iOZfxdKn0GAZqlI8jGXVoHU8HOUFdNB6pKVCjiKs3lJmrKf3Bi9y2lmf+Iir5efroFRmpfmvh1H0uJlxeH5VXkfX2N2Fur9AI6MGXwu8tGXyXOlHTF6JeeXmz50cAl9C0g77U6nlOflhDIWjCZwdNGf/7Ro1IQCEAmw2+qotgaXKAoyYtQuXWMeuWTlomZ8zxt+Wvng0jFGZW4yLC8IIMgHH3t8by3SMUow60nh975iGPR0rzSZCqboKtXg7X1w/9JhkqtCYbd1lx7up7DuY+Ze+e5yHgUOUYxHamdR6nbj/h4iH1QcZ7zmZlGg6vEvABn9+iVjU86CZXKGqRdO5N9LcXjxEDQZSH0qCDtg3QkhT/oGt5xkT1/kH8anLuM+avkg1VjpLY0hgAr+UD7x7GdfDJ8kPFhLaTke387e6E2RtqRh9SxlsWj+7XHfPa5UVBLYujHhrVsXGRIzvsoCwhr/RH0PBjfmdVHhiAh+fFR/T/AVTz+pKCOB9JO++GPr/fWr9q/BJhKXjqtpHqrr443OYZ4mnuU9ZDv9IQRA/c5+ESEMEOha0SGvgQxY71RgD0dhOPF7LnTudvNYZxjI8TVb/ygCLrVkN6BKMOUGNyP18x2RAX0MLqQcJyEiieh4L3z5Tuuqbq6qL1h+eSgJUgtFYTP37v13EWC3/sE7shbKZzUe57iu/7xL/zALf2+g03WWRvhMP8cqGVweCdcaXpj+Od9lb91X79RamWPxM3ZkOaSRBUlGu7OYWY0xDsoSMiR2X9nLOZfoP+K8wj0Tr9eImYcuPIwQ79/g0EAOGQWDQekUnlktl0PqFR6ZRatV6x/1ntltv1fsFh8ZhcNp/RafWa3Xa/4XH5nF633/F5/Z7f9/8BAwUHCQsNDxETFRcZGx0fISMlJykrLS8xMzU3OTs9P0FDRUdJS01PUQEMAhCiCg6gBvReyw4KsgIGAgwcZMd8MW3tgI14iZ+O35KJaI2ahWifU7UWBAYUBAyeAgSKCIy6hb6zFlqfxpe4mdStBAKIEBakAhJYBRwayL7jyc3d8f4dCbcGHTh8UP4VxHIAVhWFRdgN+RYRgDqKUQJSYaDA0oGB1wAg0GbA3LtdQ7jlKqlKZIACBFgBIFBgQENmAxzcMnarIk1YBhI4eAfggC4hIhHwFDK0qE2UAwaEy//V0Ng7kksHNGhFMtfQnUJ4OahH5EC9Wz6PFOWpQAErmK2mHiWpNCTUoUkdONBGpAFUnt/KugRAUy/LVT1rHrWrKug7pDwLtCK8dwiCxSEL5IX2asDIlqry7u07gKexVgIahGb2FnRhZpxLq65Yca7mrkJG/0XyklXmxIM5G0AbUtvEvUmJmBZS9G7mwmxPxgUeeTDOvT4fTl3lzuhsdrmiVuRu7iuA3Etpi0RskzldiAIg7K1axHJ3vK77PLBZAAKAf+wIEEAAcyqC4IAGGLhlIgYScIeAxAhYgJ6hjmKggQMWMECAAxNQUEKzNpJFAV1Q869Bp75ZoC0JiXDggQD/qiHqxQXkCaqBB8QDwEUYuwmAgawYMEBDDgsA6kAGKARggB8DoKevgYSwpoGxBKzpQYZmlEeAE1tsYEL/HmhgxCIkRLA4JZlEALWyKmKwmwi/xGfCAkL0LwAHOAJAAQfUvDCBIuSk8kUF5BkggdT+9LFBAxhgKEgAygwSKHxwFCDMMVG6klFHKVMygQMc6GbTAx4NcEBLxXwASG0iPfOIAK68MIAxDQU1gQ/fSUjPhhIcYtIb9SQxH1THrPKVLD29tU82ETj0AIUCy8vHVWXKcccYAzAQwSI3nPKWVmUSUM134BxLVW6WEUKBA9YVwkYcu/yS2HTvyKja/8KZ6T0h/xZwoFp69kJnHKiIaHe5F2eVZWBZ/qGzyVD9c0ocAFTtVIhe1bGwyW8gyGepbjDuMRx3DkB4RHajTJIdBTzucIgC/jSPI4KrBUBjWCN+NSqGTYJSlb6Q/DecEZusB+CJlfQlF2vsTNmA+Bg1gOgviViaZ1X6ozkBBI7GkN+fgA4A5SHw9WY5eSB1imbA0F4AFn2bZucfA8Ku+Qh0EMCzm7WFIFhXesyDcuzBkLyzm7JpvvkbkIItetaGFOr145SFtvkWi8Lpt+Qmx6R7SXJ50jVpOvumNz5gAegYCavj9lmPMF/ur2y7UQqH4IkGErh0IjLaebGF4/4RKljsnbgABf8YkBxpdR6ESpYAHoBA5JoxT9l3XWi2V+6hMvpub1/Gad7vJBmTsNie4WFAqLFwj3JEvyJaGCjzr256XZQFeJ80X29NuOlqs9ck2/kCKghQ34RoRrmLAC9pROAbzW5HNvTZyYDrI1cSxqGAMEGMbw0UXT1gN4QETmt4rWugTJwni+zprwABUUhBtle5cVQvaddjxQHZJ8Ga2WWASEAQVAigDehJLzn9O1+O/OAREXJkdtkJB+zah7QdEgNTBlAiWKbYNP7I539E+MZeFkCMkNnMK6pwlwAtl6PtXVEVY9Ne5vxlM8o87WwnHEfQzFg8dowPibtrWhQxpYr4lW6P9fv/R7MGFCxf1W53h/wTzeLDDtSxLIBX1MbsJIIbeLHMgeAzzybzgY7ZcccXokOOF5f3PaTxcRweYUARLLlFLCLOF3jUBs0CKTXIFcGWMWzfGNkRJjYaIIB2E51fXtnAwxRMF9D7yRkZ6cEJ+qEa18gGUW4lICmiBAIqylcf8+cvBkLjVirSkzUeIM7dRUUepLoGE8lXrQeMiAEEwuYAHtANA9LoTwzg53buqc0YYgOfeiknHsECgazArJpFYKfLOrjPBfypePNTQAKuRhED4jNoX1RoA4Ayoq0NMmkWxaiSBKCloTQILAkQKYFMyjBrHApNOwMnW/T5owcELX+GMiHv//bkH5w61JNCxYYUR3lDjl7QZvasmQarocosii51EhOqT93JFhNOCwESfaQvQmqorv5oAQqZ0jWEMrILqqMs+OxRN496zoJudKdM/ePuoHpSnBEhPpq02T/5p6KTYtIPq7BnV68ymyKQpKsoYUnVLrcZI8QEGoJRbAF40lhBmkM9EDnKSYoQmcRWhEJNAos5IgOsxHa2AJZNj8VWsRfXMoNCmEUPSu5iMUFi9hbqGW1lSSJEsICWa55xLHB2a9uQtIK1dCnuYl1iW9SA1i6lOSyBWhvcz8rlsRDJrFORq9jlHpc43VVPdtXzDphNFiVICe9QbJtesDzKCFzzFWV9i//a0sLXuaA9TDxXoRPOCjexot1KV+3ZWsjsQr7c5e9RCtAvQSbHnkMxLXR5W97fTqMQeBIrh8lgrwRGgiFfGHEqCFUN3YK4FE1aMYu50FnJwri+Ly7FKuJJYx3vmMc99vERhjMYq3ZBGJaglyCCXJ0hp8U9P1bDkbVQZCcYYw9Q9oPriqGxaFKBYOVAQvEwMo9ulNhsXfAy7c5w5i0wyku+0rISWBkStCnhIXHgRxRI1ShIgdcNZOZdJscAZiXcw2N5qLMdhqNc9bKmat0JjFJS0p2wyNY6mNEMcCblmMvosSbamAxLbsObrfRCwMuksJ7a0imm/OZlvbCqSUiymEz/yyTI0uHtYZ1D6YbchbstFcopqeOSrAyBOc74zaOJbZb6UKgo+ZCuSbDJitKqGtTduUlDFI0e0EIDJzpRzWo9DZtoF6klwOYzwWbtK64NQCSq8c1Ppq1ulUwaKzaRDnQoI2pas7rYFL4NaPYH8NiIRb1+Way7GY0V16gFwraRNKlDGxxuu2Y4XGE30j5dByeFh2+wYrWSXqSqmpb2R2YaVZCmdCd/WWpWhSJNnQKVqyRFi09rSlTJg+TxAwzJW4pynTqMhUoVwShJsgqkOMQVczqNqVzv2ByNkjVnMIlJFk+vUStU11dohGhs7XqQkxpXIpQciuNMEiGTYo5qosd5/0m66BXpUDktM1WN7FINn7gqYyEMnRygTasVB5nk864PmWBLJ4bc/Ul18xzAf29P5lJwvgDFW11GMNKSNSB9JZngKuyFbtOqeN6h0BfpUwhyid6lznedDyHlmpGSoFIF+m65TISHEktIbF6RurcJH73aR+7rwEkAdKiDD3kUo/o4OTt5LW0uUsrcsla/itjUXsqbmtHUWrPNJexok5UqKit2hLzFVSKQpv5QgKc4JeWJd+hTf7/EpID1th9rQurrOG7kMMMVrGWt9VlErAbuGmmtbEcewshsYmgIhI/4igpuFJA92obxsq/jpCIBRgJqtI6oKKdqso8dxm9vDPDwOv8QZLwEZ9TvxOxmYfQPYqKJZEymJl7QjW4IvJjPbdDM+cgJN+AJiVyQc4hBaxDg+mal/9hBwr5BCOsgIEgJaR5Cdy5ieyCoMwxFdVxImsrHf+ylIHoKfrJvYKzBLi6CkVDwG44neehCg1LDZ8ZhfrAQ/XZHfFQoGcoGDmVG/lBD6v4njBwAbWbIHYTn45QQjTjwCokGSuKMHZ4mEREw+3TITooPHCgkCmOIApUPUnACD0WolMgnhtQBDSEmETOQB9GHDulwDAHNLv7QKaDwC7GHFcGDcjziQTrpDRdrCr1EKg5ngrjDFWfRTraQNAKxkO6FhepAwuToEYtgawYjUf7/T60mCaRwIxdD4qt+io+GwJZyyZeWYyD67pQmxxTBiBj6sMyEsQobyJZOiP4ypoyAAkcWIIQakU4kZxz2UJbMaAiMMeeaEYn8QuuI6Wqi6JzYL5MSkF/iKEiQkZnA4hkn0ZO852XMEDM0sIuUbw6VDxsGUhRzBB3R0RRXiTT8cRCXjxuHSQbloyCeEc1EIxv6gyhUShSHqRfjI5fyse+gSJGwyBvfgKGYhj/waRzCiS8wiqaeMPvy56hCpVb8Y6bygWDYKaYo8qz2JKxGyiiDiqDSiR3qaRC5CvzoyZ6gSptQqXwuSoVSKou8Kh11SB3S0j/8BQGCyKHOkmLYjwAI/8VlsmogefJ59hEqd2ZA4uxphg0umyyK7GUvB0OhHiB8nKGcmGio/qqu7AhrsoIi5ilKRPAf2EkkyyYsw4Ew98WE0jItu5Jsggp48pIz3wEr/YU152cBkISuMvIov6lFZgoWHuoWkkqu0smBfoRpqDIpsul54OqbgrOp6MC1Wku8ZkuQ5MOpwO0osMuypus6viu5egu2XOu5orMnKkvAlnGx9MuzQmLb2mvDKCTAlKuxHmwp2hMejMs9X0a2xM8fKGQmksSwXsW6xHO4MmwwTiK+hMs5k8+xuhOyXgbaxAsiCESznPO8eMIrduG3AkInW8uyHNS84pMVEisMo3O0Lv9MPitrsiIrvPTz1MoLQJVCwVBCu06UPggknlh0RLmrO2c0E2fruZYiQgckRisjQGOGFAStz5ZsEyji0N5gSAEhDMFASZ1sIp2ASY3Az0ZBxp4UDJTrtjQuEbJ0DHLsSp2hyZRgw8C0TM30TNE0DqRhDGghRBGtSLfAykLr4yBhTdPB2vxATp1AT7/ATsuUT+dASvHRqdgKTuPu+5xAzbBAUeWsEsMASY+Azb4UDpqlm7BAUCerHvgsxjDRCiA1Cj51A8eyCjA1LQwVIXIsVPkgVFHQDSLtwOQi3U5L7fJNJ8ATfUbM4phtf2S12trNNaRj+n6iMcjCLCLNKyDuNRj/TuAm7jqsROEsZjiQ7WUqjbjOotJuzVqV7LT+rTxeJRwwa1nJIuAeY/rCozoKI7iSBN/ojTi80dy29b1gySymL57uo15xw+BqprEyrjIu49rWMFmVI72qldvsLcnaqFrHAyy+bcBoVd0OozyUgyjsYy6gAS6qDVmFQtWO43Iqtrtg7SZywjz0NWT7DWA11F0z7D4oTSvQIFuOxP9SxvAGMej86vb2sHJGDPEuKStA5OgQT/LGhPKsjmbPrplwTkhmjy7+TlSWdln+pFku5BtaL46WYvfajkKglmJ4patyz1BuxWASZON6JGlHb3Vs51NYkGx8NldO5Fr0Kfd8jnes/8GAOMVENoTY8mRdyHYyfRN7Qu4YiEVV5g5cAAMCvNZPAMVLxqIynOWLlvZXKiUAqvZfdm/zqOYohAJiYHZbVM8oMQ8l3GT0JLfz7ARP1EWdeNZITK9geIUmAvenTKVBUQ9SKLdUxKUQPU9qn0Ujt2RD/OZSZAFuXxaOYkiPEBVrwOR4QilHdlat5k9MKFIjM6YEv0H9kLcixeYFexEwXlAIDeYbcLAIFlBmmclxGmB6hJBxACd99YQI1Wr7jk4kOygHZSZn0qgTm8loLFADa5B4JCYRE7F861f5ju/xFCj7PKejDKgVkLDRmOYBJ0Z+a2Ig3WF8q6V8s4gZiiKKNP8nAhsSIvqXggdnBXNRgEsFJvNEe/7EfQ9Ydt3DYBbyc2iNcB4GSsLXdxuCjzLmcrAsDArpeDcxeYfvccriTNTheVPmIbPXhEgxhab3IR2RFzNxYmzoF1vIDYkpAVSnEd3hIrDYctoFixMIhIaFewRxF53nS4WRdpjYDXMEi8PQKQlI+vDxEv9nCdEMQABtLdWqgr6EABTKfZxHKdjw6KrQhkbMHbZYdb4hEDd4OT4FZwpJEifwGPbIFUcoFe2HIfLEMF9xes04BWUXEvPOgqiHkxsRlP+Hh9/EUckgmG6RcrIXBd8RpB4gZtpHie2EjlwyikeQjLAIHZt4jbixe4n/ghtzKYdXkghq8iJySUeQR12A4R+JTQCS6Znj95h1kh+LKqHqKCDGKBtdh2BSEszk8VsO0pr3OByUcf782Ho0kdY+BSfv0Ztdd4JJMhwuCbTcN0XWOZL/J4rChCEvOTRLkp/tsZ+nMZEqZ/lWmHxcyV0kg6Im6CGqqJjGYaHz+aH/ISBcOX9/GAyyxZsu5h2DZjMZqTSXoiUfgA+dVwQpJzdRSuo4Maf4KST8aaJqOjk+aqDQyWr91jVdSqw2qqx05DaZYTgL9DgNQBYZ46VGzEDIqaGAuqD8gxjKEDe/uW9SymUCoq3yKarFao5LCTIF7TKXsaF8cjEX66POiqbU//GPdaqjQsJAjrOlBIsYjjqDgvqqLDop65kMmVqgxXoiitN94sqfJJOlI4I1AZsofkSrAoKlJmZ7XhMC4omqzWMo86EsomqbqlpF6Mqul2OyB7KvT1oyQTqjxgyjxNIMGAumGOw47KnA7HXGrEIy6MJGkyRDPzRGVUZroXNCHVZFI05Lb1RH/+s793NW62vbrPS5sjRqEDRlkVsi7ysmsi20tDbf3Ouz4vM1KqNBV0x7VlRBk+MkYqvGUha9BnQ5y1M7//O+xGu5cyu7SwvSZuxHZ2O24YG2tQtAUdS5t2u4jjtLd7vXdkEZk4O+CFQ6O3R19Eu78pOy1luxYks9mv9Lw1ALAVAnTUmhVSmhVEV8DjBKq6D0EDzMwU9cFKz0Err0xfGgtfgsxg3BxWh8x3m8x880XY6BgNBAyszAT19lUp3hVHnMyHUmnoQBUGEp4OI0HZB8Hqp8CYjcx+dAIaiKCauAxJPASamAUe/MxP0Ilst8pMMMILiAUb0vSjXVlD9V0K6hObHgU8EcCcgcbU5MVXVIzZ+AzPJcy41tZGfiN9Rjo5913wqt35ZNLpIivnINK1yWd1IDWH/j1tDVYh69Vx/tWBlWykunKIzr1j6dO+JJOzY9YweDNcojZMlbOB7LW29rwKyo0nS11THc1E5iWd+TMYRiOURdPFQi1GP/uC2oo7z+pmPhcz2AveCo4jOE7bMDLuOwI7RcbdQ7w2B1+9mLVdhqIuBWTWIe3U707dXTY9LfTV1STdMnjGKvXMQN6ELkoenuinfDRxdoSnd1hHHdFngZRnh1ZEZ8Zl4qD+rAthyAbwiUrk6OtknMdmkdyPaYMeqylme/PS+2lmd17mxntwiABWczROKHQBmzjiQ2t2xXZfWu8Sxe6fWYasRoFuarRlsS5GzJxhqu6KMvSGzpIiFwxfD6dm7LZV0gZmvxHeQZj1YoXveeZDKNtm+YpGknZuhYhOH93U46XuJn1+CNTqZIo4CSqWRMl9B3ZSzjLIdrJv8KhwVZJ2+t/7CHC7RsTnBv93cTzy8014h7q3j4uGZv8kSKq08phFAbK89/HNCnl5dlKNiZ8YEt5o8zWPkhBiAEo5cjxolyLl8kNYfvd0eILTdwiuCYrqZ8u4+BjvDu1R4e9OaEtoaAi6qJHzH8JivvW4l74WZ2PvCECIZKTu+GzZ4igUdXzLEPSajTjKh+Qnoc5xqFnOeEwliv21Dv1cqGevGLpUrwk0QLWcjwrR9J6+F+LND6WQ/y7xCbGG/yiyE+IgkXBfqnKKKSqfjzjZKpRpn+hl/mljh3/AgICACBYmAsCAIAgHC5VDwaDgHAuEwmrwErU+tcBqjVwbIpLCgYjILTkFgEiv9DZXMgMA7ozmwYAJVScVkdKBQwAAQw4B18NTo+QkZKTlJWWl5iQsoBGHSNzXUpMHo2OSwUQHRy9n1mtSr1rSGK7cFSMShxfvqRLanOLlm5OrGyJh3Q/u6m9nEViw0D4PpurkLrASC3eSKwfS1EGTwkZCd/uT0AgDeAdhljNyoQcUIsHSx4ctXS2+MTi0XR5uuLlXegmiA71ChLHTJZFjhYwsAAq3y9hFQzIKpMoybNeqWCKNEAlybRgO0yo0tdL5TCsAnU1QRUH4+BenGBIBKVqk7dMgENKnQoUaAF3ixQYPEgAASKFphRsCABmwOKFChwkzSBw1wvgR3gKoCWlz7/ThdM3eWmSAIEbd4o4FpFgD9fEAY0MChvwIOITgYougOMi4G7ea99acBVgYO1A9oaJBJxb19PDNx+CVAPwAN/lP3uiYiAQKewfIVEZtxotDc7U9lAidsyGN25rzPrlPfkTuW/vRiAm8bQCYRRX4a/AnB0geCKDTk6but0ANR4ncdWCUxmuWBUp2nXpYe3JMcHRS6/3dp1iOrPnmhSgcKcSqIBCLgsSGXvqlLBRf8DGKCAkwSAWS4FsIFAJ7lQhAgYBeTiS4ESIpigKgg21YkBmBWAQAPpfKEgJ5ghcqA3SyAQgDKrVIgiiRIasCGKFwZw4hII1uiLWxjCKGOGjVB0/2KKGmImIiLeQOiNEkc9wuGJSTpSgCoRpuigj0bmmBlZEGbW4mocRtgGAmN+AWWZ3lC0oU8L+jKRIyKa+OODOhJzo5JODCmhg40UKCOONmapHCx4vriKATzmkkue59SIIZZIZkklkWAoCKZyaL5IUZE2Dtipp5+CGqoTDrBVqKinojrJAcalSslJrQ6lD6yz0lqrrbfimmslAaioq6+/ghomsJMYOayxxyKbrLLLMtuss89CG62001JbrbXXYputttty262334Ibrrjjkluuueeim66667LbrrvvwhuvvPPSW6+99+Kbr7778tuvv/8CHLDAAxNcsMEHI5ywwgsz3P+wUMJaWywlPDpbZZBBUQxGqxMSu6KvENsKcq4SM5uxwyiOlTI+M9VaAKtERbMqn17NNpTLmMh8CTinKMIOULK+J2BLYrxhiqnHiQwrWUE7ssDRnrIM1NLBwJz0sUD/d3NT4aHINSU5XzsMak/26gjHFIkMoccQGjh1U09HkgSZlzYiyABcRln2xU7gXREicNNdYpMkPodi2mULCvTYu5LIcUd1smJklYS+mmYlZv4dCZmW73lk1Kt5TCnfgeJJOt4Pfs7ni4EemCXLk+f9y5iVIy4J5rBrajvivP6i9hinf/kI25m5xYqPF/soaJdRCgm4smI/MAAEVd3R1jlwKcX/VVpMQBUAMo+tHn1nfkAgAKtE6LYUXwyQNdZjjAijwF1qCHBfArE1Ypp0YsF/v3nkm88AdMEKIhIgAJYZQSsEPA5WqHAAAtCFfgjACnM6QYDufc96UwBMzQhwnhSRAwANIIsCszJApQTAgAR4YG0wUj5kKIGCAuiEefITpkR05hCpuYv+FHRCR4xlKnxZgEKEoEAhECIb6UhiEtCyBLQIMClK6eEXSPUYdjwGf0es2wPYF0UCbrELPWQhPmRIERWWA3yckQoEbsiAHHLkE+szH1esZ8bp9MYRGXSLVABTlTraD3/HqR78upgE8eGjhPIzn1kU0Zdm+E8pYfTNEOiS/4CXOUtswRiAARTyoW/0oicppAM7OrmETzYCQqhZWgOU4gd2PMcOK8qCIVrhD7vF0S49oQo/yMOKBYwCMughSB5CqIxWPgGWmxShK0VCgFJ68gGFWeYXEKIU9DyAVQsIJTCXIEzMzGSVWkCmOhyAymi8IzL+EIDPDNBNALQFQjniA2KEIJIu1HIc7mREEmopjQK8sy3sHMhqppCScuaSNp0IKALuqZKByuSUzXRAItxiShFGAUTorOcyZTmEdpITItQhKJCiSYwiFKYn5EGacg7h0RsFwJ6hfAY8GfQRjji0buvx27M0OQbNqIylvhBA9KbhkfIFMUT3G4A4ibnMWP/WrB1C+MouVgoGskAwZQc1hgHHkqKpWWGRPqOmFWLJvrEw4qgqY4XirpqNQihkH1foav2c44SmJgEwKTsAFzaqhcgkigH3EyBdU2QEJdDTC0JwRRPW0JcRsiEL7PykAAqbiMF+ISxJuQlHGKvTuaYMAZ51h2Czko+zMlIMQA1iX2/IUTn24rJZ0StakfDGo622NkK8g9+s6oUucAEBS11shGjKspt2YbSUTKy0fGoEp0Aim39ZJzag+wiINtUJSVRHWjsaVVq6dD1VvUiI4gqA6TnVHQBhFU93IcLN2KOZ3f0EqR7XFPMKl5p3jS89ttkI6S4BwG7NJV4DUN9RUVf/S39FTDQK0BcBA9EWiuWMz5oglQOgQSFZ+JAC2AHhG+WRCQvibBeikNBdQNjEpOBbZUrhygFbdwmm+O2AkWMFWTnYAQc+B1+aZN4UbjLGB2VpLftaYc4Yh6bodSt5VBy1r7S3Wc4lAxS8F55ENKABC1DMFozqhCrf4xsKCEB1UOG4Tq7KTQJwgGncuwc4RC855aiRb4cAhzyEJcvpII+Zx8SAA5CZV2DNw5gdEMI2pdmCy3RDHnT8HjDjIwHm9M9dD8DlJ+onMwzIstP+HOiKeFq9WmC0gR1giAZYxbWj3jRgEJsLUaSwAU4BNBwWImGmcNkBTWgAadjzWzWgyNNw/4B1AsYKT3M+gMRCyPWTezHrQHOZqRwhNjs8TWodVwTSp061gkGx5jZzgdrX1jGh8aEY61h523Khyxa2QN7jwJkM+BlzdbCs5T434xgUVbYIE7CFZsNnWhj+Cxhy0YABmDqVCGfDwb3HhtkcPOFVvFts7XMOHV9oAICGBcRWlYeCZ+NEfEUb1fKHFxQ9V3BVAIPFC+CAk2stM0qI+IoMgPGS88oXfD1AJyC+cE6wOecE4avIX1ymn7sc5sYpwMm3M4qBG2DnnWC6w8v0dDa0e+ADV87LD/RyY9uDDVobeMWZrnOQh/yUEUo6O5IuLJI4AAGMEHrZayZ0rp8cEXerA//eD3TyqGv8UKyKuNjxbKOxF37jKne7zgMP+FG8MzE/v4/is3Fyui/ksGgHwMvNrpyfb6Ebo9gCz2+Geb0XIGo5H3jMT+Z6Scji9alCAEWdqK0ZgupVoqI9mb0m+99fDpPA95TNNc4t5xFl660qvvCH7/znQz/6dAqK1eqErb2lklO2MhlQkhcg7zer+rQSPyVINizyowr9l+MU7CLB/WxFWY+M2HrqSs60Vg2NKIbIu8qxFiLfd8ogNB+e+F4fgA0miFbKsJvbAMvS1N8V0Er9OY0lPATyZZb2dcoZNJ/QHeBQyAz9CQ0ZTODOdOBn6crwEAOJwA7wMMoIrZ9UHYn/I4RTDMJU6DiO8NzQ0cxE6wgJyHAO0NgN8JwN4LAgJBRh4myHkkQI8pBI31ABxcwNi0yCK4QB5zTF4VjComQOJGxO2RRX6klC0jgO5kyCFVYTF/4C6VCOEpif7xgOjREPofBJD4aOqBlOa/QCj7BgFE4ChniWGrqIJKQIHv5IE+gh4kCI/81KACASJ2CPH3QGObgGLxHBXaSQHWzJIaBCS40BAkCAATFB9CyZPUDQyogi9ahRG/wQATmF/YCDJP1QCh0QGYkRIPmBVOCeEyjGFUkD+5CIBGXR/3wRCgWCIRGEJSGIJtZDkUVSI2yQIoxBCd0XX+xbFbzB/9xUEF1S/1PwjyRQ4RsR0RPgojIEIzF6QSUOgHyQwzACkSUNURE5YlIg0RQtkVIIQbF5UwOwIxXdiDJy4i7i4xx1gSeeDx2c4n+xkatxDwF4T/XwUSR6IiimBwGhjxgQwEGqY8CFwgtZET4Co7whYyVNBavU0iYWmX18IhVcpPRwChHY0FJ0JBZ1BRkNgkNy3h1Ao6+oEkv4ggtywkWFWW3AU/EszRoYWpYpBVUVzn7FUQKZlBMwFDzl2S6sAUNVFIF9VE9O1BfwEpMAIU6Ql1UGQi62ST/801Eik29NE2wBmS74m4SQ2Bpko4Tx0lpCAhVeQ0iBxlYxmD/02kIFUzfwSmTd2v9w5FQ+JcA+iZFS1BJDQZQyGGWxIVNXSmIuksaf2dpS6KJGKeQzcUI0+WQnnIR/cQI5ddhS/KVGZldTGJTdACU+MJcTRCZSytlSYtSEuRftcZaNcVI0raUiwopwFQFxUdKA9cFo8VSH1c82wY942eZ7NERuhUdlhRYnEABYagF1epVdcYRskQRqscoMfiU1LZZlkdg/uJVyNpTx+RZbyRuVlY8yoWdrzSUwZBV2xE2iXANtmU96FVg7OED5OIRlaR5zDcdoOdaksYERhUREaGddlZYyqCdzQqd7EYBcZKZtthZTIAJS0YWsnMQw4NJzBKhgMFdTaZZu2A1NxWYyLSf/ezqnfu0Cb2YDXOwmNhyWh8KBGABnq2AXko3Ki/kTMrmCfvDUPfSHADxcjLpZhXaieX3BhyFDYlKlg7EXLcwgiOmY0X2BLJjSeB4UhCEX33jSFCVFJS1pQuUXbOliPYwicsnljQLDKHqjfmrBjpngf0ZDK34YSxmEEDjZEwBThsURRLhJn+ZYZp3pWLCBl4ZXpQ3TPtjmjHlbdZkXnp6EgG1XNy1lK54oSvQach1BmWqkdi2qktamjFIqjYaqnDaEkK1pj6ZKUpAZamyalhUGoKXDHVyaK9Bq+rSBZ25PWG2ZZsomoC0FpJUXrRXIRPSYHWwBFTwbHIAasmIEoBXb/7gRxAMw4nvmTz+Rx7QKWpMOAV68pQEIawjVmaSN0HvGgYFVpvdUI7TawWDslANJZjrE1HXZ6Rxoa3EaEasJRy5M1hqIa2b+ab8Z2K712jx4Quq5krhS2zmkazBwa5zpw7JBwIvQKJmi2sA+GrfeQ64yoh8UKzHc6gKgmVUoWitk2Rqk44dYpHK0kXAhmwOBq0OYq0LyFLqyw7BSWbHa5ra10RCwmVywa7Ilx3MoK7tSGq50Xh7+XPFhBtGFnXbFHSb5hdbknM1FRGwJC9NhEdoRXip9HedhRtylo/HdyNnGnNiuHONxgtTxycepXGZx0umxnXLMHchYrYzdyOh5Bf+QBB3HiRDCTUng3czajoLpKQHrjcJ9tFxUpR3fXu3jKcPpZV1VeIPkIsnZ5o/YXd3KoV4oCa79SRzetV3XOcLWJpnd3l0vSMEFku7d3YjhpZ3PJRzVAt1eft7u3lztsuER9K7c4Zx9wJ3xWh7JWZ43QG7rBi7Iea3wKlwYLInGdS3CGe/qPRzZTm3hSl96KYyshm/5VoLuma+n2C7CrG/6um8lKN/7yu/80q/BqN+xmF9R3C/+7i8l9K/G6IrE5C8ATwwGYgL4jQyb6AoC1y8mPOAjTGAjRDCA4Gl+ZmBR5B+s7MwFB8UDD0j8CtU5PoIHF+fPDFgkgLCnyAxy/Ef/Q2EC1zKgsbSvBh8N5cIK5yzOI+SOnEyOiDAvMZzIDHdppM6hF/zwnMhhCnbJ5+yNGeKw9RnKAfcKHybx/V0hMdROGwBiDpdIGkIMF7uhoCgDFb+hhGDGMPCOFswNH8CUN3Ax9iVizeyw8sjgVVlhGreDJJjhCxOmFWvxiWDfEBphFj+DFbbfH8PU0xzy6CAxHaMd1hwxDQbiI5DOHv/ID7/O/1IfA0gFla7k9LTlCOGRg8ZQJIKC9oTQJ0vJI0LCh1BqNX3QKVNHKh+kNjICO05SsFEjQLIDDoUjLdoqHCXsJ/gyUmwjA+kGLX6ZKfeRLKCjcNnBy6iyyfqRNMIy/2C4xR6lkfXYcjyM4yhHZHxskzMTElNQ0TRDc38+42yMsm3wknaVoi8rRDN3SEq2gX6kFC+XKiea5KOy8BXIj3104yizYxX+JWlo85e9kDyLYwWVFzV26/jIIkaMI0FE0kFO4ipLUS/WD1fOchnEsvtsIzpyBxkkQidbUPdkASpnQyneokOfCitsxHNgE1/5g2gGQGi2wxnhaDGRlCOIgj+d4Vvt9CgtRWIxVE5xJYNQJkqwcIENc0Eght+YpnzqohikoRwIZV3CV1O2RBz49EowJSFc1IeU9a7emkQ90cvddB4jglYvySEcaDstBVf/5myM1E8qRJgNtUGAAVzHQ/9E1FdTt+hZSmZSrkfUbDUbTNNbcoJY+sH8ZcVTGmdebqUTODaN2Kpb6KV/btJrtmXPUS5PewITxbWdPdEoTIRMp5XPuAJp79pli4p7LgUhlKQA3NYcgKiKEFWrJWt8RgIE5AURe8Jx8nZR9XTAPaho5ULUsMwMDrMdJkFUm/RUk8WImuATiYVzKqB9WcFuwSdEMaX16qh07jN/YhhuP4Bb+Op2w+BweCdqKiBt8416f9UJx5FBgLdbc6IszGBhTyiMcqhc3adKHod5FtBQmjd6OnWX7dVQo8hwuQR4evZPqVZ8ADfQCBByFzcVeJYrgPi4fsJMJMGG+3YdUHhMi8H/TC+aTrQESaA1pm5Bgi1lA3R1YnDFENmXaec1jSZWih3ZF4yiozZ4habTa0l1WZDFps5XkBKDuooXnQ71YUF5m+64AsAqlLZoBXNCj/FBlYPXgCfqc4xirEYVjA8pl9rEX4E5xNCFGBB5YSMpmi5tZp6XjYyimBLNuQlZt70Dly/BKP4oKwD6kI2qWp9SPQAhjfNXmLvCRsAThKx4k+cVo3Mel8b0prGsZuZHJ3SdVPhrcZRsEkSbl/1UoZHDvn4BpAt1GVjaW5K6v534MiWWuDJb3egbX3RrkYdagXXSwQnH0Va3kp/Dn2161JDsA6ibeOUZKjHlqKIaV7yroXXE/6uXspVBIra36Lh9ehlt2bLb2a4Px8Q+R7Ong9PORreX66V16cZdA7hLBdjxmldcrLx1mNJS7M+2OdO4grnPhbyKKys80CgoK9/U7Dv8K23IK63WG1ZLu6MBLK3v7LSTAwydSKnTgbWHe5xRYbHVK5Ydey1gvDQAWsKHSgoFL9jy19yyLdS9XDYzHO6qPM19njP+QmNU098OXMORHcg9r+qynOdlRuDp3YGMLtw63dVu7ucpHuJZ7sXhPOlenMVRHvfiScoRBMhV/cwhbt387eFKXNn+fBtI3eP5gqNtfTbwVS70vNyqfFOknM1VXuMZx9fzDV44fdpPb5n8mN16rf/yVlH0Ck7P0y7KWZze8RzQaw1JSF7qspzoXS7dDn3iR+3Ts3ziYzHOsf3dnFLXL6/kVd0KcX652q3yMd3oSVrUt8TO4y7cYm76xbBsGnCukHADux6k2z4kKDb6xV+ytJ7wDGCu2HDuy97wE3/NpLARBj/xM3/zOz++vJ/m1GH2BcgAX0L0fwv2XQv2OwIDP7+4aLL+Lb+ATPAjCCAEcyz5kS8Fqr/PjNkTMJ3x+4oLp9L48z3/0crvxwo7cw0QFA4AQEBARCaVy+WA+YRGpVNqNSlcHgpWLvHYBYe7zidBfC5+iYHtFIHoIgxINrIQGDgLbaWc+BYIeEKoA8hbMgj/mPsTRCJMAmwMaGRyWAAwILg0gDAcuEsKgENKXIwqBRMlVSQyGCWcMwodfTr8o4VSxZx8ujO105VdAuXKI3ZVEjZCVUrk021lBTBzpKxilnJm5AMgbi4cpNWO3hJOCnTEHbR+JPJdy1UPD3t7gu6mTKSk3t1HE1MAQYCWBAsEkFmTgEiDIwIUKPhC7dCABwzUAEBH4MEACFscHGTgJE8DhQBIYhT0QMECCIIkOnGgYECCBp5CMXiwgAGRhwbn9BQwRyVLRQUf9lLYYKbJB4YSKFCJScCCowFw6lQioCaABAFIzqyJzhwRihYNTK2aYICAI7KgLlAYcOBZqgqKJBDA/w8AA4sIHEIkoolAPqN21cINvGDwgYMJcAXYmBOA3CFI1sLd8vJu3iQzF0SVVdahwANWc+6EFPKBA7pVr+48QGDq5JVBA+DVq5VI1680Uabpo9pBTLBOodqFpHZugiEHEpxtPASBcunCKTuCgBfjw4ubzQD9mVMh45lwzPjm2qA18oQLG3IH/ns0QozRDVUMitbuzOO7ByCObbbDStLrHyuEWaAyBn5hAI4HDmgAOQVq0mytX357iROyRHKCgS0UGCKQBprCcENHPrKJji9ERG4BByIkwsURvZikpAuTWHCBZRJM0QweuSJkRWsOaAqBnRLYogCFxOrOQgB+dMwx4P9kIWCOWL6AkpAGlTgExsko3AqJBchYJJGupqnJANRmVOIOM8bCBLUDLtHMKnVs8TC0oOITBh0kzsQkyz5dWqhFB+xUgkgAjOQqySUFgRPQRRBA0ZYCkcSkkwIYaMDD3zZtNFOuGkmku9+8nPAmOLyU8QsD1FyoKTMOsAvULHF0EEIJGxgUo0uyEgRUJ7O0dJUz9TKTUAO76PU3JGgVloxDKqSPxmk2FGYikRbQECVbMjLROaqOsGUNIQewiK0D0GVroG8FkSvMJSZUaACGtihWALzYCtJaHAsA8drAfoPz230FQIAaWWRxQCAn+jy4Xy45NLFAZ6XaiAFlAxCIrV///3hqgDe7U+aIOk19NzQySvZ3YCT0bVdicA1JdyA4ifAwYH7MYFIJvcQFrNgkZGt3ocH8NYNotgQ2dwl0bCk3PnbVLZfjdunM1AAXMYo4CWh3gnqAXv08pxEzDI652LMyVnZtdJVd9sAvAg6VFAjGBIDWGIeg1mll85jOxEM4mZNGS6zVrErgoh40piQcR+Lwixvo5Ala28KqRwAeDEVILhVYcK8tYO25MzI4RwKCK+NbtEFhUG964rxb5HsJ2P9D/A/UnN5q5DbXtOvkJsjIk9yVv2iWiI6QgD2+mSGP/fPQPSUd0u6WD2x1oVPnZjKHrAUVe+WfMRUdvZ+sLHbo/wGAntGhY3Qg9OaT4ATv8xMc2xrwwT49fc1xL5EhfjWzuFWhAC0hBE3WsgSWWIkBBzhA6ATgAOdQDFgCO0QCXnSQFCmAAG0IxKYaEEFBTLCCXHnRA4zXORoZQC0BGI4LxTYcEZIwAAqAoUICYLFMkIEAyCmWkUqjo+S1ggDSegBkRDIhFcqudUMMAFUg05aGNKBTe0CgEKM4CZQ5QU0QDJ3FrGLFBZAEDxpjGlQCUDgx4VAx3UDgOex1JhOqhXWWCcQCVeYOBBZxLWt0gBaJ6LkHFmWGhzIVJo5IliRuxBBMbFIgDuAADY5ohUwjgnOs2BQHNGWCvlJi3mgyoz9O8v+A91iJeh4YwV8IQ4YwZA0EStMUNRaOGgX4oe6gqIQGxgmMr+LU2y72Mh050haCxIMPTdIVYRbSjMKkBnoKGAU8wKEAA/Dfs9hjgBi6A5u84EWi8LUGQXCzNJBqBALSp4VuiI2d1zwnJgYQyCGE0x2VYacB1nUAK+1zDtdc4xaUwpp2VqINpSEnWdzhAHt1A5/dEx0dxNaK4agzGZQoAEO3MkmGOHRRxljDAKypUY9elKIENQQTrukAgbpznEgYaPcYes2QqmNdbYAnL7CQjH3eswiUqOZO2RkKbP6TpEJNUkP1WdSdLsFTISVVRbNZhKIaYJ4WDWe1PipSq1ppAGf/yQMlEAC4kPKTqrjgpgMw0c0rpG+pZuWmSBcyz5eyjw8ZbWiitslWPAQ0bxA9yER/ageSZnWufr1mTZTiVy/ubpr/eOpjJTtZyorhfAUcoRHkVVnOdtazBrrsZ6dANtF6NrJiIG1nlVJaA06Vta+FLReGWsBrCja2t8VtZWeb22dBlLf/aOoZdtvZAtzot8dFbnKVu1zmNte5z4Xuc/VHh9/6IbqUbUdz7zEI4+J2uuvg7R6ScV0mfLeyyCgteh+bXfIiwWIDQ8DHYJvaLgyXCsGN7Wfki9uhfqEglpBH2XK7AFy8V0xw0G/cILgEe9aiWgaOLoQnezPOUvgfCW7v/xpwWQ33YiLA+OiuFAjBDW8syi/TxUY9ojEK0qr4pzeyMB2S9N13vNge8jCwizWMj/JKIxm0YO/LJBEf67I3EojwcRTuwIcgA2PHi1oEGyTsB36Mg372TAQtwinewaYIxMCI2rXAcYokQwEWdKDFkpcw4itYQ8pIfoZvIQFkHwfDVWVmQj1SrL86EGMZPm5yQhnMh/fqWLkupAo1wCPmoCguE/psDBxG00tO3Ig4vuFPVDa3kpbcZCXP2Q5gjESRQGanIfZZCbq2MB/KlE4j6BpAf7ymFsek2lPzWY/XZDMm/IQ6IhmLtaaRYGtuIPooixZMw7TzHdKgY9FD6TQdXv/jsongp4JSWrRlnqKSjSwvEMaelV0UpTdJ7no6a8nmgFpHamPv56uF2UtfyCOlj8DaZzJxXUk6Ku3TOK+EAQk2YnJ9bVxcuiaZtgu4g0NqJRnEgtTwGHMmIx6p1AU4vTl4r182FbX0mzY+mQaw+8OxBcDlJ7WZg2BIYnE7FISDAZLvX6horfnkV63XYpVafRcwWsGKKb7iiVrX14dKKZNNpBUGiFCllF/NwU/oANUaZAJ0f8dHM5isdCuk7oTZoG83BSbLnpaOQWUyeOpiIlPO0YQ0f+f86G72XIX2pBtMqN0yZT9EILZ2LVA94Dk8mhmmunVlZjb9NloPq41s4vP/EXUrzNTQ25aaN6ix/crRXgcS3W9EqUv66OaXItWPFiS0nl1eUEfAlJIMsScBD0rtV/fdZHQFv7UfHhNJEH3KlbD0yuPWT2erWe0WphDHWM1jzgLVaZ9llM6nCOlfyEPYCiAAnEi6Eb9/knK4LgnPCQP2LBST9p0FM369L0VhI7vLwr8W+pBtagNhGvYH9f51keH5ubOJLazyFKsG33TU3j7sE53VuJcAUpqLcBuNmb7qmwyBODgniBebML6pyJYHa5qvSQYhyR8iaBgOIj+E2T8F+AWgaT4B7DAhoxHSsx72cRiuiRkq6bAwI5hz8b/vq0D6SyMHFLAAujts8Rz6/yqtB+gd9mGPgREGmlAI90FBLzCIMtAeZZKc+5O9+6kMq/Kk6wsWjSmJvOM+a/E+E8EkJbQ9LiSC+TlBW6DC9MOkMaQP2Bk6fpA/IVmfKIQ7/NOWK1iNoevB9AsEIXSZldAC0ME/8emMASIVioCpTigXyrEJJVyULbTA2ckUvAG/QNhAR2gQMyyA1RiaJxwYP8QkABAfukESFWQdI0GAyTsC6uEfv/G3NwTD2AMRWEwCRhy2ysCUAqHCS4wtM3IAM3il4WC0TCKAyqilSyCbBjiaR0uCSmqiYqkhNJK2EVqQL2IlhrqhS0glUNqIGrIjPzmlsYIkAFQ/JsSDCBqhb/9Mp0LSEfOzBWsMo1i8Ak45oWlsAG55IWHkh22MvW/LR5aiR2mMHXSoIwsCkdtQj3/8Pz70iq74RaNxOuSYGU1ik4VgJo3BxpW4oRzyhI2kpLwJoWNEIYZ4MAgBlF6qREUIJjR6OivyEGQ6SGkayWc0OocskFI6FAVqi654oxnECJcsAGQKjUayoNYTkmDUOXkcI1ZCSoHxyJJICKWIiGZYpWpcyRIyL9HCA5rCBH9KqZ2yqlqkq7+yA+Bphquqp0YgA4Dardtgq7TqJ2w6KYwIqz/4JkGYrWpKK4tKqS7TqnWpibGKp9nCq81amXxgq8NUKEi4yzYZy7eaA4RIq6//fKiuLKp28is7qMycQqeFEizIDAW1TCh22koyqYxwYieEGCu5EsuAequ5IiheGKhFWJc5iKm1iqfOuCltGobK7Ct2GqrVxKmjwsazpCe/DCmuJCqzgqdn+QQyeCfpAKluOKrTFKwGy6QkqUzQVMyvHA6U4k6YmqcLac7FpB++cimyzDAuoJt2jJsYkwIgXM/5pM/6VL76xM/8pE/VnCb8sgL70s8AFdDj8s8BNdADRdAEVdAFZdAGddAHRQNVqLECsi4IHa/SEq8KfS4NXU8OPQVrkrNlUa8zyEpS+DDJ2q7yYq4SnQX81Ko/kRG1+DAFuLkukM8uY7Dpiq8126/j/5Kwc2CCF82zSyDD5PLPG4UCAH0tJH2ZxRHSZVkYFj2wvgxFzYyeAkII/3IRAouCH/2s7pAwLa1Rz9IFfegFPFMzprmDUSii36mcdMgzWggEFzuzchkHGUQvbUAvNnMylWLRErsHaHAxfhgzcGiENPXSVoCDIq2GMgEHK6OmEG0zNi2fdMoHLNMF+sKGXTCF7JpQYEArQDsxKlhBGRRUdTBU89ojKqCyDhszPrGNTv0uK0tRpllBKGOEUNiwYZBSRjCFWr0FToUHDZOwW/0yymo3rvgPAlGMNYq0WSsPmFMiyZALltAOJnARUIy4bJI5L0A1iuMLhDk3+AvXscIPWf8YtdVgGJnAtG0rQg4Eia9SnaxBuIo7imTtVr5zOS8yCmqYFVpTp137l72Ag+KxCdJ6iySkjkdEt0KMkU/Y16qjg8jQRtIQsEVTt3QttWu1yOIwjcxJWJAsj1Cg2CKYtk0jiiQIGBqVvWGMGnyFj5DjiOKCt56RhXLlzXGzi3KbjVcjRMr4WNTINt1hN/3wDpi7llaDF5RTuM5w16pjNYrLtazgOIrIHGDsV0nU2aQljXk70Qsjk2g4ljRZExLxgq3QPWDox6z0kPMpnULhibDIwmmwkhQRPEWUlj2RBUkxB87TnDtgA8eDQKFzt4HJEko0gLHzEQXRms8bGM2rUhD/mQ5u2Yk9Iq3Lu9tQGTw4Gp/ca1N8iL2ysbtkASCn05/U0yEh2TdgihVeXdu385qdJb7McFLcS7tdITvbM90puaSy3Jy/CxG4ubrYcT1DacbQw0UtGYWdaTtD2bubVKbeo9vbyxLAXbVbBZfn7Yad8DutEb4jYDyzfSyyScCN6ZiuWwMG4D+BmQ6ZWNtB0BhbfNvz276B6cCHa5dL0j+TYSES1Jxk4iITST58UaYPHFUwnJbxMwKzMUL1FcEqnRMCCwS7sFxruN9pyF8MLhqVhaCdxcIial+RuaMUDL7yXcAHsD6fcdVzQYgJlK8QXtt3uQKa6CSf852ocT9pcQLN/4hAm+1dJPAQAhSA62Wa4YVVEm4X/8mNiDEH5p2/4DNBpfzBRrhgAwZgnywRAQziDaLdhTnfHo2b2zFE9nWsYeBEiBvCz42RjSiO+U1DqNsdVLQFQkQ/4BAfKvHEUAwc52tCzWke2EnD78DFTRxCNT3jYRAAWgqYCl6zBiFEQgwFvICXQS4iugtdIVsfAPITKxymiIKVxmEPRzyHNJbDMcaRBRCCo3DZNlwn2lFDk+gEH/ayYUsQgEENAjJilkEJPRwf5vGfJl5hwylCUIReI5zi1EhF1/LCuNucQgZEWzbm1iFTTrnHZ0KjfUwiNuKJ0vANdnSj912ggZXE+YVHp/8rJq4DSsZgA4psCnWurabByb1NoeZTgkqyI5M4Gs0RSmqm3F8SM51cJjzwV9lDyL1AqGa8BMophxUiLa24InYWpU1agmtFyAVSE6UQyCf5Zji6B388JGuGIbFZickoo84gSn8jHMiYuDWSLyl6o0GJRv0ROFmKZsbh53LOXRz6yFizJOBw51pUnO/5jUJ6ZY6WGUOCpc6QpEBixwDGGYRaW6T0xWK+losWppa8ImS6oF4xg6mGyO2I5pXWZslaqZZiLLFkqSsoznaqiZnSA9/0H24iBbWKzmZgKwgSLOHMpK/aqlGozS2zTn7CAqs6TsOy6/pzh90x7ML0prSGy8X/LE+q2lU9WOvE2r02WMu0VE+7/ATOfgWyUgK6aaf0+U2Zes6a8prR8crF0oLXXKsxpapD3U6GGoXbfJzTRirMHK52GKq3xtHGHp3ETKjZfG2LEiq+JoXTbIR3aqjulCgEyG3QXE6jaqimsmzfJkvQLE2T6svSVk+9ps68Su2SSs3kNE1Bw26TGEsLZdAXIYk2EG3sOpSSg66oY+/7xu/81m/lSiY+eNICiitlTi7s3O8CN/ADR/AEV/AFZ/AGZ4IRNZBPPVAuEwMI5ywKrwIN9VAr0FAMX64N1+9epS7PsnADklQHF4Odgs8u+IoRUlAZxL2vlYUFkwICjwK4oD61/4LxKGhoEWcC0trxaUqkJAWhErXxyjqCAi2px4I4KkjUFD/NIZ+CIKfSJvjxKzfwktmzM/1VaZhfYK0GJsOzNfvaXOADK7OyOzimMqvQR/WKJMcpaeBTO31VryERffIEQA1RPzmybzAub5jTUbCFT9UzacgyXg2wQzVUeXg6UaAzzBZSN78rQweHM8OHNjBWPjUHSNVVHkMzXVWYT++HE2yzSanzNThRLQe0WZUGY8CoQtCL7HovoGJTd7iHTVVQoD1ZZGtWryVpVUMAU6OMXBONx2HXmghZy/gVvOnWsQG4oem2LRhX6VjYeguJiUMMAfPZclCOFSI4g4s3cV3YSv8QX+OIiobjIFOENjdjgE9LuWa9DExhi5kYgkPw9Yiz2p3QWJK1Wu+4FoKb2j8wtfqAiyEAd5x1r2hnWPgjuGnH9vEAWK4dCHCnDIeHdljrj1xrWqy1OHULxW8/9vswC6NlAl33uKFdpuLwjKggOKQFD2nFjaqGtzcp2aB1UF1mEdojALJt3a3DYmJhPaIzmbq1g8rpCN77wR7VjMy9W8Gd3guZmQyCA5XJuttblKLbjdF502YQAIeJTGXKPRWEXRXZ5rXzucKBY08IXyzOo6ZzXZNd3p9shVtZwrf1Wxlceq2vehfS+qeX+9u7ZL89wr53R7BPXu29FsQVW7jJGq3/u3py2RO6z8CB9Arj/RNHSREPgVxqeL30jXvF5wc3kdgFxfkzSmKn/OLsYz+2jxgZ9N8L5mC9CRtePMMdzuADrEAW5CBtrxh4FpuL8F9LyWAoSAQFqJcCxkIVlGGytwmFQZ6GYOCwSv3SCSHqQ+HkcF/WeRMHPouuqfsVDH6tSpz8HYsD1P2H4f5hFKVxsbrhr/3HjRgB5Jl8SGRoAr9MYj7n8/7J9zcgGDAExAPgCCAglYPBURAIMBIKQ/IoJAqMSkBAsARAkVcEdaD8PgPktvsNj8vn9LjaCxYHHIp2F8FAFpCA5TR292CE1ORGYHUHAIggmDB20AewcHA3NuZX/wgAUUAmimQGeiRJNtbFCPEI1gRI5ogHwBg6KmcVhqukoJhQ4LvmsLAmmAd8BVAQCNDQN+Z8OzC7ysbJBmAw8LDacJSWx9z84JAI53kIVquGSwtamvp8NE+mau5wdecOdnfvUzVxANIheRCOmRKDt47pKRepXhJYAwsqspNHGx84DEYZCISr45EC55htjGeLIMMrAhKOQ1YnpsyZNNsUgBAAgTYDCQbs2dcFgIIHAQ4scNbgQM+HN3MC2rQgADwkCRw0eACmZQORZCod+XjgAAMDHxsIYeMJJSOlDa4CYOu2agMBhtpyRdbKyQIFARTEMhTVp1ysb6EUgPstQFAsCv8aBHhwjNggs/8SBFjQxTCDpAy2HZHC2UpQug0si4n6wAmjoUWPsSvmU4HDI3svvyQIbPLTy56FLgj3ejCYA4bVOkF8WmrRBG2/ae2Ym/mVpmasEqaO3DjB3VFL7+mSZnOD35bPQkwu2PpfelADGKiFhPrOnj/JeHusGsoAMNHDMdjEk08O7PNfFOSE19YxStSGWUpp1QRhhBJ6Yc1hRxzg0QEDHGCFE0iY5cAoCGwYxVu6SDVJAQ4MEE6JbXTjAAJGjDiALmQs89WAvCiHoYlueOgijZNEIgs3DmzCBo02XjgKkNscEKMRLmoYDowyXjiAFUI24yEZZvn02TYeDnP/kYbDMMllUUsOoiMWZJh5oYbbuAjiKD1aaKIBGl6ExIpn4nlLMytuoyKLLw7oo4VWKqIhL256sc2WbxlKpDWVjlKomJ9Zs+imk0i6SJiPFpqQVGcGymWI0PjUY5dIUMnNAFFCGt+K4UTjBop49qjnho5uOueeIw06kqG9cshlA4COKWuTR/jpxK5LTkhttdZeey012G7LbbfXQuJtuOKOS265EEZlbrrqrstuui62C2+8cgAqb7323jvukPjuy2+//v4LcMACD0xwwQYfbECK08ZRwMLmNnwwtzpFTHHFFl+MMb7/rBcfn/a5Sq6LU2WMxLtxLAAZySqvzHLLLr+R/w3Hn5Gjky4jGxCAwwjoCzPPP3rYRAG95QTHzty495XJXtgYhaNCk4Hzkk8vHR/Spgw5cir6LmaHw3NMHOavSET9ctlmn93yMgrss8xLUykAwRZ8DCDdagkk3NMWbQiggF+ZOLTAAgYIsFcfgwiwGANDjEjFA30MXvjehPcE2TM9LUBIEqmVIpsQozhAFwNOmLGfEXQPNdQApRBH9yREYG6E4gLwzLffBxBA+CKA15jAAnQ5iBbcrg6FuW+eiyE86XqjzXzzzgd8iRiECMOPzCmlAno1DtwNAPUGQOAlJo1p25EmRySgEwM+40KM+d3THjNMOJuWV8kKZAn+QN6DT/9MNR8d4ZbXjAxXQgkH125ijwK4byzaOE0b5vIV+wHmfB7J3/MuiMEMqqsAzEHH/6pXkZldqHd+o9srxKEFclSEEVpxTiWIoBMVooIYAnjh7LABvMGlpjPMYATm9uOTPDACd1qoSF4CELfXPeQdIGOfE7gmlLBIYxtQaOCDQpiJvBliG0Qkgga/CMYwXosBR7kEJtzmqn5QxBt9S+AbopcJI1ylMRZJxs9QsRCPIeE1ehiAQ1hRiEEU4hQDCUj/ZCGRJVrvLZgwHxQPxwYcCcOKvQHASbyQORZuIyBi7KQnP3kyQnxPEWgkA3WEo78+ZOcr/xELLxTHHt6A60KGIQb/d3rDRyh4xzx5QYpSnCCXpSDnkE5gjVEUWZicja2VYznP+TLCnP1wYzPmueIoH+PLpXgCOYoBpTe/CUaw9ShQFlIaijpVom58qkhQaxMAPUOqZuhxUjjTlKAo9SpMMWoUZlETqko0IiQZSUMe2pLIRLUqVd2JUVlqpwN4AbIj4IhLF+GRnRZmgBWtU6DjrFSKIgrOkIp0pGG0Smm81i5tkXSlLG2pSyEklRrxS2kvralNb4rTnOp0pzztqU9/CtSgCnWoRC2qUY+K1KQqdalMbapTnwrVqEp1qlStqlWvitWsanWrXO2qV78K1rCKdaxk3SBKsVXJDFYSAWLjqtDa/+oun20LYnO1GrvYGpO0ygGv3qQUXySK0qxFqKMCASPXrqiuKc1TDiBtQ1hIVhpLmXKx2+rdPuyg15gINg7jXIBcIyvXNhR0NjTxXQoRgFg4cM2zjtVFamtC04oZgxsEOMb3UpHWoHmmnnIg2t62wVuCtAFsJXOYb99AtgglNxLKxC0vcPYr6CbNM2lwbaQyOzU3EJe5040DLuiaXa01Ah9ypWsk9CW0s46tuXNgb0xwpq+mwcQLQ5ple/VlNEFgak7kCO8iIhrc4lbtZseV70MiYQX4wkRoPPNtFxKWtOjaFWbkgEJ+PyPX6qZCbOtwyhveOpIJ5xceyz0YB1dFCP+39M13vzqd487nx+klhDmQa6MpIOCVy2VOCQiAgBFWLADRbG5JNe6DdLrXAOWZ7gFDaMn5cJm8vBlhbtIhXop7Ih0pVA7GxUvC/dT3ECC3uHcvPtwvZBNkoUBmejEWLiNkR6NbTG4Ur0sAn26Xu9rJkIWTM8Iv0dc/vkHAGlK2z+446DvVeCgzwjOF6ErSuY70uBJFFkrcHHDC77WVJ5HTszh2OADUWXoL+8EcnYUH5660WXOq+1zoXAUIb7BtAZ6bdFZy8ugY4RgKqUkZp/uG56iAIbJZZsCWMbLHPnODcDZewpddx4baEgDTXqmzx/4sI7qgTwzKhrOSb8FkGQL/bCzCNoAmCLiAy+JxvZaJHjXct+097nYQ0QYLNBoJFFTQJhgy6gM19idnKxzgG9fYo0MAjr12JLh7mCJEA49GvwtNEd3qrkhHpDAJikOQG0mL+ECc+MFj8jEM95ZoQkDxGifHatFPOHgFTZk/USywGyx3oKEj+Jn7PQTeMZToPi5JBlp/hYB0rB8IQ+4ahwh2ftEuxG2x6Eece0HnHY46x9MitAV5SDQipN6JH05heduC5yiJHisS0uHrceOEzXhGAOOHC4DvB67/agwhWCSAYTR5eevW4Vk0nW7paQF+y95htJdyi71zQd+ChyHggZLCEELHY57o4nBICAZM/y4o/7eBgt952AU16EfxH1vDHbJQBBILwPA9VHQgM3Jrtbee8Zq0hRSoQHPhVj7yN5LigfVT8ysWQADGnsQPf9cJG/a87QC4Cw5n+MR1q+EOohcTyD7f9Gqc3lXDL34Wgfj7nBH/AdCOxBmU8KDQtyMMYM9VheNXw8GjpPrlSDu4IIFELbgG7ouO/Gb/dQn/sACBAHSldwVWNwbp1kwrgUMIGG1iMQkFaHRHwIAKaAWG1CWh1kzPFxD+4GiA4BGBoA0OyAxmtweYcEfNJzR5AHSXRIL140TagisjJ1xw5D4oFz8jcQ6BtkleA0lRREE8iFz3kUlbVEclU2G+AwcMYYOLZ/9EtiCDU8R4DYEXg1SEbtANRHGFaRcrzoEWLnGEwqUGIvE/7dcGkPAaDEhyJlh/VJSD9OBov2ULuICBCEMAi/Y49IEo/0UQu8RDBUAAmHBLN/Ibfth0DQABbKWH+YZFgwiImDBMXfIeEbVNzBEX6iEGdjEMRJEawGOISXAA3qEHAVIfi6AfG/MVi3hNCFEePCQARyJMtWQILGIaNNh8AMJMLWaEatAf9NYgB7ZKVAFNlIFJtjFfzxIbR7EZv/QQt0Qd0EAAbPAevwIa4wEWrjR7ICQGtIgWT1IcANSK2ccIcvE7fZKM2VRMv6EHgyIbO8cXDVKNx1Ag78CJTmBFEYX/hvEziEsQirWYfb4BHG/YcsphTPtnC8SRM5EYMaryFsC1J9RoT/00Tgx5TyeXI/sgkc4CDftwLB2CULWCTxRpUL3hfGiSCkXSKUoCLCOxT6viTxsiUz7SkfZxP4oAKDOZUZaSkRQ1JVnSk7qwUDZhLO5UMmwQlJmCJafSUaCCBBNFJq9SIx5CWNwgLETCUboQTxSSIm6HgvHRLEbyUI9yUIACJz6CJb+yk04yUCZzLCcpUBm1DxjSlmYJLcWiKsOgLIqgHCyJJpvgBmSpT8OCT1hQlq0yNogSlI5FKXWSKAylJUUSW2MFRxHzf56kUvWCI+hSVps5MFNZMJH5SaC5/y5dElqcaZqniZqpyS0Qpi58dYbDRXdwADGuCZudxJr8cpt0QJvispt7FZsQYl7m0pvIVZoAc1zwEpy5AgeVNCcGY1/e8lipdViZBQe1V5THuC0IQFrWQi/VogbaSQeKFS7P+SbWZS4JWJxihy0+lJ7UMk4P8ljudzCWVS+VuVqTwDXgISHxWS5fIF1HM2/ldZzD1VwQMwYBpmEHtl2m0FzWiQoW1mChBWLiBQe3GV5Tw14TSqHkuV5aoi/LhTMQxJrJVTOoAF5rFVoGRqFHs3Gm5BkddmElVjST8J/cdTVjwFfEZWBXpBO/6V4jNjq8QFwKlldyBaNDYl75xaFUk/80NpJcy9WjIaYLAVYHkOBfy2kjV9qh58WgNoOPQ5KgeBUUOaOfGWpXKhofNhKjE0YtWjaAXEYIsVYSJdNrx3BkHXQ/dWOEOiYOzxZmaPYrVBYODtp8i2NtyxY5b6JtriMbODF770BmfeBiqbM6i8ptsDNq8+SmvYOp3zYI+4GKcjogeeofi8MIpUY9h0qIx3Oon+pF9jFntnapdmZ+pQNuQ7AKk+MNbyoUgFoQjdqNalY8kUZnvWFlT+hlQuA62mY6Rihmotp7QsE2HMJsXSmrh8pnmKoGB5CItDBktao3ovptx4pt3bNq0kY3AKRCcENqc4Y8g+atrSZnpnarUGD/bJgTOLQqqFj0a31AAN8KSL8GHn7KOttGrO/aBIagbK4qbhHycExndW2VdYzEfAk3EJ7AdCU4cfimXdlDqLjwGmTHSgCEEN/wEPXDREfQEcT0QW9new0rQsgEcNs2fWBgGhwXCR4LNFnyDCInkBIks5MALkgXfrYgd2mGQ9qgcSbbCQGwcY7SF0a4BAvXP13AhtSgSRQXsW8iDdOjQPz2fAK0ixvTYz5TPzMLXABXC1agcs9Fb0mQEGC2EmpAtLkjEE1AtHMHPNeDADobdFs3e4AUeAohcS1rslM3QRcbPzQLs7CVB563emfRfeSHD+e3duYWl5inuNjHDNWHenz3/xaa+7EeknLKVzJJRDggK472yDHA52Y+gboGWbPIhkyW17mouBhKsRcc0wTUF3uzdHxje7t2ZAv21w7+R4k5OHpaQFDI4LpIELwH9ixx43qEW7xcpLifiyHjxzMc1AAeFAjxB0Nhy3/IJAWOerdPFHmLYbuaZ49TUAWcGxSXcJkvK0KIdUSwVxENtK2i6yrph4Msgb23m39KFL2eUHtqoH7f8rhS8UfA5Q3gIFwWOBFzuEUvKHHr2JW0sEZS+6Dxo4YRQQazdbKgkLIqSEwFhwyzu5wNbAsBcUKzew8eGINciUwls4XxE8MqFIVFqwZ1KIca0ZUk3LSXJEiKq13qU/+1GTwNILFFBdiFbUBGh9FGIezD6/EaUrA9YlM/MGwjnBQRSLqDD1wO3yN0dtTD+FsIPYwL/KtwFkwGK1E/gIQQwmW1CqDCR2ydCQwGO8zAa2CI7EhaDNIFj3g+mJi14QiKouh5i9gViOzByTR8+lggmilRRGEUvuSor8iM73CKyLoamCy7YEAd00i8r4EcteE3nlwU24OJCDkMs8jIAomOyKTKMkQapiEbAXmQlvgNWZNL7rGIvuSK7uFj2LSM2oRLmuiL4NGPaIEartfIAjIgydgGxTNKEdEehMjLKZvFYIA5v1I/wwQFUIIcz1EA/fGJi7EAbIeET8CN0ktyLBT/z23swmqASlMRj4F7iJbhAM4sigVZywgsvLVBGNzZkhk5lyMclX0ypbJyJSXSI2lZmBniK1AD0VJilNPSKImZlV7ylcPwBWxAJiViIaG2IQillgl1UfLkKQTUMWiCJ5ICJVeCJ1LBIZ1CTz8p0x4TUBIdmG8xK4o5pYgZ1CPpBonJKw+ZJj3CKxpllUCND0GTlItWlnQBJrSy1L6y0Axqkh99kY2p1YGJJ1ZhHwglKTj9mJaikkjpkob5Khvs0klpkmdNK5NyIoTSkoqS0XftlaqilnBtKkBTliwd1RstKkptFY2rVK81hdZiyapJcuqpUyWJU0nxBRb5VJ4pCNQp/yHtaZogw9kv1Z05FcueLdmprdpYlZttakrqhVMaWjALGiG0jYXudS2tfS3DudorA54wxdg0wWOR0VgzgSczvZ0yMRekiwlYAdvjoiHeFY0RgzjWUt0ivZx3WJ0J8VdCAdtLWgel7dgGM1oGw1pJ/dzaldwsY6F6haZ4UKP+ZTQ1SlxKAGEjI9tS6tUpcQftrV9xgAAEIIIE4AiAaEGxpRPUSaQwsyb6Ut3VGY0XyqaY9TUTDuA0Vd0XRl9QY07Tohik6SIfDgez9R62lT+2HaLkgNtX89+ypwcXVqKyOeEMxuGbNmH0rVcI+hXo1RsaPqPkdYb79WGo7ZrNhXUihv9fSKPbIQZXvkWlLvqb4gKporaqzuemz4CqdKarxyZmIGQ3emKpr4JlkyBm7HoJcbMJsdA4ebgXUIQEDOAI7UwASRGIEUHg3boIBE4ApUAACfAASsCtBM49S8AAEEDg4dBjgt4Neg5SaJAAgi5Reh474KMYx/DnBQAId44ADVBbmTDngyPpYlBb6Ctaeh4QiPPonZ7ofW4F/6znoo44BGAE1a3nTGDqWddYJ2YWKfYNXY7DoNoMvVOOyYapiPY7Zp6rmCqopjyNBdtgdeoF95pIxNYiDCAb3CNmZmauxRNsU/5iv9rOQ1MJ6Nc3j1vunyYEofbtpkiv3oCrYvevrSb/q84+qz+2ZvC9to5A72NDQkZ2rphRFGG+Lifs5lF7yu7Rs6MMyByLRltsuBLMDRTnuyLUPpfl5pFeGnATOLLePWMR4F2ZM9qp3XuOt/9qSRxP6N+LO93zCpXOQRH+BmgQFY/utNqNOOZGANoJAYGAYx2fMHW+8yzv6WwFS4hDa8aF6Zjxv7KOiEqQAC3f6QJeAHoi6lMf9NX9z38V8kov4hxhbv55bhxLFUILzoqwgStc9iqLM+I2cn3LH35WBW53uFXTeb3hdQ6nDKGIbxjHbtlH8NDAtEMDZkTXFuJjQOu2TBcSGUgL7wH88K+xtrawDJfw8NALuBAXbVUi9+3y//dBp0UHP/HBrL1e/vSPELuCAL/doHgTD8cCLFxvFIiy/gAJ8OijUOsr/yoQgGMjnxG37yq4v/LAnxUXfwvTjQZSYfzRqBgOYO1zPm1JUOvg7PyucfuiLgfcuvtL/wRKIPxCoefUv/3W3/XY/+g+od1wYHe3MBd6x7zzF3vynHJuaF+orLmChD4FbLepYLntx3lAAAgIAIDBkSFQHoZFg+AxYAQAhGLzWLRmAQJqUUg0DopHbtY61oLDVyKX7a2WyfIARClYdKlNB56sKSABIAHhLm8PTM4JSooqDVFJka3S8hIzs40r7YpQDayJr4ChqEGBr43PAZXNCutBARWhNP+z4MGBlU2U941s7qFhDdOAwLjgwPiTgcGgqMCVMICAjECsgOABDBrMWouIGQAbVSDNYEAYbICAaj0g+QBAgQAaIoGemQABgNlZHAABAQb65BH8Vw5MgwH+tEijFicNwnDjhCA4cG+IFQPhEE77RcDhAI+ZDiggEmBBKV2XIDhroiBeIW5F7BCBWSRBAVFx+hAh4FJMggaEaGESkO6VGEZFGEDbqArmSjdlFMmJ5GuNg6pfpgIoWWTBga8Aws4B1UlcrVOgeJrNIqdo2520DgUdCrCWpQcxjWw1G1dTYMGBsXxkQ6rBxV9d5QhAl4BKTZoBDCQQmWtO4UKoFDx4R0n/HhOhlS87KAAhAILTqTXPGRpgHc3FYO4RwkZAUTI8SdjcEwDhobci85JAmC3cW7IEDCDsm5fAQQMC6cqwM8KuMh4CrZ4XrKVbAG9+IIsgAC7gXpdOCT7RtgZ8NkL1XkEy3yfwd4In1gbGQ4jNnkLeo2akaSwp5iNUSAsAMzAWUCAAk4QQagAxFulpQoWIWG2fC9uAroEHxIBnOM8OAO1BlJKajI0BPItCCAYSa2bBXER57RF+mGjNCsQOQG0XMTYSi0YGiHQmDU4qcew1tjxMkgwFFhCms89SaeKoBpoShUR5TAQtABkbmBKyHDup8sTB1FwTGSG+mA2gAXY8LKYD/7g5YIA7oWnTK6fwPMAZMtoMgIpz9lHItMMcEMmJP10aYB/YVIuH0DKuyDMNJixRKJ1FOxRn0UTBOEckRuVkA4EjAG0xplPjFNUAT1OqBDZoagXAADypS1UYXrcJlRvYuMr1iH3wdIIAvpw4Qlg2jvXql1RFTVVOZ8rB84tnYXMAV2ZFKoBRcC8RVVNcHa3kAAcsesZVZ/eMCVy+JHVXnHjOUTemc9hAdKYiFhWXTztpZXTCXPwhFlA+AVDonT3RGfRNdofgqt5RDXbiYiOuiBjdPDe2ROBfKo2V24UHSFTgNql9d9l9T+5XnJdNbljjhGReE+ecdd6Z557VRMABlP9A85nonhNQtuiktUw6MPmYfhrqqH3eSWqy3mmv6qy13prrrr3WOdZ2v5aa4rEDKwDmqp81m+22bUE6ajwdYMjtuu2+G++89d6b7779/hvwwAXf2oAA0n7agE+jRluTxNlGgG5NyralX8cfj3wwyAe3RPPNJc8cc7AV95zoznM2XZzDM7F8b7FqPowBdBaPiWqo4bik9qwFTmUwtLyC28ncn3bdksZwXopoC7dGfucFRi96d8F8d774yXUWXk3q4YRederXVKBk3nNG/nbBsDfb8Geg8Z0tBJ7HfU+K01dliMIZOsR81enQaZvU3LAfZ+4bFWU0wQgvCDAUz3sFNxj/Jw6uHIF/qlid/8CAQAcyRCfOaCCh/GEHTOCvgghgnk5mAkLCJLCCw6LgYVaIKwKWR4STa+H8LmE6GgJkHwAsT9nmx7xMLLA8/gDhAZ9XuPc5IX31e2H+gmgWF75vhTcUAjeWwsEmXkF/aYGAh4zYvwKmpkNciOAzKFa4BiiPjFVTUhWiAAFoqMoaoGGGAEQoC6UowDiuiELsOoOKAiRgAY6RBx6YwIAHzEoeUhIAkhZgnWcAUpCDcJoRABkLIUThkEKAwAIWoJ8BKGIB2+uCHo62MMsIxQgPEA9A7EGESZTyCQ9qRTfa+EYyOMAxsaNkH8NggJbg6pfliR0uRjmA/1IewDGG8MopqSWPUDYlFVYI5G+ipEhnxGIBQAKDYpQpi0AWLgHl4CRY9qARQMoikd+khYvCd0kX7SFMh6wFNrXZCFmK45wrSoVVFCCFfbzynbXw5iLZOAA3miecbLgJ+EJTUDemojOdHGUnlbVOYkIJL+yMJyI9JIpsGBQaXkiGHizazsrI8o+B/EgtEWqTZ4YUErXMxAIcEIzJlNQIpFSdEowZjyxUqJNv1OmEKoRGoOakC3gUZc7WiFE0WCILa5GHMPRgCYzOoSz8KJwYROEFqdK0CtQBS0yaEabRcQGaDtQnTE5ThIdW70N7IkSFImdADGVVmd2gwxh8uVclvf+EW1LpixNSQYqnLOwBvjwYHCJUB0hUUD9fjY42xNeFdBhAsmZNC1PWR5ZfYLYVNP0kYSuhE316lbLIwysCwJoZpUTmsV4hB4b4IFm3OBZd5CAEUjHqVSFdSXmjxdVtC/GFrbKoo2LobWyFS7dQOiGrzSAu8hobzb1ioilj8UJzD5umS8iBFHz9zgK6uwdlUq28XRhaz5rq12pAlQxnwG0lrmoFu/ZiMlLIQzzYd180guKACeinPrMAk7HAtQmd2ML27NoG9ORBcU4ViRh+apgmhDetzwjPA/75BXbgYRJUy0InK4RbczBgH/pdAheoywABnyMJS9hJlihr3wfGWAD/dtqw4hAg4Nh0FTa/QN6DlRDDNQDZug6m7XZxzN+9jlAoNT3scm8nmW3smLhoQXJyh/GW2BYAyx5CrlWe/AUSC5LMTkLVFBqwxVHsGL/f9fAYeoHfqwRpKj7kWXvV8NRKZGEsZfFhfRsqkzh7QbBOBMNNDP1ftIIZKVChVDitB1x+OKUU5eOdZPaCCQn32L1HVkogL3EObYAXxXnBS4tE8gkvmyXH/polALSC3MPgQrA7CZECIt1pWR/IRXGINJBrXVlfF8GmrmVRmr9iZUTPerqTY8ACkIHOaAvWymwwNXHfqooh03a5it42GI7NaN6WeULovqolFhAFY1LVuC4K/+/CoO2h8EJQLQqY91p+SbV9z5Zpg1BRl+NLBiNRLAtDOoB0B33dV1BoQ6ipy2RqxC32DUJDElTHdomQokbGaEb+SChZhiYZFwUARpqWErzbQAsmLIBiEi5EdCxzFlVIp2yLitAe9IDyKH1JvcLCd2JqTuZAEqoAFffRFBQqmgZUnGrhOLKYyGsZBuVCJFJig8dPazgZLZxiLkdJAHCkERnlyCoHaJKzKWN1zGB05ZWQqC9jsly6o9zSYNC51gXgAMXk9B1Be22LeC0igqfi4HsHE9UxXqHDr9xHRWdufNGY1mYzKOs8fwwV7hIHmKe8DpvvguhTJKE4iF7PPMOTuP9qVqlKgUuslcJVxqKnjo/VLF6hgFTA/FSt1x3GVQoLxZ/0nidB5WJui44JUunFp2a56UCYSRm8FiXW1vehUH7PguwFBS9VN8pVjiGYycglu0qlak4hgxazzOV7cNHsVwRDmAGE34AHsitR80eYJf7V/SKkTCRqD1RkRwgw5VJoRmCSxWP6pGIYcP6ub/baCSCyhRtEhgoEJmyMhWVGhfhiZk4KMGHqpHJyYV0gEACfrgOBL1Fyz1Kgj2TiJP3e6GPeQdvCJ1b6ZP/+bwGzapuw5fZWb5sW0CvwBWQWUABJBwnPphaeAHCiYyiyqNC+KAmTkH3oawqvUHAICgu3UG//ZI/+ACfIoPD3SEIMufBulsr2zFAN7+aI1tAN3xAO41AO55AO1ZB1riBnJqdwytBu7pBr/PBpGigOUQdvUAcQt0YQK+EQN6eF3KbSTid06lBNaqcKNcF3SIEAB0P2vIdrzods/stn+ETTCsgRHxGuSPG7LgENB4O6QFFrykdkXBFqZHFnAEkCv2YxKhETiGdJTNFBnucIs2YVoUaJ/KETbggZseHPRMmKyChQokWIRseCDgFzmhGGBuiMLGGMXKhftrERyahDaqdwysaC9jCFgGJ/wo4rSAgPHQiKlkjbpCgUZkKHNG0cUcXIrlGHVMgfvoAdFe0bdwgfW1GHJhAT/zJIG1uoIHWifK5iIeGRjGYiIC2BK1bIhLpIEV8od3RCcQoyhbpRHfuHGxRsivqHIWSvgcaIESzIgSrIGTDShzjygyrNG2dCF6PmDjhJP+YgpQSpJ8ngpOahEuYoIBpp56QAGriJFpLAyATAjmiClOIhorDGmZByokppEIqqEnBJCsigxyrEpwTMkmIJnSSJHTAJntDIMiTqKuPhK2NtKgcpx4yJl9JpkZQyM9CyEqTEKp3SON4SaT7qoYbi3fiBKXvjkz6BniKDlAJq6uRpDZRypMhLD8oynKxgoK5JSuopRiDTLhmJHZDJmBTH5zJpo2qBK3Vpm+LoNP8vmRRHKf/JEhXMcpxIbg6CkjOsCacS4pSohJBCQS9bkw1YoTDp0pI+UzLjyKGS8jVxs8+GqjGektZyybFKqqV2ITgv8zNbRCz9CJLIYDK7RhRuQprIygCi6zxLxnc4Ifb6SbGWRcjIjjtYLsFeEnf6ydLOS3n6Sg2Qqq+UZLU0i4z0KR4hIz+dYot+YrhEQUkk6ygIqxNM6z7rQBH80830qj/lSs2QCDJCZNmW7LGQzL4uyywCFMXoDSwmy9a8TT5TNKxwRS0oi4W6jj8bkjEoI0aFDbqW7xBOdN6gSZo+S7Kaqzc0VHgkdMtQBZdszkFJlCTFyxQ84xOeMb28aj5r1LGIVM//kPREbUsdDAM9FW1rGPS97MpM54zVhoEsLMMxRCw+5cvS/kCQto5NcSvBuqIr0CAPsGIOiIyORKHHBkzjnmCPYKsNrCEPaA0QVEFJVCzHwuTF5iBQY4NOS4x3EFUJrFANSLJ8CPURWMxQRZRFM8PFFABJaCKcioxBmwxU8YwPHNXJNCkRUMXHuo5MNRXIJKGqQqFUnyBV/9RCaGwNlgJWwcyQIkyvamdSu85ZzolPt6DJINVUnQhKdHUP8OhBmYWrXCnI6OBWvcBYOayyAKJWGbXJ0rRPvyDNxFMMyLPQcsLcbiHS0DUSXA1SVA1UA80/aAsvPmUQ0K0J+k15QE0N/7rN5o7N24YtuPxCMgxWmCbO5hJNHC7KstQ03dSAERwWQ7MAmp4CFrei2BoDRJUtySbW4pBNWURBsEJWfl4r0dIAMJZEYW/KXnH1tWJWG3EBYXUtFnqNLyR23DgLRjWuYkkWeRSUR2it3m7hZAkOZ01hi/DNFGZLXwn21brl1MrmQUlWYh3uXTvLa8Ik5DID4jLE8V7DAdbTMNKC6ChUWJDJcLxA4RgOQ7IkwyLPTjsOQkyPNmgOPIXCQ5VE7GBOFLhO43CE6STjIhrAQ+0WbSROSSoOJjAOqyDk47bh6yTv/wBXRg/v5GAEbmcCcb1uRkJ18JgVM51OR1Lj4AhXSP/czjS+julC4bUqzonQBEUsl1lBZE7B4OCQDHebDuMGl1CUR+pIlXGrrjQUr0VeJBDQyHCTdOZC5FlxBXYnF5UOjrhwN0IYZK5Cb+1w9EimV/KYN+4cRHdVwXa/9MjKdnW7pgCQzx9+gQU9UPdYLxQ4BgZlT1d0MFecgvZYZmUqAf0qZfr+jwhrEE+ipVigD/eqrwFpzfgi2BQCMCk3kFr2YYAL8BA4Zv7il2B+of8IWE4MuIQauEVu7/mghW4YBgARcAPVj/c0BoT9UXZAWBgU5gHfr/Zm+AFng1+2coJ92O9kbxseRgQrWFSeQeeY+IaVxf7SEFzyz1FycBcIRvj//GWIk3hUTmZduA/8EqaJY0YYLFCJoQFRXCJbjBCAk2/2FhgHO/AFh3OLOdD38rcF6xf2JDFwnJD5+BiQA1mQ39CP+XCQD1n3hBCRF5mRG7kLIciRI1mSJ5mSK9mSwbDURscXpYZxCHEbDHlvDjERF5FnPHlsEpFzIvESUHlnSJlpTPmSYVl9SIeVGdl1qpAS1yQP9G0XofBqb28UA+ckQPF2PFEb4WZ3Uo9ojDgTgnlFA8OZ18SYA8N1gnFcnQV4/EaE0oETVY+KTDGa+SacUWW9WMtvZBITmpFx0gCdi1FNJ3IYasooJucQKnC+rguCQjIiU6iG5PEK3jES7xEP/wF1fvK5K8yxtCgod+yqHP3ZhBAyhK6LG0EmJqixFy3IGhFynGkFZtz5GpGIxzqEcaroheQAIz85ohNSZ+o5nT+FpdOZPZALovtZzm7qUxBajJbIiC36IGmIJUvSG48IgQy6p52iQ8zRcl46jfZ5TPUSlQrhFF5qU93JNDepk05VNn9oam3uOvWun1Dplw2TjoyTO6wJLzNzOL+6jFVpkSoT2viyKTrvLtbyE1aEOMG6kmaTCAATO99JLvniOl/JLdkUaeJSNJVJsMXafQg7lZKAceIyDpJJKqVaKQtsJ7msCvrpRHnVM51SQnCKp0qpWFqpKqHpgIapnd4iKv9sqP+ciq3TujjZOqvv2vpo91Tk4LARQK4JAa1xgwD+IKESm68BrTnPiTMOiSq3iZmSyvQ+io/G0q2XRLJ3yZK2FjKUsglKyg/UmrpRAS+5RkK/Yt6EAD/9TK0kDat41NOUYDps7poBYknDGk5dI7Rw6bK8VEnfgKBWiyLxE5oYDZxC1EKAhk+3hAgsNCEJVMwkA8ETQkgOq3ExhAsQnK5cwT7bYrwb6z275WT0Yxw7TBUyZdaATKp4TUup4N7umbyzVBHo5tXQa7yIq8I5J773W73h2xXrhxDkNkf/W+3q+0U3DUMofCFi9F+HS0EjcWtBaziEgdD4294yzTAOQBuKYsn/m8BAXWjA49swlnxrlhWY0nNNLfWpwPxW7etXj4id3WiNmOciHgQryOcXGjVaexVWmxXOASzNK1WQPqmvPJXpVuTNJQRUE2xPaVVQF1pdMQRTg2sxrNXSOOHQy0dO4YQRpKlORSwBfglcbhvc8JRF5StcQXwOrvbMHGvU0zTb6McnQg1dnFXPIWzQc/wN4BbS/Txqz7UTGszQE5VZQKyqsFUYKj2d7XzO38vm/FRxLt29m+ImpPW4tIwIZt3moH155pWmyqpmn2pr18rJENbTLqTNywZp4xzhjj0rlhbX6k0L0JELwN0T9oru9kC4yKw+N+EXDBwANLZoFXzMMITf/6UCZ03uFwx2FOkCw6fAXmPWRaxNLpTr/0b8tfR1WbJ2s168ZhkhaDGWXzcLRWWOvtz9FxC23NOZCCrjtBURAtLkZRcc4PulWL4Paitos1cZFyie0OCdRVK8yxRAup4BFwJWIn1C5NWUabfGcMVhO9j2754qemX3VIm3CsidUIxpQgbOmcQKRAwvrEM3cq/X6dYXJyaLT6X+GTL3F+YBjcsk0D+E7AHP8ZpgcT0UfQeOQxRqSixt7jv37rQheBUXXPdezRzX83wOb4OuVMhAwP6s8JRL7bL8Ruc2bHYu6EAv6w8f0TJP1Tt+9NbO72pO07a+7Ft3EN5+6l3VHbzESv8Kwilg93bzXnE5Vw24F0IcYMcZtymKgW6w9+mMZOFOlatJv/At3ywQZDicDgtESvCml+sNg/e5ZoT9hRsKGPtqZoTjN2PoF4KNAGbMYFWghfXmeFmI0IQ7RqA/y1FqOIzp5l6+eB23v4JK+AtKcGZk2F68mFI6kE8yWIiBoDAAAAIDBJFocDgAhwKgcCAiBsek0nEFNAYO6DM6dQ4MgOo1EMCerVDs4TBYtw9qorxRXBu2WQfCGIHcW5IUHtSSg5mB3JiAFd2dYt3dU+PAWJIl1CEbIZGQ3dodWx/gVGmUlt5pINFAoZhSLFHXF5Um5oHZ0J9T5xgaUukt1K0Z2rH/AluBFp2iGYBvqa/zgB4W5BxRdRLD2/WapxHvoWsq3ZA4W7v7O3y8/Dx9vf09fr7+Pn+//z/AewQCCqAT8CDChArpLTC4kEhBeQeYPaxo8SLGjBo3cuzo61+YjiJHIkSCMSQ8lCRXsmzp8iXMmDJn0qxpEyMCafsKBNBpsYCsm/WACnXnsFlQkgFMZjwqMic/BE7bEXVngGnRhFWzdoy4r0ECPwyx2rNSMc68Umj5meWaZCCWah/PLIinMmCCBU323ZUHt2Mpr/kWPKgrr22oMQEEZJ2LBYHhlJqwIAaZdCZPrAZ6JkGAQHCSzT4NGRQslfSbzSahniEboJDUN5W7/11uHZdzZ5NbH7+GZS3cUc+o2bgxmBne5svC48paDkB0Z9xFsL7+69s3TyWrpUOcuqkQz9G0uzFutzQ6m94ABIePN1B9FOntz8CnCv80cV8FnU+f9zd5aOpVthh50FHh3XxYHOcOfqbAd147fy14FWlUwWZScXGRhR5z3QkVwAMDFFYEA4UxQMQDCiwAgUMBMKBiAmYQsAABRgiwQAIFIABBAowpoKIAjYSVgGcMiNhERAL8WB4BIUIAhQMKDJCAHpUVkBckRfQ4UIorrqHiAOCsd2MCU1jxmQAJDBTllHowwIAAaExDJhQCkDnFAUNiNaUCKRYR4ohUEkElAmEJMP/ZeksSQYCUDCBh55RTgNUmAH3i+NyNPz6XlwLWAfBmnHz6SaClCTzGIySGLTAEo2EicQAkRCqI5RAKQHBoaJwy8+MCQQLQ5ABP7tijE7E+autcrTpa7JSv6smmoBERmGezlQLpE6ho4jiFAZkqYAAEjISbxAEE3FjoALiii2tlth7qoolE8OrrjDXCWu0mgNYVwJbW9uoTAkY+sIi30zwAZ7k3gijivoyJSlESZtm57TQJ9MlMtwtoyq8AA80ro5M6oloUT++VV1ADD3i4SXkKTEFAKyc6UVdEDVCklwDZ9GGYGShTpIAecCGGgAMOz7XAGAxstmzKKxch5XqkGJ3/xAOaED31NGXIfADNUq+nM2W+SBjAQBNFcWKOz0GAhc3yBo0HMxEVgHYnphLACABIDwrZXp621ZbJv+KtzThrA/Dkr3AbIHPTSej96WblOe6LAW3n3YTQQ0S0uC0q3xih4ow/AK400lwddRGM5ayE5XqF7SGBjxOpQBNRsgFX2uACkPvaA5ZHYNStYx5z5/a9x/TNew0KjexV+Jo4aYEDnh/qBE7fvItICA+9xN7BVKiUgUfdFmjAmwUX8ARGFKad7zJgsQEFCFDio0b4cv51eWqM9coFma/fGnCULs157W8U0Z8CsBaJ36nOay6C3+sSB74BDIR0rjNX+yKIv9Sh/y5xf1nTrTTXIzt9hg5+u5/YOOiAELLBKy4zG/QWE4BbTYxw3QFeEgTDPju97DrSouHnQLMo8sywfQ2RnBM41UAOPvBbO8RVxADIwTS1DwFz+1RQ4IJBO/2qffzjIBgL8sQeFgGIkTmDxSgIxjFiwTpUJCFi4DJB6aXwddLC2kDeGCfzwYmH3COgUFaXOOAVxAGGKV/LyHhFLsRtDbZrxsBo4bkAwFBvmRMcB9s1hhwBz5A3NFXWqjc1fknjbplE4SLbdkdDRDKKQxQkXPSitMNdppJkNJvcTiQmzlHBUVXDwgOyccLrDFJyAcOKVzhmQrgF7B0uGxRPkAiAXxLhkf9v8eEammnD2zFTZr1soxnU57VQDMya1BPlNBF1I2lCD3FJcCcxySPPqJkTetpsByzBWM93FoKa8YRLPq1XR1eucnr+1CfEhhhKIc5EYwGgURhfw4AGHIABLZpoRWWUQ2wkYA2bC0sAmOAyfjXgGSqK2uLiMMtLJsABKfsiSdMFxrlRlEU0pRY63QCBUezOpQ9gDKxeIzGOetRrIxWUKxPnUIhGgVF4oFLjlMAAlcroAGDxaENCZLCFfa0B4AiYHRpyVQd4KqhCSKH6GuBVWagoG8RalFU7WqkHUPKMMWUMDrsx0QYswAAgZcIfK7UAPfSprh1sY1y/RFeurachc2j/6UunAbSfVsoOVPLrHABLroLIz2tgfegaGlAj0CVRrSrLk2lDaQgWSeVkPfkr5pJQWMY6TgEPFR9mQ6q8OVESEFMFLWJ+u1Q6KpSgBUzhZxsCvNwC9pJtFYoWhDALYERhDirhFxOkMRdQUPc5jojfM7ybCUQ8J7uw6AYfvPAKVYRivNOtrgwrsYYwHEINZzULOvBQBrXUgrqHYMdtzguA6H4EF1Q4kynM+yvubsMgRqCDMkLBim7EwjFk2Iw6ZhFhLFCism/hLhe8EBRRJIYqIhYvL6aB3vLuxRjdpQyIXUyGVqiXW0x4BYB3MRo5NCIYEsZGKLxJmc4guA1pOIoR/6w4hjDoWMVJkHESCPzeJsclE2a4hh5UIQQ9SLm+GQ4wfdMhYCxP+btOnoRm3WKPvKq5HQ3JU5sD4imGxmSRxY2zTZ6J5z3z+SeI4rMcFtFntnyiNi9hr4UH7ZJEK7rRjn40pCMt6UlTutJ99l5GKKQRTXdGPAoy9Ep2gxBOc3hD/hB1PzANEFRbutWu3gg7oScP9v6DGrF+CJvpnFQqnHEet76HhWfDBsjsg83yXEutHfNr//iDMZ5oh7BfLe1pK4QOPHmDp659zudwp0PZ+c41U2eg+HhaKuJRA8CYspkGSHM/TIkNdqBhEgAdaDQGGTeHpeMcT2Xt292YN1P8Xf+Ey6xbchAiEKvp844E8WQ29+42fZLynkKM29wBksY4Ix5PanO84/rg2EDKpicJ7pRasvoGnBAwKaS+JURGulgUaOUEczWkRAvYmrESBYEBlIoNYBLTxMqkpXS1O1ZTgFaV8jIqxqxrCj1vI4niFReby0xJCZz55yKmdIwVzHoW85NfNeYpfhEdUxpjhkDBYgtTfexXNKJkzosWJsccT+pRlhLLFxUyLgyJsIUxlYtgpFF3HQDpqvU44hM/62UlTpAySunXlBDBtF2Jm6odyONWOs+C8LJpWTelpwMAtVXKKtfj8Obp2gIOAvEOk6MRHyK7YzmgyTqp4MAeHi93593/EYMxuA+lmFy2PZg9R3S6O/wQCemU00E9lJS3G96A90zxUaFoyFc89rOPw+NBkABh0SsEk/pBy0/PKxFBn2uLWEOvrDBLWBBgllaJ/hYuE4FY8x9jtsiY9tM9onFx7d+wCrQBkB611uV1kKfMXwEK1DT0Ve/0Ea6gjxn9DzcpHxwoEfkJ4BDx3xoJIPDY3/Vlnwh63PaxEuZUVMC1EjHtkpAFVuLoWdrMX9Tck9OcAeNpCTZx0LiY3tlgEgNiEYHAU2fcYDHVoPLZUu2tYAEc1A9yiTCxwQ4yBhNODbgwVj3JkZAVysYV4WH5oDRdEgsOoQF6mPiY0g+OIBp2XAke/9XbNAAEIAAbwgFniQhXNd/03BUR/JYFzlbXQIRaiUmQUdT3rZJDXZ02ZNUQQBZlpYuNcBBqed4fygLstYhrpVRGfYodUIYYMZ1wqUHuXZUavZ9tXV1yeaJqdUoiwJas8WFPsVv/WWASKOIXXgcdalXOrJWLUJTmFQBryWIoyVQaBqOrPds6hJeTlRSAwUEZFAE3EMeKORmJtVcDeEJIuFhIbBiR8VSY4QEqfIIcQEONFYEjlJiRIQE2nhc1ykI6spg0bFlcjOOP6YGXCZgRFAC/Fd4rrAKQzeMZ6IKZzYWLLQFPDdk6hkY4DtkeUBiEuYGWKBg1HEF+3QElCSNFVv+kRQ4a0TxUr6nhsl2kR34kSOLZEriX4j1bSJ4kSqakSq4kS7akS74kTMakTM4kTdakTd4kTuakTu4kT/akT/4kUAalUA4lURalUR4lUialUi4lUzalUz4lVEalVE4lVValVV4lVgqlHPRXR+BIQiHeHZwf/dWDqtFDtwjAbn2cNLEGcpiEsb1DtMEDv9nDXNrDf9VGtG2lFVQYo7mESb5liZ1lWs7DIXQPURaKoHWEFopgWK7BnJXl7umDJ/0DD8ZD+nTkrtFDXWpmPxQmo0WbVDhAR/VEXPrlZADmLEwmPnhmFwal+fXKLL1fAnxfj+QFpsyPHhSKnfiEASjAbBL/1q1MBo4IHRw+gMXAikXdpqwU3kn5JhclkW0WZwKoDBqlyWfk0Gh0C3aiSZzkjTmeUQFgjMoYwGlNgVhqwwMcDBKc5cnhAc1BhkzV5iHBphngiJF8SsrliW1+TZwgTdWwJxLIDxWdCrGARfjJS3Dyi3FSp372WroczBToptDlzWwKIHnGwSMQwQIQBhG63fyYgYF+C4XeJ9dAKF3gZ5zkiXWGIMtEzE8xwF4MJ6Js6PzMV4byJ2QkwH0CKD71SkfNTxMQm4ASCze41IA1ALFlS4OywehUChQogI7UhWGSS22up50IynAOwZR8X2OlyWLA6Bn8iMUMSprM54c+FBV8/yWkeQUBQIHrRBl1rufeDIBhIMEswVA1DQHnsJkW5CFPxMjuSIrK0FUPhgmSTuZAXGdlkRLvHc56LiGeUCeTRuo0kcIkgdE7NYKjgMhCOWYLZZmpEKqdKdQMOQAf7M2vuKmpghISmIWiTl9DnOVriOqJBBOmrswsecH/dQOgEsmrTgadqo0BlM7aOECcNh4zTM96pAIovYWqQs40rCoVSJaw/qA0NE1p4hDPqc2A+QIgQoSgHqDbBYDanUGl9uDtuCnGrA2B2CqBeJIAeI4BumoiAdM0gim7Tg1oXOug7gXRxKmidmeb5s26aknPtAKqDqzrIA7tVBqbbhxoEB2LBP/eIqjfW/WPKWrDCE2sa3HQFg0E+SzTDhmJ8uWVOBnFEo3fKgETiGxlExjmYw7Rx1qettoJi/zR4oQIFJjFyGogArZPyM1TDo2TyTJQd/RsBHFeAnVMFzIKRSjrw9rhHDBQztZCyP4gAvwUkfaltqbQG93s0J6SQsFF1ULBzPaKwBJT4MzfZ+To4Ygt0kaZFwSVyjAgaGTtgLqRQQSgC4oPz9qsp/6i1niao0VtZQjSgFHn5qSMbTUrk2bDHrVbNmye15hSUj1ssLZo1PALG0xUC2KB5xLBuLztysqt5zxAqwJSzOqO5ZJWJylu4LbFQ50Iz/baX7CpT8hg2C4mp2r/rvJl7gDuTSvl0eT+im/2Qh1tjuGE25mAUu/OrmoRyQ++odi+Q9e+UvHaUBPeGfS2LmndYf7N084RjYjA7UZSQbxOk67arUNQL4G0LuJOpq5eEhfqhbF6yCXxIp5OmuFuV5A0wv26CLk6ksq01Hs5wei4yK3y3TGMISF+yxKoVgAPxNxkUwNY4ET1R7k8wo4Ngrxo6a4sQq80w05VCijBbAuZCTNozLCm5ZNETjXVbXJmzivsSChV8Bm8zcqwcARHEjBSTYpZ1IU+xonAcNTgsMpRBtrVahOUS7EMaw9NSSOcFkCpcAZ+Sk9UTQ33zhKr0LrmxAibBW3tqtoyMBcg/5PXHAAVK9QWE2wLfy9aSeHLtoypzE0TMCASZ++YoqDYgsYbGsAIn1QBUNT/PgE4zI3ZljEpIXIAzzAxoWKloe2j4AGiwIqt9gqdekYCiSggx2v2wgqUnigbvFRfEZt3inLRoKUTaEK6OHGYKolnqEqAJlBfRYHhGBsvGiQkXFl6jjHVhJNhoMUCTLIo7nI12UlauqIp502qEHMcdDLqrnKawvJ6OA5TpHIT9GbV9FrWqkx4QpEmIqksv7ICYMVEKEki/BS74YEnV3Pe1EUCrfN6/NQyagMlR0ECcUuvRDPRhTKx9aYA6Ei8MhZa+DKvkcuNkrJPDLMox/PJKME+m/8ENuPTPVfzP/cJbZWUvHynNJMzWXCDdp6oMGPFZ2zzc6RLOReLu6YnHZTHWuBViRAqM2eyO6+FGmeljnABZsLl/fxZaWblO+gaPvw0UKfHTo8lVi6hkhDuPDSpE7iDUxf1WAAEskl1PCzzUKipVW81V3e1V381WKdhwsVFuKXFUVtvNhEuaIx1RrB1P6ixMZOEtETMP2ymUTgFrQFEY6KmRxI1We40W2qH0P41yibkCPr1+NEDX6dFUQW1Q/i1RUD2YIioaK7EeTpZP9i1eeA1ZOLDXp91MEr2rO20EF2mZ8cageT1oKV03ixFFZ0yVqOoZ7w2udCch86Sbj4Pry7/KCxUqIbq6BBsqHqu8rD43gj1jENkC3dqhp1ksEvjCYdGqJg+rW/jaLbIlknEqm8Kyku/gwG0LqGMM3OekYQKNAnNDJBW51eNc0EkDM2EKW8P2AiR9HQvCn2iaZiO6BCgRXkL83G/c41CJxKF53OMZ3lurjTRqEXxtoRKd3zjyG5qiR/xaJQt2SJstx50d96o8WToZwGXqYZyOIVTQW06+HTy6vw4hofzHQQp+DhcKVDdqIcXNxYQnoKeOHT22pCWh4w6YlilaY77IVrWqVa3hO3kMqFyaukSU5JLanEpbBPcaUIxqq+ejFSw6rLi4JRKg+tErC80OWXUaWBtK+kw/2rOBCwSzAhpOsaRF6ue0u5AGXXYWKChYgX1xg+Yk/narE78WOBlv0evegYolQ+grg6U01KlSKu5msWdn9VzaCiShKspkUW4oCCndk+uSUqgE6vBNiqXN8G4mAWtEnEekm/xiaud3AduP3qjpvoSnh6HKQG7BvrhIC8RJwO06iquNI275l7A4Hpp/06g/6q9qpC3RlPWkE7eHEG9qjm4POlgusTi9IHP5lHGlfHuJXYk0NDFRlQAli0CdqotNDcgiV9ZkwjtaJTg3lB57CUKydpsTPuUilGck7Fv0Llj5NX4TY8DMIDe+HngciG9G2G7ayDPDi64L9DrsFuKo5NxNv8j1bSsFbwsAfGg8gE001ogw5NswXeRnTzmyY5P8h5FZUhsY3s804bG0k4iBe6aacufPE3P4SKZ0Y5PH91nuKnPxpqiWTRsuCDtX1jBtNcE7YjJ6O75tavW0VveH3FuYdOTYehqEdwc6uiOYf66uCfV0nMY4465L0gvjzNB1MfWFia6mNjqeshJEobG6O7OBXeswznu0iurFJQJwMvaJIYsGV/QdegvxEBvJDjumeQqIAEP0QihFpxu6iL4WCrf8EYU1it8KHkvHKTIFKB9qIw8cUTG/aIO7kJ130RUy8NCZPDupb5vzKcQ8LamaY/P+caQ6hQvHk9Ustruau2vTNj/48+AcKJ3MhvYTm/yPha8cGAZ8F+6FiIjchuzS7IOwX/+uvyUezVhDNRs65MR8KdYUZZsqwIv8iF/fyJPP6uHglMh8NIg8MyFOBuwsHyfzdKsgbBl8FJUf/NvIBQMzNy8P+oQ/yQCAYJhKDACACQgkCAyCgACcjBAKghPxAGAgACmAEZDiZgKiQKq4BgQeA0GBiIJKEC0ioQ0HWDPAWqltr+ABweAg6i+QbMCNAAIBIMHqgWFN0M/BgakgweDgM3Ow6hBv7onB4cHJaNSgMrLucLRQCRASEmqpFMAQyNJLcC+2YE2UUQ6CFSAhwODOSGAT0G1oiMEsSTitoaEpwaE/76vv1brLTHSqqvDBT/3d/h4+fg4JIPigeeCh+b2OQMFAgrcQ/NsTgNHgg5oMbBAwINsSBD4WyCH0IMjDR/KeVjwkBYE/A4JUOBAS8V/AQfiMygxoKVAJbUUI/kEFL8jSnDaSgJQYCY5nGpWEYAQyQItfjp57IUG5UJ3BQIueMPyI88GDxw1HYASJcI0WyjKAZsgJ5KbGHlePbRKmsMHcqBKFUAV6gGSJl/Jmdi0qDtPSvxBrdh3DkrDFSUVbZNYbl6QDxQo0OVAgABMc0omwavgCYCARve6I4T5lVM5KJFYNt1Tq1HHWyTrnVPaEN2kiNsB7EdUtG3ZbpMUAzd2y//LoPYU9AaQta6BvlCbK0iCAPmfOaLYzePe3XsSRd/Fjydv62x59O7GoRWUPnx6+PHTiynSstY8QPL17+ce4E3+eOCwjz8CCzTwQPIARBC+Ac5bcEHVHuROOon8Sa9BCTMsL6C4/DAsHqk0FNE71iKKp4HMRlRxRRaRCLFFGGOUcUYaa7TxRhxz1HFHHnv08UcggxRySCKLNPJIJJNUckkmm3TySSijlHJKKqu08koss9RySy679PJLMMMUc0wyyzTzTDTTVHNNNtt0800445RzTjrrtPNOPPPUc08++/TzywCS8mKPOdYrj48tBkwiHRwLEPRBRt8p4DP9JkXLQfT/3nsnkfaQiHRFTaNwtDvoXHz0T1QlTEAZPVxp1b0jFJzj0xpHzZDWQnXRbxxE5dPUHU79wFXEUOk4FR5FbE11WQQRSGABTL5QcACtGIg2gQSoMOCyMF5Z4IF6FuIigTbIfdZTD8kVALrADmhngW/r2VaABORyyNotyHXiEGx349bE6O7FZAFsB4gNqWYOcECBd7FNCg8BIj3AXDk0ESA5AMz1py4BhgjAH+vmsDiLk+4lJAG3Jj43O2zbWOIBlJHQGN1QHWIi38vsUyCoBQJA4LKL2aIGoeQAwlYMUPCgDgqx6AC6HWfpvQMCAQ7o6+fL7O04RWa79g5aZ1udljoD/7r42RYyQP5DiyUGdcWgepkW+ZkDqKOWi2eqViIPtYrwguwu/iLibNAO6Eqi2toYAPBe3AqHmlirGSAMBBzQxQkH/InUoKzc9gNuOdaB9pEnNhtOF2m16OaZeglX4FECnrHo5rhBZzrUZw4f4pClV6OuDmbWWGUcUgjouSXLpdmk7T/QqQWiWgwq+75hhP9bmi681r67ffeV9jziPZ8iaQfyzimK76W4DIIjGA2AanoFATeo/KIgAGj0dYnCAQaQ8oIBbjWIASWxjzj05ypFACI/44ifANhXPw9phVyeK9T62teqKQgoV2JbA+QmF0BZZKuD5vGCBW/XKbmx4X2Xmf9gT4bwhXTkD11ym0N+1KAIGNaCFH3wScSo14YYem5Y2yMiF7hliPSdDl2Zk4IhDJAV6gBieulTBQndlwc/zI+E04vdBuXmqAQYzkL2gGLihNg88EDOFQw0EQTnAIlaGKpxVmxVHermh3GkL4EBOBw8KqeMPVaxFMGaFRKywrx3lGRfEDBIF8JHQ21k42KKGF2wdtiGWZyQPY9o5BmJ+El3jC5fbpvWAYswKSc04AhV1Nvi3NYMA1QRFBecQwJuM5OdMXJt14NFLM/ogCcUwhzYUOUc03hGvLzhAPWZ5Rp10Y1vVG4VAYgULhzSC7IlQZatIMU4rEAp30lDj5Abpon/8gGHx5lnmxcM1UCakbFbmoIAS6PM9Y5RPHd04hPLY8IpNbkNZhgCGdGYBmio4MpHBg2Un/SMNgxAGIxJRxAXucZL8qaVfFwlJKtwSFc48jm4gKNd7ehIRv0i0KRwA6MuIQkCrEMS+0QnpUKBnmU8Ohq2NEcrVCmhaKrzEHdJQyWHQQ122KKdlAgEok0bzUt3NocSMdUrRW3MGP8QkKRoBHpAsYdVQMOYtShlKBtVC3b6wptiSOM1giDOWa0iUbQtVK4HkpWB6qqmuyLpVxJCwBMWoKu5BjZHEUIQYdf0IidhSEVs2IpgHftYyEZWspOlbGUte1nMZlazm+VsZz37/1nQhla0oyVtaU17WtSmVrWrZW1rXfta2MZWtrOlbW1te9ssfcIgkeCPYbtkqXl8CB6IURR6KLQgTCkhHr4NrlVx5CAU+iEnCHHud0q1VM4cy0DA5YR2q2NV5spDuHN939LyWp7zdmeI8ZBjjI6LrOj6ARDhJU977foOl0U3vce8z45QOMQ21Ke43ulLEl/1oOPal79J2O8m+xtYxj4BELjhROX40ICAYIMkQtmKggKAYYV25gk+sQQ1BzAT6nJYF1ZzAGMH4KgnjMpRxbAaP8ApG9PgZSssPkIxYPIORB0gKw/4DEIg0odlGgst/GhFkgeAkKXRRbFJcMhfClWJ/P+IWArU9cl0N3KQnHzYC0KF6ZgnN+U/UMsT9xhOS87MBzS0JiRWBg+Ij2CrJPN4zs/8slKGTJBoCcUKSrgzfWbyvwb5BLB45ATdJjUTQg1nMgr18YCeXJcKt5gg59RVPhBFl61UWpwdka+aq9Lm4TCgQWwoBibmbKKuqTCKR/jFOzvWoGIUgAtaeKd/mBEM8K2LC23ZZ0Cb01cC+AwKYpiFr22t6gBMxj/CcNkvVB3L3tEhDr50djCg/dfmxJeUVFlYc/p5gD5Qmw7eMIBZBslrLbi7ngdRHjhzHQ19gsJTvCZyNLLShJZo551RmAU4mDaxAIDTEVV0NyL5lfBZwmH/UuyelkCisUdyNAgXhvh3feRLbrNInGkdDxbB3BYFhBfA3eDGr3/soEkDe8ETwwa3Tz3FbEPcOtoHpU49ovEFeVOCCkYBN15KPceGY5ETZilAxJ2g8oE0eE/pboTPJrqKBR7QbQUohqpd5Tk1lPViy2nAZ4JYC67f2pkk7APG38PEXXQ90hCYwgBwNU5mRCTdI4S7AmlZBizK8WMOBN8BxR66VxGcMpM7jzL8xjSym/3BJDw4dV5nxvuowab48CIh/Y6E/jl78UbQMbAzf8Gt4rOlagmWEKYQEHhMwXBxyS8pC28euk8hUpd0RfYegc3CDSpsbsu93Tk5eQje8fL8/w0kGjivvbYHBM6bzPoMp1AEMcScgSokYd3YR8NLYt/2r1K32zu1HvEnMdl8SO74935MdW9/kHrAIWC7wZHbM82Gfz8gZthvnylIHrnxPnbSr/NBAkjwPQfbo8VhP3s7IIzLj1h6AEbyPz4YEHWbPzeqmgVAkU3QpCVgP4ypDX7YFsOJo0gjP2piPwfhPTdiGgHZnfFhKypYP0ThvRo6wEcYNsxjQAVwwO1JoFbQpQHIuZx4pPHBonoqJezphd1YnqOoQYMgBWhhniU8Qn+AHqMzv9r4wHBQwkiTMykAQEIRh6VJJy3kBkFwN0DopnzQJZaTgt1wNyViGiaCA+s7IP9qsQdwKoJ9uZ0ovB2lY7Aj6BxEky4s2iNQ2K3OG6V2i5Uwkxk+cgsikK8Rmj9wMwBScIC4uQyaaYOyCQo5KACuyRjq4MQR0j5tCRxXE5ajMEIkgB5CIIqlySA4TINWdDebKwVDPDNEdLAb2p0t2B4KAAEk8IAEoAAAMAESUIARkAAAAAFlBAAREAGZQYJqBIARUIATKAFrlMY5EAEWWAASMAEAkIBtLEcAUAEUqARoVAEFSIGMOQFnhMZt7MZvnEYMIIEF4AAPWIESGAFjLEYkAEeCnIMUaMcSAA1ymYS3gZmYiYYNUjejQYO2AyDYe4UEwANIlJsvmJiV6omGpMP/xBOqo8nDGSIYerkxyVgUL1CXZyCFy3iUBgqKAugi+aoajJsYejEnrYMZmOlIZuiXozCXG8vANpSGyzC+LfjAeSOkqMkW4MsiLbjJTdI+AEoAMZAEbBEOT6EXmMgPrFEoBFgHtwFJh+TKiESZjGQwdbFJnKwhnVQjntRKPKo7vMxLvdxLvuxLv+xL7xqT9/oOccORVIARg1i+J7mjMukQFVkvFmHMXflLyqxMy/zLwBSTwfSOwrwRk2IRPFgZKPlDMqkuCYHMFSFN3FpN1rytCuiADQCACMCAJJAAaMwQDJiACZgDCYgA38QAC0CCCghOP9CA2AQADeiAedCA3yTO/+6wAOecBwxQzj/hreoYsB3hrmbBzhwplR0JBxXRTnfwTiLRAAo4zhDIgAhAAt/MEPM8ziSIAA6wTQz4ACQwTneYgNuUgN2MBw7IgAuQgAroz+5oT+/IgApAj/bYzAy5ixtj0AdREAXyDl3pTEnJzO5QsOy4MfGQuhrpg/G6lHzCUPn4FtNEEA2dvCBB0CQIgQ3wAGhszwqggAmgAA5AAt2s0QngAB1FggvQTRuFT/akUQq4AACggA+YgASNz/U8x2nUT9mcgAyYgA74ABqtAAnwgCn1ACOdgwF1Bw2YUt3UAACQ0h7VAA/wACrdAB6tUSONADMlUwuwz/JIh3HQrf/+GMF/SDjusBRZAa5eCS495Q6XIsRCLYWz4FN7CNR0SFRwwlPMQwsOJbSeUNRxaLqWAM+vcxFlq9RM/RkHabpBlS5fq46iKVW0GNVDlQZFZVWj8M5w+Iz2Ai5MdQdNJbTi+gQOTQdI/Y6mG4/rOwtRZY9eBRIXbVHk/AALMFAJwIAIgNEy7dIiRQIKkIA5DVAJyADaTIIKyAAkeFEL4E93eNYczQAyhdIIoM4y3c9p/FE/MNA58AAMsM0I8NYJkNYYbVIOmE8JuAD7TFc/qNY6VaJuGAC77J6KibpKsIQu0kToyJZWApfoKgMIaCE9aLeFvbJAJAnYi0AFoLsamjT/W0CDMJo/jB20jOmKPEAETBOVZ3GEm1iAD0yCj60aleuof3iWycgXGjtLkpWD5SCYcekUQqCWdojZD5SMBfg+8JiEBzhacrGfBUg2hpkcCauLkl0CmlDKjJVLgwUJiGUbiK29hTFYMRgZkig+fjFYjAnaPKjafUlbgwnb7LifDswWu1wCH7IHXSobgiCYJ3DDvdlbKXiWlizap1UCCIAXJrAyksyREJiDyAWAGW1PCuiAABVYKF1XHLVND/BN37xN9mzSdRXXdyXdC7DXfE2CzTVd0+VWAm1R0I2ABN1cdG3SHZ1d2STdzq1ToPE6b1i3wnEWqtgE/8kY69CCOwre/ylal3eIuUFhHvsAHtLBsCpQJTXCtIOgJzGYsE1ISlHi1RAEv1dICo9RI/46XmHcG3vImBFzpHz4wKwQDfORFGo6PUOsq6ZLhHpYttq4wlqImz443rghRG1z3yYU4NqTCMsAO3+wRelJAvoFjyX0B+ZVQLkJXpVjhRHcjIXBw+0QXFAYwXH4w/29j9cRBYncEYFFgskFAA74gPX8ACytT2i03duE0sulzy5FAgvwACyNAGV83fjk19SlzdtNggzoANt03dhFgv8M0C/tAAAVUCTOYWjMzX69AArA0gtQTngFgA34ACH9DjutQZd0l4pQgyhSl0nKg7i5H6ChoLvc1P8vqFlYS2G7QZ0GyV4HyaNIi4KkhKBtmQRucsn9wzj+2j/NoBp0ABrF0binMRRZcRbK8Dw+0gUFsWTjC490IBjOUzcXdGOMgSA59kTeQzKdjWTKm8HnBSxQTojzgWRXJN9f8RsnUIQ+EOGJ1WSf2chOpkEwkAoSjRF3Zc8k2IAIgEYLcFYNGE7KJU5ojmYf9c1pTmZnXVILWFLenF0ypWbbxOYI0IBt9mFungPmpF3iTGcMINNpfucIMNJmDt1zFF3ZVNfxOONhVh6nWYXJgDc/0EosYpU6VI8UPLAGwGC9PQLGRIoIdJCGNj2/ScrU84KNoSXISwpvUGQHW77g9YP/hCadXFnhqaQ8BssGTO6787AyQkqhwCvDNtClYfAu7xXpJJDp2usiA2plg5lZqOod5kkiggYW0Bux5Ykvjjng6fBIKviVEm4ElEZhXFrfHekADihjPMGAaeSOZKtlt6GWopWZdkhoLGAAdOuZUUiKiWmAzvmCbqhjhvHJaAsATnSHFoKDhRgCOGgAxttUvD6A3amLsE7KbuCjKCjsvjZrdtLKtOLoZPCZJeBrov3Bul7rtqaC5QgUqrCDWYzrw/jBqT097APs86iEj2lpUhhtqVQ309aKpjzrle4Zh7RsjvrBji0XB3COkUi46hPsKSsbdCOyMJiYSKPtWgZrh9yr/wbo6jQr7D8wCal0ajVIK9MObVBoAMB+Bk3Un/ZrTSm4MV3pFT46i7KTgl2wnGxgs+ooA0o9XvDIiMN87+YoQkVRzFgqH7RokDzj0Ps2iIVQLCfLb6uc70CJsScbMzo4MVPhhBvjo1FUcJCmb4lg717ha2CSBsuRg/v2A8vhOiU7BAMvcA5/MSpQFl0hA3Rj6BhT69wWBFI88Boan/U2GE5wgCxQsnuwcbXOhySj1EOA8Z7I8C04sSCjFDKg8UIBD8VSljl4PE54MRch8js7lkCB8F4gcTpIBfwu6u9eEbsjADAP8zCHZDIvczM/czRPczVfczZvczd/8/URczm3UP8Rcd79cHIRsTB4SRXsZgNYcwcPdRLFHBHJ9G4gGdVM6W4EiSUr/xOuQzN46HEtWTQRkXRDv3RMt5JPYMGPYhb6io8QLQ/s6q556Fka+XR5QHX9CK+JqnNSGUEIpTJEnxHrPApEtxSfmHVObdV4CPUamgfCIk8RefQBUnDUbJK90o9fCfTxSHZgPegUFQXuHBFmz8GW44+8kkkRQc0C42N4YOQdIazzgorNmPZAaDBnn6F42OQTlRAAIQAoU46tQAgrE7Vd4JBRRDcq4DEdW7EhG7FiOF4jy3ca2yhZLbMPkz5E8w+Lqg0Q07BaFNE9W/gYL0EyW7QZqxqD14kyIwj/1w43x1zwXjDvEoIJ7Zu0oBj4P0CDScGqTOuxMpPgMBMDLeuVFbMwEgSXHhPRkh+Qi2iypdS2elI0U8B3Y2m1JdN5sUJZbWn4OQMmtcaClSKxZ1D5kUDZ4Wg0EB+VpeQ6LDuPIlhCVSAy9fmx4Yh3BP80fS+hDiF6UzAcjbcxENcJnbeVQOODsB+6PnvlLduwsk+nJMMzkiCFV0v6VtgFtrGzOj8LAgDoletpIjgJvW9yvlgeCHBIneu2PyA36ig6lQI4p8uHcqs5xbG4UGC6gsOYe3u5gWuVjXs4haMChjuCOGQF/7i2cusr4PN8nQK4QiLrAZ587Zu5Lui4IZA2/zjwj2drENI/iKHJt01IKGjbBXZzN8FtfuofiIZ7BliypSN4fMpvStuXOKh7xIPwhAEnOI7rq21rMTV6/dQ3/idC/0hRA+DWJOS/N59utxYDAoBgYXAoAIsBoCEAOJ2EA+AhJTgHygDkMXA8AIgGIBFAKp+AACNgYAyKR0GgkCgYyABrA1IINLF3DgENDwYFDAZoaFhQUlRIR2F+QmWThIZWdHZymndlT5MDAgUIDIqnqKmqT3JPVgBYpVgKoxCCThBYA69PB7RWk06tAAWibpRpTRCJkw8KWGvBrZO5WFaMeclOCg8NBYrYr4ziSgwLbNqKwwSyA7Ro0pVNRQ8Jyv/MTc7Qn8IBzw4OlFTbBUvJsCtn5OgbsIYRgiZpvgwbyMsJgwKHpnwSgCBcP0UOFnwkB4AimpAfiwk41qrdOzS+BACDKAclsifdoOjk5g2AzXStzKHj+W3hmpzZFg04MODBQ23YPKIZNk2ZropJxyFMdyDBAQRg3LjjKGAIUHmUbLaS8y9gQWRG+YE7Q3IZqCZVp4jJ5kAAFr9q5Yaiu6qwYXX8yAUgEyAA2GL28jRujGaBgm8zWZU5JIZR3leTBAhqbCCeNgKTy3gMBsAXBLlStb6lt4y1ZiiLJ4O9+3FSAgelm4DGOxrdky4CDDgrg3ry24NvKYmebIBRsNCfmlP/PqlggYObcqRCj96KpHbYCecw6GywEmPHlS9ni4cN+jqdrRW8xnYWAO1ErvlRnAH3wfNAIQIwBdUZUt2GzCTnKWLeVqwFsIAbuTW2G28P4hVAfar1pZwCqrUnxICpxKZERdhpc587kxWTHjx/EHbYjascRI4BEOyGAEb+WSGaExsKIUYBmfWWwDYm+lYGE7B84V8fNKE1JBjRAbNkGk4koRR+jNj1DJdjNLblVE8W0iORNPYmHIBN4AFlU04YggYCv02x5ZVgeYaefxBEWaeMuCTSBXjfYYlGG4j4JFIbjhLzynhQlllSImPyiUaljG2ZqRg8+jjVkUnKwalcXhrw/wowXQ6gBpF4+ofHJ4y1SueUqWI1xhEOzPqHSFmqs1demqJRF6ZZQIRAIkyEymabHVJyKhh51rNVK7faOcA3X2ZlkBRgNCPGAU3kmkajYEzLW4M4toumK1vhKUAC29rjlX/1JCAlkQwMkeRNCtjDRbR4HgjRAvZS6Sa+CegbrBAJDmBPct2S5EC/A+cLbFngCjMxWPLSC21eB/T7TsEvITwvt0/w0RpEyjX8hZ+L9JvAXirXgU0DDSuQyDAxO6xId3UGfLN//S4wqVxdJhBwGRcLMHDQ+zb9NAABS60Ez02EfAa//vaH8NVPEOjXqrBMbKjAetZThsZpl5VIzpucff/KI0g6MQkdHLG7RGR5US3hVlEPHAzXCYBs79d6V+liGWPjUdI35F77Cd2SwcQAA1XEW5YADUyihgDvmE1Qa/aKEblgNeLn7uuwxx57IvnJbvvtuOeu++6rXMT778AHL/zwxBdv/PHIJ99uyXIr7/zz0BfmS/TUV2/99dhnr/323Hfv/ffghy/++OSXb/756Kev/vrstw88AsC67z1ExAOZPRPxl78AyLQftuwp/yse09oFv9cdoGPA29+NFHg8BhqGforAXwAVYb/XFTB714Gg/FbBn9910HXDOyB4Boi7D57iEAboX/la4UBjoaKFXSrS63QFL2G4K4OF0ZUJdzf/HlX0UHg/RAUNUWgAGDpBhEFUhW2sxxBX+UEUiULAA0B3BamBxQC0YBwxaOEUYhzgQ7AoRgEWUJa9DIAJR9iiXz4hCp+loQG0CAPpiuaXIxLiAd8oy7akWEeY3LE6QyoAuA7wDSZQUY8sywO5gIXFPoJiim58giCdkCglfKU4h3hGJpXQyDMc4I6JhAUanVAAWoALkZ0EB4YuyQZRvMGLovjKgRIZOr2Ni3Tf2I4nEXCL4+CPjmcIwIHW0JpvkJGKASDAUsK4LUKCYYrfceYxzTjKRdHCZ8lc5jTToEwpKEGQUNTbgbZVMyf65UrbzCYCB2CZYTChi2goZYKOyEu5/xhSDKKZpRPeKcN84jEipEsEH7X4yQMBMlHbjMgDiJlKRZBLAa/gY2dW+Y0zzjEN6hmTRBUxiDhqQ5gBfSMt2GjFEJKhD2toA0bqQKAAeCFdlvKSJEFmCi0MjAB+KQCofBeFKUgBD2Py0pxGgQAIOOKnkDMIEYyANRKFqgjqWCoZVBqPUhhCCgpwqrHe9h08yJRI32CqC/egsJW4ChC/YUNaY6pUOEjoqABI6SOyqtakwuSkZvWHEtxxLja4wa1PqBToDlCIV4kHQ8YSwwO6mtRO4KEVO8UIasCC021xggHL+g5kkYYZuOLkOw340WSXwFkkwQcYKb2IY+XSlTmowf+vhSztaI9DVFNcAoVokKsU8voEq05yCG69LbqEsdRIhPUIPYLqVKQKW9KqdLVs3VQh8tYJObS2AOWBK1oFUV3YJKeo2viRT44gClKY4qVhGB4O0+IXV3blK2GZhQZj8i9eWEgAr/FWrN5iEhW5xEMLssg5VBgtSsSjALZgoxaT4of/LsoLkUFTW0z0nI2UwcF5cWFBnhKRtziYQxNpWX+WqFpTPGAjHbFRD4fz38A8iIz55QUvapK/acCYOVt5AlFcd98YwyseLuaQaXqM47noJC69hYgwbyLJBC8MybeZBD0iIxQCZ9jG+HXpxhwjlpc4ASlW6MtfXOU4ktBMzK7/7JYcpAzh1mXjvTL83XrDQ6LG5PJCrnpPkSyDmXQkhWdgKQ9CgjGO1DwMCxmCT16w8Z93xcM0kHGzhv2Q6CL9JjjgENFybkKzB+m5wDVEtJJbV+mRZefHjluiEbwzQvEMcDiVBpG0EocMGWumg6aitaCj0wv9FBnQtUZ1P2Qt5CoBe9cVOxF1is1kSUoMwKFBUZTjBBw2P8Au0+7HsT+UnlI76Bp1dm2Zt0IzGNlZzY2hNqalYqFjCG8xjeuHGmiHgP81a02KEgap/CyOR+FhR3bxkqZU5CwsLRpYtJLLlR2zJE8ASVWwyB9+vFPwIhEATorA03esxWmDDAtU+A40/1o0HCZDfYedgBIViD+RkyUPWYOMSgRKIIWSvDV74sAJ+bTC42/m0G7GjTGFwT/Uc2/Bo1V5MFTRL66TeKhLb1uiz9IJ7JFsJdIuhxrPw4WEFqs7+k0vI5PkFkYJlHviVBWvDCdRS2/TmNnj56L3l3h0Gox7xN4a/B3HTNOVeTUAcYqbF+NKETbWvOIOUvv3VroyRU7ma2Y2csjiosU3KTZM4gtv20ntJYXKG2tebvSa5kiXd5dVruN/awLXqCV4UINpaz1LROVFv3IifQ4sLz8F0fxjtJ2G7eZ5AL1AJ786SiDebWkTCdDjJhG1Jr7IHXw2xSRGBIHhgfrzcdzYiP85lQTF4/jXT0D+pIK5wMb+5ny7V4bLvzDmvQNuX+8H+CHnNDzQvk56fEXfb+Z2csO+Cfu3F1dgM2IwCe7nZnpgL3G2QYZBOwqAQAwYgcbjO7ZDQxJ4CrRDgRe4gTiyQxz4O0YjcR84grczPbdjgSNoMxBIgix4HAvWgjAYgzI4gzRYgzZ4gziYgzq4gzvINCL0O420gKvwgw3oUdEjQhVkGEl4PHwEPHmnCEbEg1I4hezTBIT2grejAN9BYCnCIFioe1t4CknEO4xAhO/iUCtYPJjFhbiDgh9BhXAYh9/jTPBBGXuFIew0UovyNW8gT+ASTHKxSS8jH4IERqyQU3n/6E4lJUkM8Ay6RAyN2ExHlEsBIEL85FB/xHt9JE91RBnkUkeCyEqU0UhEcCfQ9DJ9xEqwEFIGcmLctEz79AmDMIjfMEnF1Br1ZCyLdER6JAxNUQjVcRxsKIfEWIzB4xlxgGPXVV6loAizsiS6ZXRlk1aEVRo1tQWMQ1eAZF5LMF3DFQjcphPgaBoDAAELUFCGMFxCIBIv5VVKAFR7lQWJQAXgKAR4+I5SEFqMmFlpMI+7hSFCBUGHgBGqNVtLQBMNUI2vYhq85Qpc1Y8+JQRK0I7uYYwWeZHA4weltCSBkn05hhXT84ActmQk8S6uKAQIsETR4RFQ9hGu1h/Y0JI3/8EOXcYRW8IIjKASLGFhCLFfIJE/OklhJvEEbgEL36ErJaYRwpCSjrNi8RaUM1k7D4iRVFmVtmMLDbAAlZIkflMS4IVDJXkbVJFupxAVhDEdpPEuL0mOCSFtb4gaenaFBcEZFfaGooYK/EGXnRYhLrgVurJqmmVhDPlqjaOXFPYKPdKRVrmYjGkYU0QthAFvD1NOhWKUl4I1WtQKM1dTeYdyweJ1t1FzkyIGseIJKykldnIblxByPDI38SiZn2KXb+AyqXkuRAKbFFYsRLInlIWBmyNzj2IKpflYhIkEguApJkIIA/hNX9iYzkmVYsV9kxIxNhJPTPc3TiNzGJOZZf+ARQ1TgHlXeeSXMO/SBr+3evWAfPzBfkLwMawnMow3MIyQNQOzesPACFwzCovANvRJYYKznyKTFEPDSL33ZfpCnKeAU9mJNQJjEO4pKczghs85oRQqPWk0g2PIgBqYPCZYoR76oTeyoTGYofLTocojoiCaoiq6oizaoi76ojAaozI6ozRaozZ6oziaozq6ozzaoz76o0AapEI6pERapEZ6pEiapEq6pEzapE76pFAapVI6pVRapVaKpKWRltXzSwAkgsrzhDmScT+TO1HoP49JPRf0BGX6PAoEpmaYCgYQZ3FaPiRkPGl6Ixp0p7EDpq2Rhi8khKmgp2vqPWqwD9T/Q0TMFjwSCkKHgRUKtKiHQaKpsIYa1i4qiSNLJKk4oqliWGRl2ZxEIoJ6Cj58SjyXugpJcqrtghVmiad1mgqD8YZ0ChFRwYpt9CNchHtsVEVd1FAwgUuwgFjLmW7hpIkLdqsH2UXgNCTq9ExUxEzFwKtFsqzgQgDV5Ez6B6yN5EbCdJIWtTFegEfBeAUq1K2V0E2ggK7bsq56c2GNF6yu8qupCEr+IQpnygrhyi0PVYtMwSdTZEZWtEkIAC4FkCgO1YvBFk+00EdtRDu3OkkD5UX16hfMAEetsK1URzpgsa+w5K9D0lCiaLG72lHD0K3kRJT6uiyuBCD8egVidBfF/7pRSFBGOtFExHoljxRSJPsJD4UViJSIn3CJU5Gv+1RS8tRFoZFT/hRK35MbTGBMW1MukeANNBUs6CUG7ggThWUK19ULJ/VaKhVdajq1wmWNsGVaP8JS5ZFTlPQF6QUKa4hZihSRgqaQJgZaP1JimKFYmlVcliKZpKS3aCtJo1VZNhcm/Ni1oOCP6+hWXnJ6rOC3dttXz6W2LuW2DQCOrRlxqIAOj4BsTgCPZnCQkJAu1MCPkzAmfMWMd7sEeza1kwu2JcaPWZtXrFuztUUMLDV2o9uaqpuM6WC4cHu2lutcPIU6rpVaiSReTHW7t4UV2ui83qhCwMVUZUsKYaEN2v9YvRcaPoWaZiaBbUf0C8ECZ/E1FmhwkhyxRHPGZfKFBuIbF/3nE+1VRyDpFTIklyQhaOqLADtWlIcyHNESkggEwEeZoDVkdFXmZ85mVtFiF5mKFv0LZPW7FPj7hlOJosRgDCZSEfsVJldxmfG2wNQgYh6xY/DbPxNcJT+BYQqGH9dAGEEWuLWjmIGSYbpCwWOWBjfmkf1RNm0WLGBmZEL8DAyhcBJsxMREXwHmeuATDBAXIRXBZ9nAbnjmbW+4ZhrUvlgsoMpGGvNrbnPgxXqDZ9AiGzTDdR8RIK0qwBmWmEQsG5Vqa7PhBbWhQYYZLQIcf2NJH+F2ZzvJL8p5Quv/UZcsQqsrYmiH7B92jGm2JhUBUqkjRB9fU2r3aSMxXLMzkr5d0Zs6gcOn4Mcxsm0+bBpPcGmxmg0F0pfBgpbGsTCuXETykRmypqrbEwzNqCnzBAZUlDeiCQbMkhwhdxLBycBpEHVVknasAC4dgZoKU2vMgC6e3FvBDC20tr84tplkkgT7xRFJwWoZ1kQZx5tknHSuIyZZELpmwlHIGS1yokF5oc2PJs14ZySsQEyzCArtDLqbK3BRJATMLDrqLC4dthpIt8xEIs9V8irAPMyXDMPB8nR60y9fVoBfkBOnl8MLLc1mp3iSacpQYHeEYS6LACxV58zxZ3W9TMtbZsxN/wsBZUFrgvMQZUR4SoM0YQN478k43nk0Krl3jnN/vEyzdEOO4oc6fkfGOg0KMB2g2JwNPd0ZapM2Ti18BYYkXCgxTl2WR80LhaME8McxaNCfBKMvXrYwUd0fAajTq4c6XwaBZA26qDNODOMwNA06zXB54XV7nznVSVZGaW3UUrPTqJcUmfzNTsN9ubUXd417JgMRGr3GqTN/SQHUstoajx0spoMV4mkj7Ll+CWPTmVF5GXalq2DLbWgYJkqFUxlXFJqBoZQRpp2jqH2ChqHBOyjbBUuhKqh7fjrbwB3cwj3cxF3cNMqluzOq6nA7FyYSZqjcQ9h5TBs8ehqEYggGXv9qGBOE3cjzpuMDJC3k3YGqISH02517Pq9qp9mNPUuoPYjKO6gNqWGayvHWLmVo3ruzRFroHwhc23/KYKVKhqDaPUj0J5H6DAEDqDiiQwM+FS6dY6vKO1QhO/KtRAH+PNgg3kcIrDaLsvREixh1BS57ssccS11Cs4pkFgNLSgZ7i3WoGk0MdSaerDLEiVnwJCh+q4+4il10T1XkRoB0r5DoiLuafeMKC/1DGTolsYSkTk+Es5SUsoD0Ss5ki8dxRCwLtETyr1dQTam04sTwHTK7rixDreLkrSXl45ThFwY1G1nkQ59gVQrFNDt75ucKi1fQTkFbUhgLC/DaGJD0M2z/27BQSLPNmrPcKrI+kbKMqLodK0v/tIqRpDfoaq4cFejOmiz1WiSf6EmgdOSv9EhcgBGDxC2EHrGIpOSmZEf61OfBM7mK27vLMLlSIbwTbQdyG1mZs1ib65nXAry0zDhqgOthML1oILqxgAiTZBnp4hFX61tSEJCjC7myIgi1rg3P2CYIU2FoK7uJlCrL8LtOLAc80jm3211z+wjuiGCUdBnFa+vnsiyYNZAD+ezK7k0GMZGQJ7adqmMOQO8beu6Ca5CryI1lu1iu+2YnxbxHoI3SvimyBR+9dVwF34zg3j/1iFp+9QZM9fCkNFkAv7wUn1zf4RvdC5Gf67fZzoh2/8AY2he1XglV0VsObJDyboXw+hg8K0xBXHsE/XvtHIXIPJxlAI41UrChGhkwJdF0kpYOWNCSHxyPCNZL4usR5jv1nxC++IAYD5MZBDw4GuuKuwbSkFjDIlbaCMEUToGA9LvD5OBgj3ARaGa/oYzIBnz1TlaXVTwAH9bvCGHAyQb4DH5kSuwP3cAtSTJlbjaUoNDDuqL4wZIRq30fucf4+AH4QFwPTUDCpHPyG+zAJNPwBbxlpmESC2yWI9l82nv4w9PHeUcFumZhQH/GZxT7RV8Kgwy/DpCVWxnjTg9Fy1bfOMmckVERVnwMkSYZzrHHt3HtwQDH6nAAWnkxI1Hf4/8B+9OsxuxrUBHzmX/sLaXWYH/w/ZFdEK3absTfOi+SZ7qRCgehAA3Qqqx82HI8/1+MDpGcJKiMgIYGBABhI4EACAIAgpAJSDgMAQFgMBAuAY9DsXlMKgFSITI8JQTQXya2Kmwzn9GpwfGARAmMQ7fAaFCtyMQAIBAgut6QBsnO0gDo7AzeqgbFBKcADhQg1Lo8P0GZHBYeGco8AxgwR0sBWAuwsJoGiwZIDRKSsBYcxhg6hR6mEBKswMTehGgRBh6EDAqYDO4AFqyqCqINlgT2ABBelxAMABoEsh+5e7+dksy7yMKvTqkYjJscuAQwGckXgVNhevAngLOBmTA1SaD/wFUuQPNSkWPHZsA0I+wAqNoTUYgRWUyWERuDYFy5c9qWtCHTwFkVix3DeGNCJlOCbzaPXHRjTBxOAR4lMnmT0tmjAl+sHcNJgNyBKbbGrNNJ5ZZDpl2uOn0IJowqTwL+HOOXxJJUrORE5mySdcqXXFIM6JmFU0EgspgG2Ovyrp1IXEkEmHUbAOpDagN6XQojJGkox48fKUiQgGDCJn6eSaZcSsCCWKggCCj2KIGAB1ZFK5C45ZMDhhm/LEF2L0zo0dVKJ4jGZMuDB9cGFMi9B8E+sHE7LyEiGoFw0XsMnE7gjNgDBZa9cPYMEROsoEwQmAJQd0ySAQkW/POE+Ztx/yMBr3vSAgDWznk1Rf+heFO0MQfi8dvsI2VsM+a80ZYrwrkE9lCptJ8eIqY/KrATLTWJDqRtKzYmMxC9JoZiLLcCztuHHCz2OeAAVeJzbhzpinqmtNPM+5A3Fp/iiQn2mlhOrPJOiW6yGN34MMMuVhQgPulIEcMQmcab0S56vPNkgYV+yWI6h4ScTssPXWyDiIXIUaxEAb6DTM01meiDzTchUwBKOOms0847H9MET8fc3NPPPQf5U9BBCS30zT4NTRROPUOhSdFH75QTUlAQndTSSxnYzVBJL3000E5BDfVRTkXFVNNPHC1V1VVZbdXVV2GNVdZZaa3V1ltxzVXXXf957dXXX4FlU0VFsQt1ganQAWXYXLFLFjIEhMGzpFiHIUVU7Kats9hgWz3WsWVtNcfaNZNAYNxakyl0QMg+xTNVcO3bCtBt/xxw2FQ/YSBbNmnyNlbZ6DVUlgH9ZXPgx/Dl9tGEQdRQ1j4MSBNheh51YLcDxhlAgIoyiaaAOW25LokCrnvACIuFwJhC1bpYYJ+wCHDKWpK7cUMZ8+zppKAHvjAGjTACgHdj3/xJAmMHpNiYxAVE7sKA6xYgR2OWA2ig6bwGcMc0Iz4mbBZhqLaaJqcUGBCNPsgzB6xZCBhARY/3+FjjdZ7uLDzyDohm557NeQ3ajZHcxxi1w7qZvj//Pv5GGJgpZuxlN7ZugmaT6Ttg7nK+qDqAtvcgoO+Uoxngc/quy5ptt5UY3SnA0dbQnIP2dmP0uqNeuei3LQ9siMdFudgIsvXuGRQEvCmgl9ipMBwNoZt5wB+wpVbgupN9/wR4N0jUFOVMMt64KbixD06onFc35gCWnL88ebju4XjQpKZ5+hqGFAPxnPDoMwJ/BdaBoICk+MKEP8QlGmfIQi9+EZ3O2WcLAdBUH7KRKa60YQAQWACUAFeHhwggZ9ILgCTuByAhMKgc5rLCOzRWAPw1sAAsgQYDogCB3zShOa5gSArx58L6NAwXSAsPNKAEiwAU5y5d+aAESdiAADwB/zAOzBQElbCH+RSCDl34YBYwBsPEgWQKVwKEcApgAEY0rhylMB51Cpe/b5giFUdsIT8aIESPSHEPjKBjO8ZDGzlGEYthIIcWetgJIgARglCMWR+TaEKTUMGCB2gjAX+4RcZYIX4HcF4qNgSK+FGlkBLcTwUv2IQMUicarqGC8wxRDUpSA0mXFA8BlMYE+N2BPAOgXxGVEMuU5eIof6xj1PLhxh85ZImFcpOeDiGEQ9RPKDrKxHXEYQpkVmEAZnMZJ7giheIowxn7aZcDDNSLTzqMJimZ0lZCBB6cKJOa5uROMOqSFzQUCxKlyeRBuNLM7BQAAkjzBIqK+I+0AMkL4P90gzjtw4D0pIlEHAxOP4EBBiVBKwAO2JjGrAAwK14zaAyaSsqgSQ8yPPGVa7DPGAGRlnTlcz8N1Qu+8OmKcE5wAAMlRDu38g9++lNy0mQIz0aSzk9IKlMGpQJCH7LS7IChnjkqzzFf0wWgqmVdUCUEE5aJy3UNwqVTUo9G9USqQWmBCwdjZryWwLQClgeojfiZAPWhC2UgARNi8CZ2JpFR+yi1nBvsmYGcOde1pME8OloE0tAgB0/EYTbz6GvDlkoie64FSGL4x6dogoS80vQRdWAlfTDTBslW6AALaMB/qKCANKz1U0QwgiAWoBdZKoC1Y7EhL+7DWZRSAi8aOtj/F0N7zpmoYbMU+ZRbCyvYfZZIqlt47Rc0G1hPhIcl6NRrUskZGydAobHZIetHCYrS5pbVpPXb6hT68AeV4HKMgyhEMgsVkGAQxCB/0ApkJYo4LDhFPLrDiBuqItdq9OIwBCYHeYpJQ58YgRq1zG45WnLOwgj1Ef4zin+NEKIEN+MZRykWWzIJvwGpBHEowcp8ESLSD1oYGmvzQlog5M0RqiHBdUHHNrqQj9e2BYYw0ahQAlySAB5BvyouRY+VIJH97LYi1GjMGpS8kxoHIo2p7QiMPbKTaWijABjO6VhubDavuOIWppBHGKp8hCxhmRAHBs5X3NHNpjh1GsoYs8pE/1Hm3M5izLCrb4rzycUw0MWrtv0x1ujjsD2xpzj7eA+OEKGj8CQHq97oEpFwYRrUkKkck2HZf0xjjBSBqENCAPUM+fqgDJ8zTNLt9D7CCKNMHqFmVxKNhz2RpPiESIwbG/EJS7OgOWEBPm2x7XLO4SMyHImzTOqCZEIt7C7gL4+7zM+PpDGjXCRoKpPejnrGM67zkGLJAm5DbwBHanLbB9oz9JE0oH2NUnMW2bEe0pefOpz1hOVpkxmgKrbTRyStk9mnfjM8VJ0JSOfl2kJgj4Xh7e89XyYsjYZQsSdOj3YXGkg/rtLmCFUphY2c5CVXlATvJBGxmhy0bxIhE1Z+qf8+QctOIl8VozY1J5bvnOc9/1ZU7aSZc+085qEwnidsfilOKTHoOlcVyn0edalPnepVt/rVsZ51rW+d6133+tfBHnaxj53sZTf72dGedrWvne1td/vb4R53uc+d7nW3+93xnne9753vfff73wEfeMEPnvCFN/zhEZ94xS+e8Y2/VeLeCilFNyFvyaP8qXYV+URVfuSTl/lGOiHJRBEmop7wPKWc7hg6nH5NlWf9njgPqNLbbOwBCM2o39TdOxUMFOuCh4CHa6eASf717eIX8Ou0LKW+SQEvf8yP4TR8x2g0Xca3k7kEu8Qh+p6yuZf+VxzQAHjRSbyJYhidVpoQ7nP/vV0ORB19ssG19ze2OQ44nuk6K74wkAg6TETS+wmA/zqCEjoOHk5rHcLg/XoEG+jjDD6K9DqCHAzACCYwCqwIdSxQGZpCdB7iC24MnJKgAmnMHxRQGuyPmFLm/VZPfyZQb97Pg6DhYvSv/qAgFJAjLLLBciQQAQjjIpZgApXBbSLGcmpwAiFwjwijBsGDHMII/hZD98qgB58BnDCPBiVCAGvCgYAQBj0QMa7QbbYK/3JQfOBiBBdQfOQIBhOweOKPhggwOwZkHGqIMGSCDplQBcchBE9wZBjwDHfD/WTCcsijTRxQCbAwE/Av67TvbJQgPRziQByxATTmFFRiIBTg/zcaAIbE6Hx0oxG1r3WagGkCID080SHCT/vgEB54RgFIwZJGcejSIxPxoASboSA4LhUmK2V4ZgFIgRWrgSE8KD3aYD+eoLrEwML4KRN28Vxw4XyyJK1Ua6GK0RksREWWkdaCQyVExyFMw2o8TxMY5TxOyyZSIfw86RQayP7AoaJ4THRgaHPchggqCgEHLAtI4SCojzZszxnDqBuI4FS6EcEoYxKxZp6wsT6KQ/xsghjEb8R4BtUYxKJOQYJELhbfkXME52OuERLxQYm4EfmOoDSs8RWz0P6WSBJ5rDSaMROdSPxgsWp6jAAcMQl+Qwr0kXNKMQnqQgrSjOpSgZrMbf9+hEABwkI3Gqt+kMAVA4A8yk2q3IezEhBwyi876swP0GBADEASn3E9JNAUFGOJ0sQqQQ4XruSFIGs/IKBwxCAp2kAsP4JRxug3VgPoaiYjlAjk8ko4huCWyKgJBqLOtqIIBgG3NArqKqeajAwL6gDzIExIMuJEKFEfMYEXlHIQK2sKiHKEcC0y52EntY9TBqTH4iKTkIEUnuwZtDIoHe4uUwLoQAKjUlGUvMEtM0JTMtMJjiIBmuI1kCA8wOsRUpOm+mSlfgsbfoEdta5dxim8DHK9VAyjCLApJaf5zhEQyHIpp2RA+qptqImGGABprOKfyiugPoyafIYA3sMyhtH/PgoiNE7BTTzJPPFrjEiGATIlXcpJPvOqEqbgrJpgG6oguMpjENbTriiPQUDuq57hPNLyP/VAE9IiH2eht6AzEbPDEqDLIDlTouIpOB7LpOZBw+bgDj5rjcBTNZVAPzXkOsljKvOzOz8iszQ0EYxGANrGO0+UpgjUt0CUEuyhClJP6pRzr4wBtx7zKNkraBICMv3KaSZJR3srNoNPJLLkEeYTJJ2Aa2ziK4ulSiWwGHSTnyRCEq6rDSTiLQRiAYrCSymPN+VKIqzhvsrkC9g0rwCztC50DoBBKW1pK+5gEPBxIr9AjLRLQa10kRTCeVjCWiRU0LJA/JZUlIrISN+x/66cCgws82m8YUC4QC9FdCiVJNIKcCvqVEN2VEoJik29lFIV65nKY0w/gkaFUzyIs0cfakyT80dNZznpAz0AB0mNrHQeAKkoqDP8si70habIUjKyEx42ZjPCgxfXaY2aIUuUhB6JQBxrwmWMbboUyovIg2koRGOYwQoukVkzQlpbtQEMaI2k9T/RI7bkyjry4rXqYku/IFq96CfLlUKuJBq+ckDwqc6w5lctKD5+JFv5Zwua4cfI4Fot6jxApiga9Eeq72AxQVjpUTGEw2VWSXS66wcX4jxIwh4CDq609VO/IQCnzR4eYCu7oqb01SZWallHw0Xz9VttQmEtxletYP8QyFJew6MZgG5oX1Y1L9Fj4YF/OGtFbMk1qy4KVmsxnNBZ9u8ZuCYaSgIIv+EKHUgZhCBZSGLarohqb8yB0KEkgKE5ytZw+OCDpuVr/7NtSQIIuRYVQtAMe8kJ9y9Z3upuAaL04NYfOoJu8/U7Iu8o+FZxI/ARKBAgaIhM5VabdCIELyIKdoMHF4Nr49Zj5PY/M1ciLJdvsXZs2+RzGxdwNSUKIiZrwbZwx5QsPIF1w/YPHVe53rYCqZY+aMwDGRNz05ZwI3cW1ABzQWI37taPtnaIkG5wzTZzs4Exv9Z3n4F5He960UUyEe/8sLd7vVdQrDZ5CW/2vrd8zfd80Vf/Vl6PTmKP7kTvUIL0Md63fYXC7943fetu/VCFfIPP/PhXli6Ce2vF+sYPFb4PFNqFYfT3MXhvVbBPURbYig4Yf8vOCGvqCgRQhao3AWtwa8FJf94QX+jwEUbQeN5vDKHh/dQWC8s1BP3Pg5UQEJ2GCHfQAldPeoUw0SyNB2uKDmoQhelhhMdDtUiwDqsAW97QCoNwEiW1HPowADkwBUO3OVqYNHjKcnYjenlQImoIJPwIEfPVeBAQAuFPhVgIEedEixNNCUkEZW4YbMt2DhWQMJiYgt+uHDOxgGayTzRBHu3PC3qouk7xIynvGn1RXMUPO6kgItEDFRlhJl3BI52o/0WPSEViEpLBA2kkEhfRxB87kTdywSQHsh0z0bRqiTLyAR2vMSNdkRddYRexY5ABwxKtoA5GsUKSwCJPJGs2Y2PkMSS7QZZB0ZcfcTKYZjZPBZZ+YifXxjSWkhRqESLRoyBFkRSFwpgTkjWoq7Q28R/BYD4ygniu0ZZdxo7hbjCJlcraYTGHC+eCUCo7gTbJUjc7wjUutSn3IyrPKSmtJZTyuU0sRzbouTJpA+pu0yhtq7sEcwpo8w1oU4KMjzDgeSL1BpeBU564giX0shzox4gneqOtxsoGDVHXwGOOUyLJoCq7UqQB9SmF4jU8MxdIhaDB4B3E4KEr2pzvOEr3w/8c/IJB/yC6si09KHkt5DMM0HMoB0Ii08k5KYJF95mO7eOfa8KRDu2iLDRGM1Q9uksRzEBFr0A+ic0yoDpPswmXwyNHx5o/qbKRi5qtkyEXYuo+fhJIl2oJDuYNuIo6TyUROrTLiAurBSxTJIU717MvdRrtAFU/4kUjDvUdkhITWtU5d2RQSeM8mDRkTyooT1VGq2s8GFte7poe7utQHW5QWZWrL/VPGdqyHdqyIdoyOruIYvv3ZFUxoyaZ8LR+nPNOofke+Es86YOV5vQmsrRX8e1QT/MNMnUQDaC0mdQ1xENVc/qLE1uxMfY+3gC1XOFZ6wgw7tVmhctdwdUKxDX/afdh1pxay9ADXTWGFB5WejCBqhn2AaBPY3ukGPinY381oZ/CHvqbvMnRHkr2XeubrNv7ZovowH/PaJ+RFTvxvTsxpRP8GoxVwkOHNiBA52TBaaUHGzcjWzfjDaZBdOg1WfWJNO61OeIVGIcGqQC0I3S2Jpphvv/3uruOcr2Yb5PhKEK3cKs3ersWb0kYJPxBDvmWetW2dklYyL+BBa9sx632G2Q3eX18dj9Xbjl3BwFByytXDRgXaNoEyedWyLf2IlRIfEuil1Y49NRgWoA3c9EczFcXyWZhbgNYiYKCdkmXdreYD07lz5VBJ658d/clccm8bXGc7KzPQSVm8JYv/+wivVFufNEtXXxn9zcHb8rHbl/UxNMtPdRFfdRJvdRN/dRRPdVVfdVZvdVd/dVhPdZlfdZpvdZt/dZxPdd1fdd5vdd9/deBPdiFfdh/5X79xNhtUNPZRPOIl1WQXU3WFzKiHU+efdr5IH6z7n2tnU+wHSRm79llpdLBt9tnhSZkC00+3VrcWVDW/TFOa0+KbjzIXVHafU2SDk7uPRQaGDLWvTucr/Wg9k8KOGXm/U0GHuB7it0Dfqig5IHr3VIOHukY4oEdY98NfuFvhQycNgxeQxJT72l45mkc4ACUkBmUUMq19rkRsI3nw4S1IQ85OOU7ywFqaBxIHjy8MAhXhP8xT3vkw5YAkyUDPd5pYP658Y+Gf74OoGT1dphELhec+vQTztxxnX4Kq6DjVbgFV+8PEMBz3iMRD5HloeQ/HKiP9c/l+eAN6+KPg3B0NfAbcn4WECMbioEsGFA4TMfoM4cO9gCLw5YKqf6C8b4TmL52CeMLlb5NJVEGa/DNPQbwm2BhixCcjHjn4S3kJZ+L494EY5hEKk6MX3NQ83Dwt7xrbx7+QH6IkLcTur4Bvj6iSEQMq8AImFaDd+Vh24C28miJnK514kK1dMcVP9xRmVahpKAXshk9ExK1VoQXbPl8wjkunHEPjD/4V5EhWhm++AACsqYQIrkBCoFRZmgnSej/Rnihm/1nHS+xPRpyKhL5Car6AA6hm7+z93Qx/uffH+uf/KkfCB6DQOIQWAAGjEFjoQgwAoBGIiAEIASNAwEB+AIEggFCoV08sFoHA/x1NBoQL+NZBDihgUIb4BAAHDwEKCi4OQweNAQQDDjgBThAADA6GggoQhQUQDhAPTSlZTWwBRYdTFY+gm0RPSqAoqltdbmZhWJ5wgIwFGBBGIyWutUFCDy2JjwKHk2C8SkMGBQfBw4WuvE1DABywmnyLhAd4D1FBTIseDY6DAx8MdCJVys4QDumAVyBKTHlnR+KMwdBgjiP4h2I52Yhw4YOH0KMqC/AgQPuCqRhRuhdQ2AA/zh9qccnQCRA/DgmQAASz0FfIBksYgSg3pcxzyYpIMdrkzN1I0vy+SLI4VBeXgpY7EWQUgJrJKPZWhWNZBVKA7D1+ugMjIFtmGY+MoBTp0KGxr6oAwtA7EyyCDRGWwnF1xskS5O883g260owoOB5GQqTJIGFSJXw/OLurjsAwKZtilLSjc0vd3MpwdJ05hAiFPNVFRyzME22l7l6JaewQRq+WwFb+xLgqqG/WniNzuasdOqgsd14XClS8h83fwEULipgj7PFmxvT1FxTCtuVaRV6RNCGykIHdp9zfJa0wIAHBr5wOpCArsT27t8zZAKogQJxYaItbniX9ZeU3NwxQf8ZdZPwB0BK+w2yhDuPpGTZAxAgwV9w24GGwH/ukIIESw6lxdYBxyT0BQHTSCEAfmS40SByAA5QgAALNIAJgm4QNAQ4DUp4HlsNNWagFzim4RFbJgKIQIFJJKDQX+2gdUAWX9A3I3A69uSJgo648aEDIRaYE5N4kLPcFRcGCAYCDyLhXUg5OeGHho0AaEBayKFlJYAMesGfmjQmYGMBO6oj5ReAOnAJjF8tCAgUd7pR4IF9BqDJnnNatpmjFo6BIXCDthFdL0V5ydEC5Ki4Z2FTpHGpaZshJ5YXxjXgh6g6CQViGwYowIAAXUFQC3y/AhuREo8QYdJta60lxSEadjj/yQAaIgvGiKhuyNZZLBHB1Y7nrVVYWqceYEizSUBrQI8NFvAqGEC2+lsCD2h4LLeDbjXtWs8Cdi2lYcQKEqF0UpvuQrex9e+p/Mm7YbQL5HUevgasl60+i5i0r5QpSRytiOcN1SED5iIBsS9oPFcuV4MW9pfENB1n73kNXosxqwb8exwYt4F0qb6rQFkhvkZNIUBWGc9b7SQ4O4uSum7WuZazJkt7npoKnVXaxw+vt+PETDU9rp7QCh0eGB5hzV67Q3FbBcPFBdu224rpRYBODSyxACBQHdJnAezywfB6xDygQCc+Bu20E7UIIIQWBX7IDaleJJ4rnoX3PUDEEHDj/wxA9DadgBODz/QxlHWb1DM/fdZHheWTiHX40mgswECqoJUYOAOPLABtSJ7LTq2BtUs+BemEG5j7ro6Nyofj/cFuuAK+Wob5EWE5kzg3sa77OYNjFPTREl8F4mvlf9e6/ANCKP9ALee/Y/lVC+zY2I7WL067PvugBW/vHRbW+vOvU28KfUqAMwpAAJ7RD3v9yVMaYNe7SGWuO3rjWzosZzbY7coABKjP3xLAvX59jxxHYp8B0VALHAEiLQ7Q20xKB5zkhXAhnhOcPZaAjQZV5m06fI/AkuUGAwTACxArmmWkoKxNgIEkDAFius5zRLoAEYhmCsB5kIgeKsomiXzwxf8Tk6isj1DRC1ZYSDAso6MwcsuKgwqiYcxWgD1YBgFlTJYUF7IHJFrxi3uQIxbMJhuVuIQuemziGl/1RUqoi4l0dAMc11jHbKBxLepCABZ/GMk9VHKRg1oaJQ55xXmx8Y2USOKr3uiLOfJxjljAYh5JacdN+CKVr4qiJ2UZR1XWMpNZ/IggYflJTq5ylLz0on5exRpROi2KXKmkGhEJxjp2kY/B3GJDFKlMMkZSkcJ85A67ucMheDOcDylANMAHLPOIM53qXCc72+nOd8Iznt3c15HgWQ154jOf+gwWSYi4z38CNKACHShBC0qjojXTndw0KEMb6tCHQjSiEp0oRSv/atFuJpSdGW2bNB9yAD8CVGyBAOlFS2rSk6I0pSmtiGI8yVEGpCMM8XEpfBbwKnRCJCvydGE2+gAGnao0qEIdKlGLKhGLKLGVH2kHXSxyAAPsDZxHHIBOgkEeQzqCpGh5BxsauUunEtFCheLlbM6DAAI0QI5H2cRRmKoVXBZtNi0aFFLXUtcpUNUyBXDAKrr6p3boRBAWqaIzxOpPoyI2sYpdbECnYrcwSAEkwmiDEGbzRnbkrApXUE9FJoEIiiiQIVURA4rQM4nKzhUMzMAGLHDRjy2kwQwwmqw1VsI2MIhDEmspAmsgpojYDuEO6RhHGMZgJCMoo4X0McRQVmsI/8ZCN7rSne4Ow6WYdxysNbkhwBfvMhS93C2AOXzIqWwmlDRwlyE/Kc5q0rAnmpRlMDKhiSaoSaN2dIpWOVHtIDayksYcpyvLo1p418tT6iI4wQqe7nGWs7NFLShoECDHpBzwpCkYgl1ngtBDruURN6QlRhN2A5kaUDPspWRHEMYSDo3BszUdoE2veQ2RFgMqcmQHUprYkXX9k6kyLTjIQh6yUJfTLXItkGjcitHWfCQxUBCKWxr8CDAbc5oFLtmFP1vLpRxDJd8puTm6suNmaOIylyXMasHYDNJ8txy2bJlmNCUynets54G67wGAQMXqaqK45VrOC+zbkefg5bsqNP/uK7lbSEIUkC7pcQUn0VAReiq4Hv59AUK/VVgY/sy4Dz9jCerzgt0sWOr10O1ZgPCg5WKFAOk5sIHfewd/xlcA7tw517retTwRYCGOUFKVwS4iI9WqRfQI8pN6XQglj5hJVM5ZiVjQ0SzvGMuiDduK3VOvEafo7UImM5NvdKIvVdJINUq7h7xeN7vbrcNjtbs86aynu+tt73vHU5fr1vcON4rvfwM84AIfOMELbvCDIzzhCl84wxvu8IdDPOISnzjFK27xi2M84xrfOMc77vGPgzzkIh85yUtu8pOjPOUqXznLW+7yl8M85jKfOc1rbvOb4zznOt85z3vu858DPej/Qh860Ytu9KMjPelKXzrTm+70p0M96lKfOtWrbvWrYz3rWt8617vu9a+DPexiHzvZy272s6M97WpfO9vb7va3wz3ucp873etu97vjPe963zvf++73vwM+8IKX+xtJYvjDIz7xil884xvv+MdDPvKSnzzlK295xQPz54W/POc77/nPgz70ose8Nz8khtOjPvWqXz3rW+/618M+9rKfPe1rb/vbr153QTc97nvv+98DP/jCH37uB2/84yM/+cpfPvOb7/znQz/60p8+9atv/etjP/tLp6RWBWqAL7VN2tpXJ/cf+n2RuuejIIfYpA3Ro18hQPc7PEZoN4ieRjSEpXgZ/3862W8596Nfe8RfOtGfGxDA6dEKbr2KkX3cnmDBMAXCEASSRZySRYyVeljbLqkVF+UVGfFVFXHX0hzgyFTGbChLIVCRO1AgeliCJC0U/z2EA66VUEggL62gAVggx1SBLwnTBlpFAg7KB35ECBogjbgDdShDiZDCWP0gsqnbw6nH0gDYENiE5RxAcSCAJxRHP8iViNSEB1XEICwaVzBARXxMJSQgWinAJTRGeVjBO5AWeRQBFmqBelACA3gQDLZHFJLYO1RWFc4hIGThZHBhj5yKAIAhM4whp5ghEDVCGgaEZ9xDp9HHOygiEliO50yc5RygF1xEH7QhR5zKYRTGtf8YYk2QRW6oFrOQw6kUoedYxDuIzjTsXy2SRmdUAREclh7ySAJ0Il74Rih64UdYRCmaxCmGQSoSRpawIsAY4OnJxn9A1nRQAiDIV2FcBcahAl6YYvuIoikYgTFe1zAyIJy8Xy02hitKCzrsnytiI0ecYo21yLXw4nts4xEeozd6IWfJRDeSo7KYo9j0SDoyhCtCjDhABQMa2VkEZC1KXCIlTTDqI52UYzWOI8AwIEAUTZfEijoOoy80Bro0xUB+I94ky4HVI0NAJDCC4kQWRkX6I0Yqi0Y2Sj4oQEcWZBLl4zRO414oi8MEYMMlhN+QA3TAS5/YoimUR/9gTgNwwlLOUiMWpMMCsEpNFIJJeKQz7p/qdM+i/JoX+h/GoGRKZomlFeU7wAJVuqRSqo/TMMFTtiVPakfuVOV9mMEwFuGgzBBScgMSLKQgTuVIBmXDAREz0YVKpIVSUdI2sVK3TRsj0ZSvJZFZZAMUiVtkJVsRURtZRkRhptFhFkBiZuZi/mRj9mBcRaa6uNQhMZEVSaYtyUYXdVx92M0ucmad0ebxtF1h3ma78WZvAmdwCudwEmdxGudxImdyKudyMmdzOudzQmd0Sud0Umd1WqcbBAEAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: the American Association of Birth Centers. Copyright &copy;2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 623px\">",
"   <div class=\"ttl\">",
"    Birth center consent form (continued)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 603px; height: 720px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: the American Association of Birth Centers. Copyright &copy;2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 623px\">",
"   <div class=\"ttl\">",
"    Birth center consent form (continued)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 603px; height: 520px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: the American Association of Birth Centers. Copyright &copy;2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43498=[""].join("\n");
var outline_f42_30_43498=null;
var title_f42_30_43499="Description confidential office visit";
var content_f42_30_43499=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70738&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70738&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    An adolescent office visit that supports confidentiality",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        In consultation with",
"       </td>",
"       <td class=\"subtitle1\">",
"        The physician should",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patient and parent(s) or guardian(s)",
"       </td>",
"       <td>",
"        <p>",
"         Outline structure of visit",
"        </p>",
"        <p>",
"         Obtain general medical and family history",
"        </p>",
"        <p>",
"         Discuss confidentiality",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patient",
"       </td>",
"       <td>",
"        <p>",
"         Obtain health history, including risk-taking behaviors",
"        </p>",
"        <p>",
"         Address patient concerns",
"        </p>",
"        <p>",
"         Provide health guidance",
"        </p>",
"        <p>",
"         Address billing issues",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parent",
"       </td>",
"       <td>",
"        <p>",
"         Address parental concerns",
"        </p>",
"        <p>",
"         Provide guidance about adolescent development",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patient*",
"       </td>",
"       <td>",
"        Perform physical examination, as indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patient",
"       </td>",
"       <td>",
"        <p>",
"         Summarize findings and recommendations",
"        </p>",
"        <p>",
"         Determine parental involvement",
"        </p>",
"        <p>",
"         Determine method of notification of laboratory results",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patient and parent(s) or guardian(s)",
"       </td>",
"       <td>",
"        <p>",
"         Summarize findings and recommendations, as appropriate",
"        </p>",
"        <p>",
"         Address billing issues",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Parent may be present at patient's discretion.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Confidentiality in adolescent health care. ACOG educational bulletin #249. Int J Gynecol Obstet 1998; 63:295. Copyright &copy;1998 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43499=[""].join("\n");
var outline_f42_30_43499=null;
var title_f42_30_43500="Strategies prevent VAP";
var content_f42_30_43500=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Strategies to prevent ventilator-associated pneumonia in acute care hospitals &mdash; Society for Healthcare Epidemiology of America/Infectious Diseases Society of America (SHEA/IDSA)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        General strategies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Conduct active surveillance for VAP.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adhere to hand-hygiene guidelines published by the Centers for Disease Control and Prevention or the World Health Organization.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use noninvasive ventilation whenever possible.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Minimize the duration of ventilation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Perform daily assessments of readiness to wean and use weaning protocols.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Educate healthcare personnel who care for patients undergoing ventilation about VAP.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Strategies to prevent aspiration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maintain patients in a semirecumbent position (30&deg;-45&deg; elevation of the head of the bed) unless there are contraindications.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid gastric overdistention.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid unplanned extubation and reintubation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use a cuffed endotracheal tube with in-line or subglottic suctioning.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maintain an endotracheal cuff pressure of at least 20 cm H",
"        <sub>",
"         2",
"        </sub>",
"        O.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Strategies to reduce colonization of the aerodigestive tract",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Orotracheal intubation is preferable to nasotracheal intubation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid histamine receptor 2 (H2)-blocking agents and proton pump inhibitors for patients who are not at high risk for developing a stress ulcer or stress gastritis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Perform regular oral care with an antiseptic solution. The optimal frequency for oral care is unresolved.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The appropriateness of selective digestive tract decontamination is an unresolved issue.*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Strategies to minimize contamination of equipment used to care for patients receiving mechanical ventilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use sterile water to rinse reusable respiratory equipment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Remove condensate from ventilatory circuits. Keep the ventilatory circuit closed during condensate removal.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Change the ventilatory circuit only when visibly soiled or malfunctioning.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Store and disinfect respiratory therapy equipment properly.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The use of selective digestive tract decontamination (SDD) is controversial, and is considered an unresolved issue by SHEA/IDSA. The major drawback of SDD is the possibility of promoting the growth of resistant bacteria. SDD is most beneficial in hospitals that have low rates of antibiotic resistance; rates of resistance should be considered before employing SDD.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Coffin SE, Klompas M, Classen D, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 Suppl 1:S31. Copyright &copy; 2008 University of Chicago Press.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.journals.uchicago.edu/\">",
"      file://www.journals.uchicago.edu/",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43500=[""].join("\n");
var outline_f42_30_43500=null;
var title_f42_30_43501="ECG generation in common AVNRT";
var content_f42_30_43501=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Generation of ECG in common form of atrioventricular nodal reentrant tachycardia (AVNRT)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 212px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ladder diagram of the common (slow-fast) form of AVNRT showing transmission of the impulse in atrial, atrioventricular (AV) nodal, and ventricular tissue and the resultant electrocardiogram. The first two cycles show the normal sinus beat (A1) conducting through the fast pathway (F) to the ventricle (V1) with the impulse blocked in the slow pathway. The premature atrial beat (A2 on ladder diagram, P on ECG) is timed critically; it finds the fast pathway refractory, but is able to conduct through slow pathway, resulting in a long PR interval, and a ventricular depolarization V2.&nbsp; It is also able to reenter and conduct retrogradely up the now recovered fast pathway, resulting in an inverted P wave (A*) that is buried in the QRS complex.&nbsp; This atrial echo beat (A*) then reenters the now recovered slow pathway, which conducts anterogradely and results in ventricular depolarization (V*).&nbsp; The cycle repeats and AV nodal reentry is established.",
"    <div class=\"footnotes\">",
"     ECG: electrocardiogram.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43501=[""].join("\n");
var outline_f42_30_43501=null;
var title_f42_30_43502="Classification diffuse lung dz";
var content_f42_30_43502=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F77345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F77345&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 607px\">",
"   <div class=\"ttl\">",
"    Diffuse parenchymal lung diseases",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 587px; height: 340px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diffuse parenchymal lung diseases consist of disorders of known causes (collagen vascular disease, environmental or drug related) as well as disorders of unknown cause. The latter include idiopathic interstitial pneumonias, granulomatous lung disorders (eg, sarcoidosis), and other forms of interstitial lung disease including lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis/histiocytosis X, and eosinophilic pneumonia. The most important distinction among the idiopathic interstitial pneumonias is that between idiopathic pulmonary fibrosis and the other interstitial pneumonias, which include non-specific interstitial pneumonia, desquamative interstitial pneumonia, respiratory bronchiolitis-associated interstitial lung disease, acute interstitial pneumonia, cryptogenic organizing pneumonia, and lymphoid interstitial pneumonia.",
"    <div class=\"footnotes\">",
"     DPLD: diffuse parenchymal lung disease; IIP: idiopathic interstitial pneumonia; LAM: lymphangioleiomyomatosis; PLCH: pulmonary Langerhans cell histiocytosis/histiocytosis X; ILD: interstitial lung disease; IP: interstitial pneumonia.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43502=[""].join("\n");
var outline_f42_30_43502=null;
var title_f42_30_43503="Severe neovascularization traction detachment";
var content_f42_30_43503=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F50023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F50023&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Advanced traction retinal detachment due to severe neovascularization: Appearance on fundus photograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 341px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Color fundus photograph showing advanced traction retinal detachment due to extremely severe neovascularization on the disc and arcades, which has drawn the retina toward the vitreous cavity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_30_43503=[""].join("\n");
var outline_f42_30_43503=null;
